BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010;51:297-305. [PMID: 19998274 DOI: 10.1002/hep.23354] [Cited by in Crossref: 934] [Cited by in F6Publishing: 942] [Article Influence: 71.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Yang Z, Yan X, Duan J, Ruan B, Zhang X, Wen T, Zhang P, Liang L, Han H. RNA-binding protein SPEN controls hepatocyte maturation via regulating Hnf4α expression during liver development. Biochem Biophys Res Commun 2023;642:128-36. [PMID: 36577249 DOI: 10.1016/j.bbrc.2022.12.057] [Reference Citation Analysis]
2 Giallongo S, Lo Re O, Resnick I, Raffaele M, Vinciguerra M. Gene Editing and Human iPSCs in Cardiovascular and Metabolic Diseases. Advances in Experimental Medicine and Biology 2023. [DOI: 10.1007/978-981-19-5642-3_18] [Reference Citation Analysis]
3 Kizub I, Rozhok A, Bilousova G. Induced Pluripotent Stem Cells: Advances and Applications in Regenerative Medicine. Stem Cell Research [Working Title] 2022. [DOI: 10.5772/intechopen.109274] [Reference Citation Analysis]
4 Horiuchi S, Kuroda Y, Komizu Y, Ishida S. Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver Characteristics. Pharmaceutics 2022;15. [PMID: 36678684 DOI: 10.3390/pharmaceutics15010055] [Reference Citation Analysis]
5 Wang J, Situ P, Chen S, Wu H, Zhang X, Liu S, Wang Y, Xie J, Chen H, Duan Y. Hepatic Polarized Differentiation Promoted the Maturity and Liver Function of Human Embryonic Stem Cell-Derived Hepatocytes via Activating Hippo and AMPK Signaling Pathways. Cells 2022;11. [PMID: 36552880 DOI: 10.3390/cells11244117] [Reference Citation Analysis]
6 Kamishibahara Y, Okamoto S, Ohkuma T, Taniguchi H. Stabilized generation of human iPSC-derived liver organoids using a modified coating approach. Biol Methods Protoc 2023;8:bpac034. [PMID: 36694573 DOI: 10.1093/biomethods/bpac034] [Reference Citation Analysis]
7 Canac R, Cimarosti B, Girardeau A, Forest V, Olchesqui P, Poschmann J, Redon R, Lemarchand P, Gaborit N, Lamirault G. Deciphering Transcriptional Networks during Human Cardiac Development. Cells 2022;11. [PMID: 36497174 DOI: 10.3390/cells11233915] [Reference Citation Analysis]
8 Wang C, Zhang L, Sun Z, Yuan X, Wu B, Cen J, Cui L, Zhang K, Li C, Wu J, Shu Y, Sun W, Wang J, Hui L. Dedifferentiation-associated inflammatory factors of long-term expanded human hepatocytes exacerbate their elimination by macrophages during liver engraftment. Hepatology 2022;76:1690-705. [PMID: 35229337 DOI: 10.1002/hep.32436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Unagolla JM, Jayasuriya AC. Recent advances in organoid engineering: A comprehensive review. Applied Materials Today 2022;29:101582. [DOI: 10.1016/j.apmt.2022.101582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tchorz JS. Retuning hepatocytes improves their functional engraftment. Hepatology 2022;76:1557-9. [PMID: 35388518 DOI: 10.1002/hep.32513] [Reference Citation Analysis]
11 Tauran Y, Lereau-Bernier M, Segard BD, Danoy M, Kimura K, Shinohara M, Brioude A, Sakai Y, de Jonge H, Melnyk O, Vicogne J, Leclerc E. A novel agonist for the HGF receptor MET promotes differentiation of human pluripotent stem cells into hepatocyte-like cells. Dev Growth Differ 2022;64:527-36. [PMID: 36251346 DOI: 10.1111/dgd.12818] [Reference Citation Analysis]
12 Tao F, Hanada S, Matsushima K, Arakawa H, Ishida N, Kato Y, Okimura S, Watanabe T, Kojima N. Enhancement and maintenance of hepatic metabolic functions by controlling 3D aggregation of cryopreserved human iPS cell-derived hepatocyte-like cells. Journal of Bioscience and Bioengineering 2022. [DOI: 10.1016/j.jbiosc.2022.10.006] [Reference Citation Analysis]
13 Zheng S, Bian H, Li J, Shen Y, Yang Y, Hu W. Differentiation therapy: Unlocking phenotypic plasticity of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2022;180:103854. [DOI: 10.1016/j.critrevonc.2022.103854] [Reference Citation Analysis]
14 Murakami S, Soyama A, Miyamoto D, Hara T, Matsuguma K, Imamura H, Matsushima H, Tanaka T, Maruya Y, Adachi T, Miuma S, Hidaka M, Kanetaka K, Ochiya T, Eguchi S. Transplantation of chemically-induced liver progenitor cells ameliorates hepatic fibrosis in mice with diet-induced nonalcoholic steatohepatitis. Regenerative Therapy 2022;21:574-583. [DOI: 10.1016/j.reth.2022.11.001] [Reference Citation Analysis]
15 Tang LV, Tao Y, Feng Y, Ma J, Lin W, Zhang Y, Zhang Y, Wu T, Cai Y, Lu H, Wei J, Corral J, Hu Y. Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice. Sci Transl Med 2022;14:eabq3202. [PMID: 36449603 DOI: 10.1126/scitranslmed.abq3202] [Reference Citation Analysis]
16 Shi Y, Deng J, Sang X, Wang Y, He F, Chen X, Xu A, Wu F. Generation of Hepatocytes and Nonparenchymal Cell Codifferentiation System from Human-Induced Pluripotent Stem Cells. Stem Cells International 2022;2022:1-18. [DOI: 10.1155/2022/3222427] [Reference Citation Analysis]
17 Mun SJ, Lee J, Shin Y, Eun V, Ji Y, Son MJ. Recent advances in multicellular human liver models. Organoid 2022;2:e26. [DOI: 10.51335/organoid.2022.2.e26] [Reference Citation Analysis]
18 Nakashima Y, Miyagi-Shiohira C, Saitoh I, Watanabe M, Matsushita M, Tsukahara M, Noguchi H. Induced hepatic stem cells are suitable for human hepatocyte production. iScience 2022;25:105052. [PMID: 36147945 DOI: 10.1016/j.isci.2022.105052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Motomura T, Faccioli LAP, Diaz-Aragon R, Kocas-Kilicarslan ZN, Haep N, Florentino RM, Amirneni S, Cetin Z, Peri BS, Morita K, Ostrowska A, Takeishi K, Soto-Gutierrez A, Tafaleng EN. From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation. Semin Liver Dis 2022;42:413-22. [PMID: 36044927 DOI: 10.1055/a-1934-5404] [Reference Citation Analysis]
20 Ardisasmita AI, Schene IF, Joore IP, Kok G, Hendriks D, Artegiani B, Mokry M, Nieuwenhuis EES, Fuchs SA. A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use. Commun Biol 2022;5:1094. [PMID: 36241695 DOI: 10.1038/s42003-022-04046-9] [Reference Citation Analysis]
21 Inui J, Ueyama-toba Y, Mitani S, Mizuguchi H. Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions and application.. [DOI: 10.21203/rs.3.rs-2118517/v1] [Reference Citation Analysis]
22 Nie YZ, Zheng YW, Taniguchi H. Improving the repopulation capacity of elderly human hepatocytes by decoding aging-associated hepatocyte plasticity. Hepatology 2022;76:1030-45. [PMID: 35243665 DOI: 10.1002/hep.32443] [Reference Citation Analysis]
23 Duff C, Baruteau J. Modelling urea cycle disorders using iPSCs. NPJ Regen Med 2022;7:56. [PMID: 36163209 DOI: 10.1038/s41536-022-00252-5] [Reference Citation Analysis]
24 Di Zeo-sánchez DE, Segovia-zafra A, Matilla-cabello G, Pinazo-bandera JM, Andrade RJ, Lucena MI, Villanueva-paz M. Modeling drug-induced liver injury: current status and future prospects. Expert Opinion on Drug Metabolism & Toxicology. [DOI: 10.1080/17425255.2022.2122810] [Reference Citation Analysis]
25 Bai F, Duan J, Yang D, Lai X, Zhu X, He X, Hu A. Integrative network analysis of circular RNAs reveals regulatory mechanisms for hepatic specification of human iPSC-derived endoderm. Stem Cell Res Ther 2022;13:468. [PMID: 36076262 DOI: 10.1186/s13287-022-03160-z] [Reference Citation Analysis]
26 Virovic-Jukic L, Ljubas D, Stojsavljevic-Shapeski S, Ljubičić N, Filipec Kanizaj T, Mikolasevic I, Grgurevic I. Liver regeneration as treatment target for severe alcoholic hepatitis. World J Gastroenterol 2022; 28(32): 4557-4573 [DOI: 10.3748/wjg.v28.i32.4557] [Reference Citation Analysis]
27 Kang S, Bong EK, Kim H, Roh T. Technical advances in pluripotent stem cell-derived and tumorigenic organoids. Organoid 2022;2:e18. [DOI: 10.51335/organoid.2022.2.e18] [Reference Citation Analysis]
28 Canac R, Cimarosti B, Girardeau A, Forest V, Olchesqui P, Poschmann J, Redon R, Lemarchand P, Gaborit N, Lamirault G. Deciphering transcriptional networks during human cardiac development.. [DOI: 10.1101/2022.08.11.503560] [Reference Citation Analysis]
29 Hua T, Liu C, Kiran S, Gray K, Jung S, Meckes DG Jr, Li Y, Sang QA. Phenotypic, metabolic, and biogenesis properties of human stem cell-derived cerebellar spheroids. Sci Rep 2022;12:12880. [PMID: 35896708 DOI: 10.1038/s41598-022-16970-1] [Reference Citation Analysis]
30 Ogoke O, Guiggey D, Thompson S, Chiang A, Nguyen THA, Berke D, Ott C, Kalinousky A, Shamul C, Chen P, Ross S, Chen Z, Srivastava P, Mahajan S, Zhao R, Gunawan R, Parashurama N. Dynamic changes in the niche and transcription trigger early murine and human pluripotent stem cell-derived liver organogenesis.. [DOI: 10.1101/2022.07.24.501313] [Reference Citation Analysis]
31 Yao L, Hu X, Dai K, Yuan M, Liu P, Zhang Q, Jiang Y. Mesenchymal stromal cells: promising treatment for liver cirrhosis. Stem Cell Res Ther 2022;13:308. [PMID: 35841079 DOI: 10.1186/s13287-022-03001-z] [Reference Citation Analysis]
32 Michalik M, Wieczorek P, Czekaj P. In Vitro Differentiation of Human Amniotic Epithelial Cells into Hepatocyte-like Cells. Cells 2022;11:2138. [DOI: 10.3390/cells11142138] [Reference Citation Analysis]
33 Lee J, Mun SJ, Shin Y, Lee S, Son MJ. Advances in liver organoids: model systems for liver disease. Arch Pharm Res . [DOI: 10.1007/s12272-022-01390-6] [Reference Citation Analysis]
34 Khedro T, Duran JM, Adler ED. Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells. Curr Cardiol Rep 2022. [PMID: 35657495 DOI: 10.1007/s11886-022-01683-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Carberry CK, Ferguson SS, Beltran AS, Fry RC, Rager JE. Using liver models generated from human-induced pluripotent stem cells (iPSCs) for evaluating chemical-induced modifications and disease across liver developmental stages. Toxicology in Vitro 2022. [DOI: 10.1016/j.tiv.2022.105412] [Reference Citation Analysis]
36 Heinke P, Rost F, Rode J, Trus P, Simonova I, Lázár E, Feddema J, Welsch T, Alkass K, Salehpour M, Zimmermann A, Seehofer D, Possnert G, Damm G, Druid H, Brusch L, Bergmann O. Diploid hepatocytes drive physiological liver renewal in adult humans. Cell Syst 2022:S2405-4712(22)00171-5. [PMID: 35649419 DOI: 10.1016/j.cels.2022.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kim MJ, Lee J, Mun SJ, Son MJ, Kim J. Standard operating protocol of hepatic organoid differentiation from human induced pluripotent stem cells. Organoid 2022;2:e5. [DOI: 10.51335/organoid.2022.2.e5] [Reference Citation Analysis]
38 Acun A, Oganesyan R, Jaramillo M, Yarmush ML, Uygun BE. Human-Origin iPSC-Based Recellularization of Decellularized Whole Rat Livers. Bioengineering 2022;9:219. [DOI: 10.3390/bioengineering9050219] [Reference Citation Analysis]
39 Heslop JA, Pournasr B, Duncan SA. Chromatin remodeling is restricted by transient GATA6 binding during iPSC differentiation to definitive endoderm. iScience 2022;25:104300. [DOI: 10.1016/j.isci.2022.104300] [Reference Citation Analysis]
40 Withey S, Gerrard D, Leeson H, Atkinson-dell R, Harrison S, Baxter M, Wolvetang E, Hanley N. Thyroid hormone and ALK5 inhibitor improve maturation of human pluripotent stem cell derived hepatocytes.. [DOI: 10.1101/2022.04.28.489845] [Reference Citation Analysis]
41 Antarianto RD, Pragiwaksana A, Septiana WL, Mazfufah NF, Mahmood A. Hepatocyte Differentiation from iPSCs or MSCs in Decellularized Liver Scaffold: Cell–ECM Adhesion, Spatial Distribution, and Hepatocyte Maturation Profile. Organogenesis 2022;18:2061263. [DOI: 10.1080/15476278.2022.2061263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Hurrell T, Naidoo J, Scholefield J. Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance. Front Genet 2022;13:864725. [DOI: 10.3389/fgene.2022.864725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ma H, de Zwaan E, Guo YE, Cejas P, Thiru P, van de Bunt M, Jeppesen JF, Syamala S, Dall'Agnese A, Abraham BJ, Fu D, Garrett-Engele C, Lee TI, Long HW, Griffith LG, Young RA, Jaenisch R. The nuclear receptor THRB facilitates differentiation of human PSCs into more mature hepatocytes. Cell Stem Cell 2022:S1934-5909(22)00150-3. [PMID: 35452598 DOI: 10.1016/j.stem.2022.03.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Hua T, Kiran S, Li Y, Sang QA. Microplastics exposure affects neural development of human pluripotent stem cell-derived cortical spheroids. J Hazard Mater 2022;435:128884. [PMID: 35483261 DOI: 10.1016/j.jhazmat.2022.128884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
45 Luce E, Steichen C, Allouche M, Messina A, Heslan JM, Lambert T, Weber A, Nguyen TH, Christophe O, Dubart-Kupperschmitt A. In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model. Hepatology 2022;75:866-80. [PMID: 34687060 DOI: 10.1002/hep.32211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
46 Mathieu D, Stéphane P, Benedikt S, Rachid J, Yannick T, Marjorie L, Johanna B, Francoise G, Bertrand G, Hiroshi A, Yukio K, Soo Hyeon K, Taketomo K, Atsushi M, Yasuyuki S, Eric L. Influence of CPM-dependent sorting on the multi-omics profile of hepatocyte-like cells matured in microscale biochips. Biochemical Engineering Journal 2022;181:108408. [DOI: 10.1016/j.bej.2022.108408] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ma H, de Zwaan E, Guo YE, Cejas P, Thiru P, van de Bunt M, Jeppesen JF, Syamala S, Dall’agnese A, Abraham BJ, Fu D, Garrett-engele C, Lee T, Long HW, Griffith LG, Young RA, Jaenisch R. A nuclear receptor facilitates differentiation of human PSCs into more mature hepatocytes.. [DOI: 10.1101/2022.03.24.485641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Imamura S, Yoshimoto K, Terada S, Takamuro K, Kamei KI. In vitro culture at 39 °C during hepatic maturation of human ES cells facilitates hepatocyte-like cell functions. Sci Rep 2022;12:5155. [PMID: 35338220 DOI: 10.1038/s41598-022-09119-7] [Reference Citation Analysis]
49 Blaszkiewicz J, Duncan SA. Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells. Genes 2022;13:573. [DOI: 10.3390/genes13040573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Rizki-Safitri A, Tokito F, Nishikawa M, Tanaka M, Maeda K, Kusuhara H, Sakai Y. Prospect of in vitro Bile Fluids Collection in Improving Cell-Based Assay of Liver Function. Front Toxicol 2021;3:657432. [PMID: 35295147 DOI: 10.3389/ftox.2021.657432] [Reference Citation Analysis]
51 Raggi C, Selleri S, M'callum M, Paganelli M. Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology. Current Protocols 2022;2. [DOI: 10.1002/cpz1.389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Ahn H, Ryu J, Lee J, Mun SJ, Hong Y, Shin Y, Chung K, Son MJ. Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma. Cell J 2022;24:133-9. [PMID: 35451583 DOI: 10.22074/cellj.2022.7765] [Reference Citation Analysis]
53 Graffmann N, Scherer B, Adjaye J. In vitro differentiation of pluripotent stem cells into hepatocyte like cells - basic principles and current progress. Stem Cell Research 2022. [DOI: 10.1016/j.scr.2022.102763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Shimizu E, Iguchi H, Le MNT, Nakamura Y, Kobayashi D, Arai Y, Takakura K, Benno S, Yoshida N, Tsukahara M, Haneda S, Hasegawa K. A chemically-defined plastic scaffold for the xeno-free production of human pluripotent stem cells. Sci Rep 2022;12:2516. [PMID: 35169157 DOI: 10.1038/s41598-022-06356-8] [Reference Citation Analysis]
55 Tricot T, Verfaillie CM, Kumar M. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. Cells 2022;11:442. [DOI: 10.3390/cells11030442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
56 Chi KY, Kim J. Recent advances in liver organoids and their use in in vitro modeling of non-alcoholic fatty liver disease. Organoid 2022;2:e6. [DOI: 10.51335/organoid.2022.2.e6] [Reference Citation Analysis]
57 Raggi C, M'Callum MA, Pham QT, Gaub P, Selleri S, Baratang NV, Mangahas CL, Cagnone G, Reversade B, Joyal JS, Paganelli M. Leveraging interacting signaling pathways to robustly improve the quality and yield of human pluripotent stem cell-derived hepatoblasts and hepatocytes. Stem Cell Reports 2022:S2213-6711(22)00047-9. [PMID: 35120625 DOI: 10.1016/j.stemcr.2022.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Henderson ED, Hua T, Kiran S, Khamis ZI, Li Y, Sang QA. Long-Term Effects of Nanoscale Magnetite on Human Forebrain-like Tissue Development in Stem-Cell-Derived Cortical Spheroids. ACS Biomater Sci Eng . [DOI: 10.1021/acsbiomaterials.1c01487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Alvarez-Dominguez JR, Melton DA. Cell maturation: Hallmarks, triggers, and manipulation. Cell 2022;185:235-49. [PMID: 34995481 DOI: 10.1016/j.cell.2021.12.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
60 Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, Lauschke VM. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. Pharmacol Rev 2022;74:141-206. [PMID: 35017176 DOI: 10.1124/pharmrev.120.000238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
61 Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Marinovich M, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Gundert-Remy U, Louisse J, Rudaz S, Testai E, Lostia A, Dorne JL, Parra Morte JM; EFSA Panel on Plant Protection Products and their Residues (EFSA PPR Panel). Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative in vitro metabolism studies. EFSA J 2021;19:e06970. [PMID: 34987623 DOI: 10.2903/j.efsa.2021.6970] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Okumura A, Tanimizu N. Preparation of Functional Human Hepatocytes Ex Vivo. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2557-6_20] [Reference Citation Analysis]
63 Matakovic L, Overeem AW, Klappe K, van Ijzendoorn SCD. Induction of Bile Canaliculi-Forming Hepatocytes from Human Pluripotent Stem Cells. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2557-6_4] [Reference Citation Analysis]
64 Bushweller L, Zhao Y, Zhang F, Wu X. Generation of Human Pluripotent Stem Cell-Derived Polarized Hepatocytes. Curr Protoc 2022;2:e345. [PMID: 35007406 DOI: 10.1002/cpz1.345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Yao J, Yu Y, Nyberg SL. Induced Pluripotent Stem Cells for the Treatment of Liver Diseases: Novel Concepts. Cells Tissues Organs 2022;211:368-84. [PMID: 32615573 DOI: 10.1159/000508182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
66 Pettinato G. Generation of Hepatocyte Organoids from Human iPS Cells. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2557-6_3] [Reference Citation Analysis]
67 Marzano M, Chen X, Russell TA, Medina A, Wang Z, Hua T, Zeng C, Wang X, Sang QX, Tang H, Yun Y, Li Y. Studying the Inflammatory Responses to Amyloid Beta Oligomers in Brain-Specific Pericyte and Endothelial Co-culture from Human Stem Cells. Front Chem Eng 2022;4:927188. [PMID: 36561642 DOI: 10.3389/fceng.2022.927188] [Reference Citation Analysis]
68 Morita A, Omoya Y, Ito R, Ishibashi Y, Hiramoto K, Ohnishi S, Yoshikawa N, Kawanishi S. Glycyrrhizin and its derivatives promote hepatic differentiation via sweet receptor, Wnt, and Notch signaling. Biochem Biophys Rep 2021;28:101181. [PMID: 34934826 DOI: 10.1016/j.bbrep.2021.101181] [Reference Citation Analysis]
69 Xie Y, Yao J, Jin W, Ren L, Li X. Induction and Maturation of Hepatocyte-Like Cells In Vitro: Focus on Technological Advances and Challenges. Front Cell Dev Biol 2021;9:765980. [PMID: 34901010 DOI: 10.3389/fcell.2021.765980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Segovia-Zafra A, Di Zeo-Sánchez DE, López-Gómez C, Pérez-Valdés Z, García-Fuentes E, Andrade RJ, Lucena MI, Villanueva-Paz M. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharm Sin B 2021;11:3685-726. [PMID: 35024301 DOI: 10.1016/j.apsb.2021.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
71 Gil-Recio C, Montori S, Al Demour S, Ababneh MA, Ferrés-Padró E, Marti C, Ferrés-Amat E, Barajas M, Al Madhoun A, Atari M. Chemically Defined Conditions Mediate an Efficient Induction of Dental Pulp Pluripotent-Like Stem Cells into Hepatocyte-Like Cells. Stem Cells Int 2021;2021:5212852. [PMID: 34795766 DOI: 10.1155/2021/5212852] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Pellisson M, Zeeman A, Doll T, Kirchhofer-allan L, Schuierer S, Roma G, Flannery EL, Mikolajczak SA, Kocken CHM, Maeser P, Rottmann M, Mueller M. Persistence of Plasmodium cynomolgi hypnozoites in cynomolgus monkey iPS-derived hepatocytes.. [DOI: 10.1101/2021.11.16.468833] [Reference Citation Analysis]
73 Mukherjee S, French DL, Gadue P. Loss of TBX3 enhances pancreatic progenitor generation from human pluripotent stem cells. Stem Cell Reports 2021;16:2617-27. [PMID: 34653400 DOI: 10.1016/j.stemcr.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Ma C, Zhang L, He T, Cao H, Ren X, Ma C, Yang J, Huang R, Pan G. Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy. Stem Cell Res Ther 2021;12:555. [PMID: 34717753 DOI: 10.1186/s13287-021-02619-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Peng WC, Kraaier LJ, Kluiver TA. Hepatocyte organoids and cell transplantation: What the future holds. Exp Mol Med 2021;53:1512-28. [PMID: 34663941 DOI: 10.1038/s12276-021-00579-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
76 Luce E, Messina A, Caillaud A, Si-Tayeb K, Cariou B, Bur E, Dubart-Kupperschmitt A, Duclos-Vallée JC. [Hepatic organoids: What are the challenges?]. Med Sci (Paris) 2021;37:902-9. [PMID: 34647879 DOI: 10.1051/medsci/2021119] [Reference Citation Analysis]
77 Lim J, Sakai E, Sakurai F, Mizuguchi H. miR-27b antagonizes BMP signaling in early differentiation of human induced pluripotent stem cells. Sci Rep 2021;11:19820. [PMID: 34615950 DOI: 10.1038/s41598-021-99403-9] [Reference Citation Analysis]
78 Peaslee C, Esteva-Font C, Su T, Munoz-Howell A, Duwaerts CC, Liu Z, Rao S, Liu K, Medina M, Sneddon JB, Maher JJ, Mattis AN. Doxycycline Significantly Enhances Induction of Induced Pluripotent Stem Cells to Endoderm by Enhancing Survival Through Protein Kinase B Phosphorylation. Hepatology 2021;74:2102-17. [PMID: 33982322 DOI: 10.1002/hep.31898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Fernandez-Checa JC, Bagnaninchi P, Ye H, Sancho-Bru P, Falcon-Perez JM, Royo F, Garcia-Ruiz C, Konu O, Miranda J, Lunov O, Dejneka A, Elfick A, McDonald A, Sullivan GJ, Aithal GP, Lucena MI, Andrade RJ, Fromenty B, Kranendonk M, Cubero FJ, Nelson LJ. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]. J Hepatol 2021;75:935-59. [PMID: 34171436 DOI: 10.1016/j.jhep.2021.06.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
80 Jazaeri F, Sheibani M, Nezamoleslami S, Moezi L, Dehpour AR. Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System. Iran J Pharm Res 2021;20:1-21. [PMID: 34567142 DOI: 10.22037/ijpr.2020.113362.14254] [Reference Citation Analysis]
81 Li Y, Yang X, Plummer R, Hayashi Y, Deng XS, Nie YZ, Taniguchi H. Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy. Int J Mol Sci 2021;22:10471. [PMID: 34638810 DOI: 10.3390/ijms221910471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Zhang L, Ma XJ, Fei YY, Han HT, Xu J, Cheng L, Li X. Stem cell therapy in liver regeneration: Focus on mesenchymal stem cells and induced pluripotent stem cells. Pharmacol Ther 2021;:108004. [PMID: 34597754 DOI: 10.1016/j.pharmthera.2021.108004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
83 Enomoto J, Toba Y, Yamazaki H, Kanai M, Mizuguchi H, Matsui H. Development of a 3D Cell Culture System Using Amphiphilic Polydepsipeptides and Its Application to Hepatic Differentiation. ACS Appl Bio Mater 2021;4:7290-7299. [DOI: 10.1021/acsabm.1c00816] [Reference Citation Analysis]
84 Anzai K, Tsuruya K, Ida K, Kagawa T, Inagaki Y, Kamiya A. Kruppel-like factor 15 induces the development of mature hepatocyte-like cells from hepatoblasts. Sci Rep 2021;11:18551. [PMID: 34535735 DOI: 10.1038/s41598-021-97937-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Campbell SA, Stephan TL, Lotto J, Cullum R, Drissler S, Hoodless PA. Signalling pathways and transcriptional regulators orchestrating liver development and cancer. Development 2021;148:dev199814. [PMID: 34478514 DOI: 10.1242/dev.199814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Pan FC, Evans T, Chen S. Modeling endodermal organ development and diseases using human pluripotent stem cell-derived organoids. J Mol Cell Biol 2020;12:580-92. [PMID: 32652003 DOI: 10.1093/jmcb/mjaa031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Sun L, Hui L. Progress in human liver organoids. J Mol Cell Biol 2020;12:607-17. [PMID: 32236564 DOI: 10.1093/jmcb/mjaa013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
88 Jalan-Sakrikar N, De Assuncao TM, Navarro-Corcuera A, Hamdan FH, Loarca L, Kirkeby LA, Resch ZT, O'Hara SP, Juran BD, Lazaridis KN, Rosen CB, Heimbach JK, Taner T, Shah VH, LaRusso NF, Huebert RC. Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation. Hepatol Commun 2021. [PMID: 34519176 DOI: 10.1002/hep4.1809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Cao D, Ge JY, Wang Y, Oda T, Zheng YW. Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells. World J Gastroenterol 2021; 27(29): 4784-4801 [PMID: 34447226 DOI: 10.3748/wjg.v27.i29.4784] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
90 Polidoro MA, Ferrari E, Marzorati S, Lleo A, Rasponi M. Experimental liver models: From cell culture techniques to microfluidic organs-on-chip. Liver Int 2021;41:1744-61. [PMID: 33966344 DOI: 10.1111/liv.14942] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
91 Luce E, Messina A, Duclos-Vallée JC, Dubart-Kupperschmitt A. Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes. Hepatology 2021;74:1101-16. [PMID: 33420753 DOI: 10.1002/hep.31705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
92 Pasqua M, Di Gesù R, Chinnici CM, Conaldi PG, Francipane MG. Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening. Int J Mol Sci 2021;22:8227. [PMID: 34360991 DOI: 10.3390/ijms22158227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Arai K, Kitsuka T, Nakayama K. Scaffold-based and scaffold-free cardiac constructs for drug testing. Biofabrication 2021;13. [PMID: 34233316 DOI: 10.1088/1758-5090/ac1257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
94 Ferrari E, Rasponi M. Liver-Heart on chip models for drug safety. APL Bioeng 2021;5:031505. [PMID: 34286172 DOI: 10.1063/5.0048986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
95 Zhang L, Pu K, Liu X, Bae SDW, Nguyen R, Bai S, Li Y, Qiao L. The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review. Front Med (Lausanne) 2021;8:644594. [PMID: 34277651 DOI: 10.3389/fmed.2021.644594] [Reference Citation Analysis]
96 Kasendra M, Troutt M, Broda T, Bacon WC, Wang TC, Niland JC, Helmrath MA. Intestinal organoids: roadmap to the clinic. Am J Physiol Gastrointest Liver Physiol 2021;321:G1-G10. [PMID: 33950707 DOI: 10.1152/ajpgi.00425.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Tsang HY, Yi Lo PH, Ho Lee KK. Generation of liver organoids from human induced pluripotent stem cells as liver fibrosis and steatosis models.. [DOI: 10.1101/2021.06.29.450347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Danoy M, Jellali R, Tauran Y, Bruce J, Leduc M, Gilard F, Gakière B, Scheidecker B, Kido T, Miyajima A, Soncin F, Sakai Y, Leclerc E. Characterization of the proteome and metabolome of human liver sinusoidal endothelial-like cells derived from induced pluripotent stem cells. Differentiation 2021;120:28-35. [PMID: 34229994 DOI: 10.1016/j.diff.2021.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Lucena-Valera A, Perez-Palacios D, Muñoz-Hernandez R, Romero-Gómez M, Ampuero J. Wilson's disease: Revisiting an old friend. World J Hepatol 2021; 13(6): 634-649 [PMID: 34239699 DOI: 10.4254/wjh.v13.i6.634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
100 Nghiem-Rao TH, Pfeifer C, Asuncion M, Nord J, Schill D, Pulakanti K, Patel SB, Cirillo LA, Rao S. Human induced pluripotent stem cell derived hepatocytes provide insights on parenteral nutrition associated cholestasis in the immature liver. Sci Rep 2021;11:12386. [PMID: 34117281 DOI: 10.1038/s41598-021-90510-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
101 Bogacheva MS, Bystriakova MA, Lou YR. Thyroid Hormone Effect on the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells. Pharmaceuticals (Basel) 2021;14:544. [PMID: 34200130 DOI: 10.3390/ph14060544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
102 Ng BG, Sosicka P, Fenaille F, Harroche A, Vuillaumier-Barrot S, Porterfield M, Xia ZJ, Wagner S, Bamshad MJ, Vergnes-Boiteux MC, Cholet S, Dalton S, Dell A, Dupré T, Fiore M, Haslam SM, Huguenin Y, Kumagai T, Kulik M, McGoogan K, Michot C, Nickerson DA, Pascreau T, Borgel D, Raymond K, Warad D, Flanagan-Steet H, Steet R, Tiemeyer M, Seta N, Bruneel A, Freeze HH; University of Washington Center for Mendelian Genomics (UW-CMG). A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction. Am J Hum Genet 2021;108:1040-52. [PMID: 33964207 DOI: 10.1016/j.ajhg.2021.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Duwaerts CC, Le Guillou D, Her CL, Phillips NJ, Willenbring H, Mattis AN, Maher JJ. Induced Pluripotent Stem Cell-derived Hepatocytes From Patients With Nonalcoholic Fatty Liver Disease Display a Disease-specific Gene Expression Profile. Gastroenterology 2021;160:2591-2594.e6. [PMID: 33640436 DOI: 10.1053/j.gastro.2021.02.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
104 Xu R, Hu P, Li Y, Tian A, Li J, Zhu C. Advances in HBV infection and replication systems in vitro. Virol J 2021;18:105. [PMID: 34051803 DOI: 10.1186/s12985-021-01580-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
105 Kulkeaw K. Next-Generation Human Liver Models for Antimalarial Drug Assays. Antibiotics (Basel) 2021;10:642. [PMID: 34071885 DOI: 10.3390/antibiotics10060642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Yao T, Zhang Y, Lv M, Zang G, Ng SS, Chen X. Advances in 3D cell culture for liver preclinical studies. Acta Biochim Biophys Sin (Shanghai) 2021;53:643-51. [PMID: 33973620 DOI: 10.1093/abbs/gmab046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Marsee A, Roos FJM, Verstegen MMA, Gehart H, de Koning E, Lemaigre F, Forbes SJ, Peng WC, Huch M, Takebe T, Vallier L, Clevers H, van der Laan LJW, Spee B; HPB Organoid Consortium. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell 2021;28:816-32. [PMID: 33961769 DOI: 10.1016/j.stem.2021.04.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 27.5] [Reference Citation Analysis]
108 Ruiz-Estevez M, Crane AT, Rodriguez-Villamil P, Ongaratto FL, You Y, Steevens AR, Hill C, Goldsmith T, Webster DA, Sherry L, Lim S, Denman N, Low WC, Carlson DF, Dutton JR, Steer CJ, Gafni O. Liver development is restored by blastocyst complementation of HHEX knockout in mice and pigs. Stem Cell Res Ther 2021;12:292. [PMID: 34011403 DOI: 10.1186/s13287-021-02348-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
109 Kim Y, Kim YW, Lee SB, Kang K, Yoon S, Choi D, Park SH, Jeong J. Hepatic patch by stacking patient-specific liver progenitor cell sheets formed on multiscale electrospun fibers promotes regenerative therapy for liver injury. Biomaterials 2021;274:120899. [PMID: 34034028 DOI: 10.1016/j.biomaterials.2021.120899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
110 Danoy M, Tauran Y, Poulain S, Jellali R, Bruce J, Leduc M, Le Gall M, Koui Y, Arakawa H, Gilard F, Gakiere B, Kato Y, Plessy C, Kido T, Miyajima A, Sakai Y, Leclerc E. Investigation of the hepatic development in the coculture of hiPSCs-derived LSECs and HLCs in a fluidic microenvironment. APL Bioeng 2021;5:026104. [PMID: 34027283 DOI: 10.1063/5.0041227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
111 Lee-Montiel FT, Laemmle A, Charwat V, Dumont L, Lee CS, Huebsch N, Okochi H, Hancock MJ, Siemons B, Boggess SC, Goswami I, Miller EW, Willenbring H, Healy KE. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction. Front Pharmacol 2021;12:667010. [PMID: 34025426 DOI: 10.3389/fphar.2021.667010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
112 Harrison SP, Baumgarten SF, Verma R, Lunov O, Dejneka A, Sullivan GJ. Liver Organoids: Recent Developments, Limitations and Potential. Front Med (Lausanne) 2021;8:574047. [PMID: 34026769 DOI: 10.3389/fmed.2021.574047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
113 Takeishi K, Collin de l'Hortet A, Wang Y, Handa K, Guzman-Lepe J, Matsubara K, Morita K, Jang S, Haep N, Florentino RM, Yuan F, Fukumitsu K, Tobita K, Sun W, Franks J, Delgado ER, Shapiro EM, Fraunhoffer NA, Duncan AW, Yagi H, Mashimo T, Fox IJ, Soto-Gutierrez A. Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells. Cell Rep 2020;31:107711. [PMID: 32492423 DOI: 10.1016/j.celrep.2020.107711] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 23.5] [Reference Citation Analysis]
114 Tafaleng EN, Malizio MR, Fox IJ, Soto-Gutierrez A. Synthetic human livers for modeling metabolic diseases. Curr Opin Gastroenterol 2021;37:224-30. [PMID: 33769378 DOI: 10.1097/MOG.0000000000000726] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Heslop JA, Pournasr B, Liu JT, Duncan SA. GATA6 defines endoderm fate by controlling chromatin accessibility during differentiation of human-induced pluripotent stem cells. Cell Rep 2021;35:109145. [PMID: 34010638 DOI: 10.1016/j.celrep.2021.109145] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
116 Wang X, Xiang Y, Yu Y, Wang R, Zhang Y, Xu Q, Sun H, Zhao ZA, Jiang X, Wang X, Lu X, Qin D, Quan Y, Zhang J, Shyh-Chang N, Wang H, Jing N, Xie W, Li L. Formative pluripotent stem cells show features of epiblast cells poised for gastrulation. Cell Res 2021;31:526-41. [PMID: 33608671 DOI: 10.1038/s41422-021-00477-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
117 Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives. Gut Liver 2020;14:306-15. [PMID: 31581387 DOI: 10.5009/gnl18412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
118 Choi HJ, Torizal FG, Shinohara M, Sakai Y. Differentiation of Human Induced Pluripotent Stem Cells into Definitive Endoderm Using Simple Dialysis Culture Device. Methods Mol Biol 2021. [PMID: 33900573 DOI: 10.1007/7651_2021_388] [Reference Citation Analysis]
119 Dannemann M, Gallego Romero I. Harnessing pluripotent stem cells as models to decipher human evolution. FEBS J 2021. [PMID: 33876573 DOI: 10.1111/febs.15885] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
120 Ghosh S, Börsch A, Ghosh S, Zavolan M. The transcriptional landscape of a hepatoma cell line grown on scaffolds of extracellular matrix proteins. BMC Genomics 2021;22:238. [PMID: 33823809 DOI: 10.1186/s12864-021-07532-2] [Reference Citation Analysis]
121 Oliveira AG, Fiorotto R. Novel approaches to liver disease diagnosis and modeling. Transl Gastroenterol Hepatol 2021;6:19. [PMID: 33824923 DOI: 10.21037/tgh-20-109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
122 Ronchi S, Buccino AP, Prack G, Kumar SS, Schröter M, Fiscella M, Hierlemann A. Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays. Adv Biol (Weinh) 2021;5:e2000223. [PMID: 33729694 DOI: 10.1002/adbi.202000223] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
123 Asadi M, Khalili M, Lotfi H, Vaghefi Moghaddam S, Zarghami N, André H, Alizadeh E. Liver bioengineering: Recent trends/advances in decellularization and cell sheet technologies towards translation into the clinic. Life Sci 2021;276:119373. [PMID: 33744324 DOI: 10.1016/j.lfs.2021.119373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
124 Wang X, Wang J, Tsui YM, Shi C, Wang Y, Zhang X, Yan Q, Chen M, Jiang C, Yuan YF, Wong CM, Liu M, Feng ZY, Chen H, Ng IOL, Jiang L, Guan XY. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2. Nat Commun 2021;12:1518. [PMID: 33750796 DOI: 10.1038/s41467-021-21828-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
125 Yang H, Sun L, Pang Y, Hu D, Xu H, Mao S, Peng W, Wang Y, Xu Y, Zheng YC, Du S, Zhao H, Chi T, Lu X, Sang X, Zhong S, Wang X, Zhang H, Huang P, Sun W, Mao Y. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. Gut 2021;70:567-74. [PMID: 32434830 DOI: 10.1136/gutjnl-2019-319960] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 26.0] [Reference Citation Analysis]
126 Lewis K, Yoshimoto M, Takebe T. Fetal liver hematopoiesis: from development to delivery. Stem Cell Res Ther 2021;12:139. [PMID: 33597015 DOI: 10.1186/s13287-021-02189-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
127 Thompson WL, Takebe T. Human liver model systems in a dish. Dev Growth Differ 2021;63:47-58. [PMID: 33423319 DOI: 10.1111/dgd.12708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
128 Qiao S, Feng S, Wu Z, He T, Ma C, Peng Z, Tian E, Pan G. Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity. Drug Metab Dispos 2021;49:305-13. [PMID: 33526515 DOI: 10.1124/dmd.120.000275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
129 Moya-Garzon MD, Gomez-Vidal JA, Alejo-Armijo A, Altarejos J, Rodriguez-Madoz JR, Fernandes MX, Salido E, Salido S, Diaz-Gavilan M. Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. J Pers Med 2021;11:74. [PMID: 33513899 DOI: 10.3390/jpm11020074] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
130 Mun SJ, Lee J, Chung KS, Son MY, Son MJ. Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids. Cells 2021;10:126. [PMID: 33440728 DOI: 10.3390/cells10010126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
131 Lu Z, Priya Rajan SA, Song Q, Zhao Y, Wan M, Aleman J, Skardal A, Bishop C, Atala A, Lu B. 3D scaffold-free microlivers with drug metabolic function generated by lineage-reprogrammed hepatocytes from human fibroblasts. Biomaterials 2021;269:120668. [PMID: 33461059 DOI: 10.1016/j.biomaterials.2021.120668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Danoy M, Tauran Y, Poulain S, Jellali R, Bruce J, Leduc M, Le Gall M, Gilard F, Kido T, Arakawa H, Araya K, Mori D, Kato Y, Kusuhara H, Plessy C, Miyajima A, Sakai Y, Leclerc E. Multi-omics analysis of hiPSCs-derived HLCs matured on-chip revealed patterns typical of liver regeneration. Biotechnol Bioeng 2021. [PMID: 33404112 DOI: 10.1002/bit.27667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
133 Jin Z. Research Progress on Tissue Engineering of Main Tissues and Organs of Human Body. E3S Web Conf 2021;245:03043. [DOI: 10.1051/e3sconf/202124503043] [Reference Citation Analysis]
134 Arai K, Nakayama K. Bio-3D Printed Organs as Drug Testing Tools. Kenzan Method for Scaffold-Free Biofabrication 2021. [DOI: 10.1007/978-3-030-58688-1_12] [Reference Citation Analysis]
135 Alomari M. Differentiation of Stem Cells into Hepatocyte Lineage: In Vitro Cell Culture, In Vivo Transplantation in Animal Models. Advances in Application of Stem Cells: From Bench to Clinics 2021. [DOI: 10.1007/978-3-030-78101-9_6] [Reference Citation Analysis]
136 Yamashita T, Takayama K, Mizuguchi H. Generation of Hepatocytes from Human ES/iPS Cells for Regenerative Medicine. Cell-Inspired Materials and Engineering 2021. [DOI: 10.1007/978-3-030-55924-3_1] [Reference Citation Analysis]
137 Gao X, Yourick JJ, Sprando RL. Differentiation of human induced pluripotent stem cells to hepatocyte-like cells for toxicological applications. Current Progress in iPSC-derived Cell Types 2021. [DOI: 10.1016/b978-0-12-823884-4.00003-1] [Reference Citation Analysis]
138 Acun A, Uygun BE. Decellularized liver extracellular matrix for iPSC-based liver engineering. Methods in iPSC Technology 2021. [DOI: 10.1016/b978-0-323-85766-6.00006-1] [Reference Citation Analysis]
139 Bove G, Mehnert A, Dao Thi VL. iPSCs for modeling hepatotropic pathogen infections. iPSCs for Studying Infectious Diseases 2021. [DOI: 10.1016/b978-0-12-823808-0.00013-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Toro A, Anselmino N, Solari C, Francia M, Oses C, Sanchis P, Bizzotto J, Vazquez Echegaray C, Petrone MV, Levi V, Vazquez E, Guberman A. Novel Interplay between p53 and HO-1 in Embryonic Stem Cells. Cells 2020;10:E35. [PMID: 33383653 DOI: 10.3390/cells10010035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
141 Amirneni S, Haep N, Gad MA, Soto-Gutierrez A, Squires JE, Florentino RM. Molecular overview of progressive familial intrahepatic cholestasis. World J Gastroenterol 2020; 26(47): 7470-7484 [PMID: 33384548 DOI: 10.3748/wjg.v26.i47.7470] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
142 Gil-recio C, Montori S, Cámara Vallejo M, Demour SA, Ferrés-padró E, Barajas M, Martin C, Madhoun AA, Atari M. Directed differentiation of Dental Pulp Pluripotent-like Stem Cells into Hepatocyte-like Cells.. [DOI: 10.1101/2020.12.09.418780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
143 Velazquez JJ, LeGraw R, Moghadam F, Tan Y, Kilbourne J, Maggiore JC, Hislop J, Liu S, Cats D, Chuva de Sousa Lopes SM, Plaisier C, Cahan P, Kiani S, Ebrahimkhani MR. Gene Regulatory Network Analysis and Engineering Directs Development and Vascularization of Multilineage Human Liver Organoids. Cell Syst. 2021;12:41-55.e11. [PMID: 33290741 DOI: 10.1016/j.cels.2020.11.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
144 Feng S, Wu J, Qiu WL, Yang L, Deng X, Zhou Y, Chen Y, Li X, Yu L, Li H, Xu ZR, Xiao Y, Ren X, Zhang L, Wang C, Sun Z, Wang J, Ding X, Chen Y, Gadue P, Pan G, Ogawa M, Ogawa S, Na J, Zhang P, Hui L, Yin H, Chen L, Xu CR, Cheng X. Large-scale Generation of Functional and Transplantable Hepatocytes and Cholangiocytes from Human Endoderm Stem Cells. Cell Rep 2020;33:108455. [PMID: 33296648 DOI: 10.1016/j.celrep.2020.108455] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
145 Michielin F, Giobbe GG, Luni C, Hu Q, Maroni I, Orford MR, Manfredi A, Di Filippo L, David AL, Cacchiarelli D, De Coppi P, Eaton S, Elvassore N. The Microfluidic Environment Reveals a Hidden Role of Self-Organizing Extracellular Matrix in Hepatic Commitment and Organoid Formation of hiPSCs. Cell Rep 2020;33:108453. [PMID: 33264615 DOI: 10.1016/j.celrep.2020.108453] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
146 Cox CR, Lynch S, Goldring C, Sharma P. Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury. Front Med Technol 2020;2:611913. [DOI: 10.3389/fmedt.2020.611913] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
147 Chang PH, Chao HM, Chern E, Hsu SH. Chitosan 3D cell culture system promotes naïve-like features of human induced pluripotent stem cells: A novel tool to sustain pluripotency and facilitate differentiation. Biomaterials 2021;268:120575. [PMID: 33341735 DOI: 10.1016/j.biomaterials.2020.120575] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
148 Yang G, Mahadik B, Mollot T, Pinsky J, Jones A, Robinson A, Najafali D, Rivkin D, Katsnelson J, Piard C, Fisher JP. Engineered Liver Tissue Culture in an In Vitro Tubular Perfusion System. Tissue Eng Part A 2020;26:1369-77. [PMID: 33054685 DOI: 10.1089/ten.TEA.2020.0213] [Reference Citation Analysis]
149 Gheibi S, Singh T, da Cunha JPMCM, Fex M, Mulder H. Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes. Cells 2020;9:E2465. [PMID: 33198288 DOI: 10.3390/cells9112465] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
150 Lucendo-Villarin B, Nell P, Hellwig B, Filis P, Feuerborn D, O'Shaughnessy PJ, Godoy P, Rahnenführer J, Hengstler JG, Cherianidou A, Sachinidis A, Fowler PA, Hay DC. Genome-wide expression changes induced by bisphenol A, F and S in human stem cell derived hepatocyte-like cells. EXCLI J 2020;19:1459-76. [PMID: 33312107 DOI: 10.17179/excli2020-2934] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
151 Andreasson L, Evenbratt H, Mobini R, Simonsson S. Differentiation of induced pluripotent stem cells into definitive endoderm on Activin A-functionalized gradient surfaces. J Biotechnol 2021;325:173-8. [PMID: 33147515 DOI: 10.1016/j.jbiotec.2020.10.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Huang D, Gibeley SB, Xu C, Xiao Y, Celik O, Ginsberg HN, Leong KW. Engineering liver microtissues for disease modeling and regenerative medicine. Adv Funct Mater 2020;30:1909553. [PMID: 33390875 DOI: 10.1002/adfm.201909553] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
153 Sekine K, Ogawa S, Tsuzuki S, Kobayashi T, Ikeda K, Nakanishi N, Takeuchi K, Kanai E, Otake Y, Okamoto S, Kobayashi T, Takebe T, Taniguchi H. Generation of human induced pluripotent stem cell-derived liver buds with chemically defined and animal origin-free media. Sci Rep 2020;10:17937. [PMID: 33087763 DOI: 10.1038/s41598-020-73908-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
154 Kulkeaw K, Tubsuwan A, Tongkrajang N, Whangviboonkij N. Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms. PeerJ 2020;8:e9968. [PMID: 33133779 DOI: 10.7717/peerj.9968] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
155 Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater 2020;116:67-83. [PMID: 32890749 DOI: 10.1016/j.actbio.2020.08.041] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 17.7] [Reference Citation Analysis]
156 Yoshimoto K, Minier N, Yang J, Imamura S, Stocking K, Patel J, Terada S, Hirai Y, Kamei KI. Recapitulation of Human Embryonic Heartbeat to Promote Differentiation of Hepatic Endoderm to Hepatoblasts. Front Bioeng Biotechnol 2020;8:568092. [PMID: 33015019 DOI: 10.3389/fbioe.2020.568092] [Reference Citation Analysis]
157 Ramli MNB, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, Tan CP, Szczerbinska I, Liang H, Soe EL, Lu Z, Ariyachet C, Yu KM, Koh SH, Yaw LP, Jumat NHB, Lim JSY, Wright G, Shabbir A, Dan YY, Ng HH, Chan YS. Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease. Gastroenterology 2020;159:1471-1486.e12. [PMID: 32553762 DOI: 10.1053/j.gastro.2020.06.010] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 25.7] [Reference Citation Analysis]
158 Hua TT, Bejoy J, Song L, Wang Z, Zeng Z, Zhou Y, Li Y, Sang QA. Cerebellar Differentiation from Human Stem Cells Through Retinoid, Wnt, and Sonic Hedgehog Pathways. Tissue Eng Part A 2021;27:881-93. [PMID: 32873223 DOI: 10.1089/ten.TEA.2020.0135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
159 Cordero-espinoza L, Kohler TN, Dowbaj AM, Strauss B, Sarlidou O, Pacini C, Dobie R, Wilson-kanamori JR, Butler R, Serup P, Henderson NC, Hollfelder F, Huch M. The proportion of periportal mesenchyme to ductal epithelial cells acts as a proliferative rheostat in liver regeneration.. [DOI: 10.1101/2020.09.21.306258] [Reference Citation Analysis]
160 Dame K, Ribeiro AJ. Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects. Exp Biol Med (Maywood) 2021;246:317-31. [PMID: 32938227 DOI: 10.1177/1535370220959598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
161 Wang Y, Wang H, Deng P, Tao T, Liu H, Wu S, Chen W, Qin J. Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System. ACS Biomater Sci Eng 2020;6:5734-43. [DOI: 10.1021/acsbiomaterials.0c00682] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
162 Gao X, Li R, Cahan P, Zhao Y, Yourick JJ, Sprando RL. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study. Stem Cell Res Ther 2020;11:393. [PMID: 32917265 DOI: 10.1186/s13287-020-01914-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
163 Al Sayed ZR, Canac R, Cimarosti B, Bonnard C, Gourraud JB, Hamamy H, Kayserili H, Girardeau A, Jouni M, Jacob N, Gaignerie A, Chariau C, David L, Forest V, Marionneau C, Charpentier F, Loussouarn G, Lamirault G, Reversade B, Zibara K, Lemarchand P, Gaborit N. Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction. Cardiovasc Res 2021;117:2092-107. [PMID: 32898233 DOI: 10.1093/cvr/cvaa259] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
164 Ronchi S, Buccino AP, Prack G, Kumar SS, Schröter M, Fiscella M, Hierlemann A. Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays.. [DOI: 10.1101/2020.09.02.271403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
165 Chen SW, Himeno M, Koui Y, Sugiyama M, Nishitsuji H, Mizokami M, Shimotohno K, Miyajima A, Kido T. Modulation of hepatitis B virus infection by epidermal growth factor secreted from liver sinusoidal endothelial cells. Sci Rep. 2020;10:14349. [PMID: 32873852 DOI: 10.1038/s41598-020-71453-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
166 Yu B, Li H, Chen J, He Z, Sun H, Yang G, Shang C, Wang X, Li C, Chen Y, Hu Y. Extensively expanded murine-induced hepatic stem cells maintain high-efficient hepatic differentiation potential for repopulation of injured livers. Liver Int 2020;40:2293-304. [PMID: 32394491 DOI: 10.1111/liv.14509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
167 de Jong YP, Liang TJ. Stem cell-derived HCV infection systems illustrate the bright future of human hepatocyte research. Gut 2020;69:1-2. [PMID: 32350090 DOI: 10.1136/gutjnl-2020-321216] [Reference Citation Analysis]
168 Olgasi C, Cucci A, Follenzi A. iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine. Int J Mol Sci 2020;21:E6215. [PMID: 32867371 DOI: 10.3390/ijms21176215] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
169 Jamwal VS, Vishnu VV, Domreddy A, Parekh Y, Kumar BK, Chandra Shekar P, Singh S. Generation of iPSC from fetal fibroblast cells obtained from an abortus with type-I tri-allelic variants. Stem Cell Res 2020;48:101963. [PMID: 32916634 DOI: 10.1016/j.scr.2020.101963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
170 Heinke P, Rost F, Rode J, Welsch T, Alkass K, Feddema J, Salehpour M, Possnert G, Druid H, Brusch L, Bergmann O. Diploid hepatocytes drive physiological liver renewal in adult humans.. [DOI: 10.1101/2020.08.07.230086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
171 Zeng F, Zhang Y, Han X, Weng J, Gao Y. Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application. Stem Cell Rev Rep 2019;15:774-84. [PMID: 31863336 DOI: 10.1007/s12015-019-09909-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
172 Saito Y, Ikemoto T, Morine Y, Shimada M. Current status of hepatocyte-like cell therapy from stem cells. Surg Today 2021;51:340-9. [PMID: 32754843 DOI: 10.1007/s00595-020-02092-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
173 Choi JS, Jeong IS, Park YJ, Kim SW. HGF and IL-10 expressing ALB::GFP reporter cells generated from iPSCs show robust anti-fibrotic property in acute fibrotic liver model. Stem Cell Res Ther 2020;11:332. [PMID: 32746905 DOI: 10.1186/s13287-020-01745-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
174 Chen Y, Chen J, Sun X, Yu J, Qian Z, Wu L, Xu X, Wan X, Jiang Y, Zhang J, Gao S, Mao Z. The SIRT6 activator MDL-800 improves genomic stability and pluripotency of old murine-derived iPS cells. Aging Cell 2020;19:e13185. [PMID: 33089974 DOI: 10.1111/acel.13185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
175 Mun SJ, Hong YH, Ahn HS, Ryu JS, Chung KS, Son MJ. Long-Term Expansion of Functional Human Pluripotent Stem Cell-Derived Hepatic Organoids. Int J Stem Cells 2020;13:279-86. [PMID: 32323516 DOI: 10.15283/ijsc20060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
176 Kunst RF, Niemeijer M, van der Laan LJW, Spee B, van de Graaf SFJ. From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease. Biochem Pharmacol 2020;180:114173. [PMID: 32717228 DOI: 10.1016/j.bcp.2020.114173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
177 Yin F, Zhu Y, Wang H, Wang Y, Li D, Qin J. Microengineered hiPSC-Derived 3D Amnion Tissue Model to Probe Amniotic Inflammatory Responses under Bacterial Exposure. ACS Biomater Sci Eng 2020;6:4644-52. [PMID: 33455183 DOI: 10.1021/acsbiomaterials.0c00592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
178 Abbey D, Elwyn S, Hand NJ, Musunuru K, Rader DJ. Self-Organizing Human Induced Pluripotent Stem Cell Hepatocyte 3D Organoids Inform the Biology of the Pleiotropic TRIB1 Gene. Hepatol Commun 2020;4:1316-31. [PMID: 32923835 DOI: 10.1002/hep4.1538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
179 Hong S, Oh SJ, Choi D, Hwang Y, Kim SH. Self-Organized Liver Microtissue on a Bio-Functional Surface: The Role of Human Adipose-Derived Stromal Cells in Hepatic Function. Int J Mol Sci 2020;21:E4605. [PMID: 32610471 DOI: 10.3390/ijms21134605] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
180 Zabulica M, Srinivasan RC, Vosough M, Hammarstedt C, Wu T, Gramignoli R, Ellis E, Kannisto K, Collin de l'Hortet A, Takeishi K, Soto-Gutierrez A, Strom SC. Guide to the Assessment of Mature Liver Gene Expression in Stem Cell-Derived Hepatocytes. Stem Cells Dev 2019;28:907-19. [PMID: 31122128 DOI: 10.1089/scd.2019.0064] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
181 Subramani PA, Vartak-Sharma N, Sreekumar S, Mathur P, Nayer B, Dakhore S, Basavanna SK, Kalappa DM, Krishnamurthy RV, Mukhi B, Mishra P, Yoshida N, Ghosh SK, Shandil R, Narayanan S, Campo B, Hasegawa K, Anvikar AR, Valecha N, Sundaramurthy V. Plasmodium vivax liver stage assay platforms using Indian clinical isolates. Malar J 2020;19:214. [PMID: 32571333 DOI: 10.1186/s12936-020-03284-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
182 Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, Tang X, Zhu J, Zhao Z, Jaffré F, Zhang T, Kim TW, Harschnitz O, Redmond D, Houghton S, Liu C, Naji A, Ciceri G, Guttikonda S, Bram Y, Nguyen DT, Cioffi M, Chandar V, Hoagland DA, Huang Y, Xiang J, Wang H, Lyden D, Borczuk A, Chen HJ, Studer L, Pan FC, Ho DD, tenOever BR, Evans T, Schwartz RE, Chen S. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell 2020;27:125-136.e7. [PMID: 32579880 DOI: 10.1016/j.stem.2020.06.015] [Cited by in Crossref: 379] [Cited by in F6Publishing: 406] [Article Influence: 126.3] [Reference Citation Analysis]
183 Chen L, Dalton S. Multipotent Vascular Progenitor Cells of the Mesothelium Lineage Generated from Human Pluripotent Stem Cells. STAR Protoc 2020;1:100031. [PMID: 33111082 DOI: 10.1016/j.xpro.2020.100031] [Reference Citation Analysis]
184 Fischer L, Lucendo-Villarin B, Hay DC, O'Farrelly C. Human PSC-Derived Hepatocytes Express Low Levels of Viral Pathogen Recognition Receptors, but Are Capable of Mounting an Effective Innate Immune Response. Int J Mol Sci 2020;21:E3831. [PMID: 32481600 DOI: 10.3390/ijms21113831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
185 Lee-montiel FT, Laemmle A, Dumont L, Lee CS, Huebsch N, Charwat V, Okochi H, Hancock MJ, Siemons B, Boggess SC, Goswami I, Miller EW, Willenbring H, Healy K. Integrated hiPSC-based liver and heart microphysiological systems predict unsafe drug-drug interaction.. [DOI: 10.1101/2020.05.24.112771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
186 Zhao X, Zhu Y, Laslett AL, Chan HF. Hepatic Differentiation of Stem Cells in 2D and 3D Biomaterial Systems. Bioengineering (Basel) 2020;7:E47. [PMID: 32466173 DOI: 10.3390/bioengineering7020047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
187 Gao X, Li R, Sprando RL, Yourick JJ. Concentration-dependent toxicogenomic changes of silver nanoparticles in hepatocyte-like cells derived from human induced pluripotent stem cells. Cell Biol Toxicol 2021;37:245-59. [PMID: 32447489 DOI: 10.1007/s10565-020-09529-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
188 Vargas-Valderrama A, Messina A, Mitjavila-Garcia MT, Guenou H. The endothelium, a key actor in organ development and hPSC-derived organoid vascularization. J Biomed Sci 2020;27:67. [PMID: 32443983 DOI: 10.1186/s12929-020-00661-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
189 Yoshimoto K, Minier N, Imamura S, Stocking K, Patel J, Terada S, Kamei K. Recapitulation of human embryonic heart beating to promote differentiation of hepatic endoderm to hepatoblasts.. [DOI: 10.1101/2020.05.18.103218] [Reference Citation Analysis]
190 Tripathi J, Segeritz CP, Griffiths G, Bushell W, Vallier L, Skarnes WC, Mota MM, Billker O. A Novel Chemically Differentiated Mouse Embryonic Stem Cell-Based Model to Study Liver Stages of Plasmodium berghei. Stem Cell Reports 2020;14:1123-34. [PMID: 32442532 DOI: 10.1016/j.stemcr.2020.04.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
191 Danoy M, Tauran Y, Poulain S, Arakawa H, Mori D, Araya K, Kato S, Kido T, Kusuhara H, Kato Y, Miyajima A, Plessy C, Sakai Y, Leclerc E. Analysis of hiPSCs differentiation toward hepatocyte-like cells upon extended exposition to oncostatin. Differentiation 2020;114:36-48. [PMID: 32563741 DOI: 10.1016/j.diff.2020.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
192 Velazquez JJ, Legraw R, Moghadam F, Tan Y, Kilbourne J, Hislop J, Liu S, Cats D, Chuva de Sousa Lopes SM, Plaisier C, Cahan P, Kiani S, Ebrahimkhani MR. Synthetic Maturation of Multilineage Human Liver Organoids via Genetically Guided Engineering.. [DOI: 10.1101/2020.05.10.087445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
193 Duwaerts CC, Her CL, Phillips NJ, Willenbring H, Mattis AN, Maher JJ. iPSC-derived hepatocytes from patients with nonalcoholic fatty liver disease display a disease-specific gene expression profile.. [DOI: 10.1101/2020.04.20.052001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
194 Esteva-font C, Su T, Peaslee C, Duwaerts C, Liu K, Medina M, Maher JJ, Mattis AN. Doxycycline Significantly Enhances Induction of iPSCs to Endoderm by Enhancing survival via AKT Phosphorylation.. [DOI: 10.1101/2020.04.13.034595] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
195 Cotovio JP, Fernandes TG. Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications. Bioengineering (Basel) 2020;7:E36. [PMID: 32283585 DOI: 10.3390/bioengineering7020036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
196 Facklam AL, Volpatti LR, Anderson DG. Biomaterials for Personalized Cell Therapy. Adv Mater 2020;32:e1902005. [PMID: 31495970 DOI: 10.1002/adma.201902005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
197 Wose Kinge CN, Bhoola NH, Kramvis A. In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations. Viruses. 2020;12. [PMID: 32210021 DOI: 10.3390/v12030353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
198 Larsen LE, Smith MA, Abbey D, Korn A, Reeskamp LF, Hand NJ, Holleboom AG. Hepatocyte-like cells derived from induced pluripotent stem cells: A versatile tool to understand lipid disorders. Atherosclerosis 2020;303:8-14. [PMID: 32460140 DOI: 10.1016/j.atherosclerosis.2020.03.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
199 Imamura S, Yoshimoto K, Terada S, Kamei K. Heat treatment functionalizes hepatocyte-like cells derived from human embryonic stem cells.. [DOI: 10.1101/2020.03.10.983130] [Reference Citation Analysis]
200 Kim JS, Hwang SI, Ryu JL, Hong HS, Lee J, Lee SM, Jin X, Han C, Kim J, Han J, Lee M, Woo D. ER stress reliever enhances functionalities of in vitro cultured hepatocytes. Stem Cell Research 2020;43:101732. [DOI: 10.1016/j.scr.2020.101732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Danoy M, Poulain S, Jellali R, Gilard F, Kato S, Plessy C, Kido T, Miyajima A, Sakai Y, Leclerc E. Integration of metabolomic and transcriptomic profiles of hiPSCs-derived hepatocytes in a microfluidic environment. Biochemical Engineering Journal 2020;155:107490. [DOI: 10.1016/j.bej.2020.107490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
202 Chen F, Wang H, Xiao J. Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source. Clin Mol Hepatol 2020;26:163-79. [PMID: 32098013 DOI: 10.3350/cmh.2019.0022n] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
203 Kim Y, Jeong J, Choi D. Small-molecule-mediated reprogramming: a silver lining for regenerative medicine. Exp Mol Med 2020;52:213-26. [PMID: 32080339 DOI: 10.1038/s12276-020-0383-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
204 Nitta S, Kusakari Y, Yamada Y, Kubo T, Neo S, Igarashi H, Hisasue M. Conversion of mesenchymal stem cells into a canine hepatocyte-like cells by Foxa1 and Hnf4a. Regen Ther 2020;14:165-76. [PMID: 32123700 DOI: 10.1016/j.reth.2020.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
205 Messina A, Luce E, Hussein M, Dubart-Kupperschmitt A. Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration. Cells 2020;9:E420. [PMID: 32059501 DOI: 10.3390/cells9020420] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
206 Goessling W. Metabolic Regulation of Hepatic Growth. The Liver 2020. [DOI: 10.1002/9781119436812.ch83] [Reference Citation Analysis]
207 Heslop JA, Duncan SA. Pluripotent Stem Cells and Reprogramming. The Liver 2020. [DOI: 10.1002/9781119436812.ch80] [Reference Citation Analysis]
208 Gehart H, Clevers H. Stem Cell‐Derived Liver Cells. The Liver 2020. [DOI: 10.1002/9781119436812.ch77] [Reference Citation Analysis]
209 Bi Y, Li J, Dong C, Mu W, Han X. Rational Construction of MnCo 2 O 4.5 Deposited TiO 2 Nanotube Array Heterostructures with Enhanced Photocatalytic Degradation of Tetracycline. ChemPhotoChem 2020;4:366-72. [DOI: 10.1002/cptc.201900283] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
210 Maepa SW, Ndlovu H. Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases. Stem Cells 2020;38:606-12. [PMID: 32012379 DOI: 10.1002/stem.3154] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
211 Cernigliaro V, Peluso R, Zedda B, Silengo L, Tolosano E, Pellicano R, Altruda F, Fagoonee S. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cells 2020;9:E386. [PMID: 32046114 DOI: 10.3390/cells9020386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
212 Afshari A, Shamdani S, Uzan G, Naserian S, Azarpira N. Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells. Stem Cell Res Ther 2020;11:54. [PMID: 32033595 DOI: 10.1186/s13287-020-1555-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
213 Zhang J, Han C, Song K, Chen W, Ungerleider N, Yao L, Ma W, Wu T. The long-noncoding RNA MALAT1 regulates TGF-β/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells. PLoS One 2020;15:e0228160. [PMID: 31995604 DOI: 10.1371/journal.pone.0228160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
214 Török G, Erdei Z, Lilienberg J, Apáti Á, Homolya L. The importance of transporters and cell polarization for the evaluation of human stem cell-derived hepatic cells. PLoS One 2020;15:e0227751. [PMID: 31971960 DOI: 10.1371/journal.pone.0227751] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
215 Mithal A, Capilla A, Heinze D, Berical A, Villacorta-Martin C, Vedaie M, Jacob A, Abo K, Szymaniak A, Peasley M, Stuffer A, Mahoney J, Kotton DN, Hawkins F, Mostoslavsky G. Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells. Nat Commun. 2020;11:215. [PMID: 31924806 DOI: 10.1038/s41467-019-13916-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 22.0] [Reference Citation Analysis]
216 Chen AX, Chhabra A, Fleming HE, Bhatia SN. Hepatic tissue engineering. Principles of Tissue Engineering 2020. [DOI: 10.1016/b978-0-12-818422-6.00041-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Chakrabarti J, Dua-Awereh MB, Holokai L, Zavros Y. Human Gastrointestinal Organoid Models for Studying Microbial Disease and Cancer. Curr Top Microbiol Immunol 2021;430:55-75. [PMID: 32889597 DOI: 10.1007/82_2020_223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
218 Gnecchi M, Ciuffreda MC, Mura M. Mesenchymal Stromal Cell Secretome for Tissue Repair. Cell Engineering and Regeneration 2020. [DOI: 10.1007/978-3-319-08831-0_43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
219 Jellali R, Poulain S, Bernier ML, Gilard F, Tauran Y, Kato S, Danoy M, Segard BD, Kido T, Miyajima A, Plessy C, Sakai Y, Leclerc E. Integration of metabolomic and transcriptomic profiling to compare two protocols of differentiation of human induced pluripotent stem cells into hepatocytes. Process Biochemistry 2020;88:138-147. [DOI: 10.1016/j.procbio.2019.09.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
220 Roy-chowdhury N, Wang X, Roy-chowdhury J. Bile Pigment Metabolism and Its Disorders. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2020. [DOI: 10.1016/b978-0-12-812532-8.00019-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
221 Pastore M, Gentilini A, Marra F. Mechanisms of Fibrogenesis in NASH. Non-Alcoholic Fatty Liver Disease 2020. [DOI: 10.1007/978-3-319-95828-6_6] [Reference Citation Analysis]
222 Cake MH, Yeoh GC. Hormones and Perinatal Development. Hormonal Signaling in Biology and Medicine 2020. [DOI: 10.1016/b978-0-12-813814-4.00001-8] [Reference Citation Analysis]
223 Graffmann N, Spitzhorn L, Ncube A, Wruck W, Adjaye J. Liver Disease Modelling. Essential Current Concepts in Stem Cell Biology 2020. [DOI: 10.1007/978-3-030-33923-4_11] [Reference Citation Analysis]
224 Caron J, Dubart-kupperschmitt A, Weber A. iPSCs for modeling familial hypercholesterolemia type II A. Recent Advances in iPSC Disease Modeling, Volume 1 2020. [DOI: 10.1016/b978-0-12-822227-0.00010-7] [Reference Citation Analysis]
225 Leach TS, Dominijanni A, Murphy SV, Atala A. Tissue organoid models and applications. Principles of Tissue Engineering 2020. [DOI: 10.1016/b978-0-12-818422-6.00085-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
226 Szkolnicka D, Hay DC. Liver stem cells. Principles of Tissue Engineering 2020. [DOI: 10.1016/b978-0-12-818422-6.00040-x] [Reference Citation Analysis]
227 Wang N, Li MY, Liu Y, Yu J, Ren J, Zheng Z, Wang S, Yang S, Yang SL, Liu LP, Hu BG, Chong CC, Merchant JL, Lai PB, Chen GG. ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway. Cancer Lett 2020;472:70-80. [PMID: 31874246 DOI: 10.1016/j.canlet.2019.12.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
228 Akbari S, Arslan N, Senturk S, Erdal E. Next-Generation Liver Medicine Using Organoid Models. Front Cell Dev Biol 2019;7:345. [PMID: 31921856 DOI: 10.3389/fcell.2019.00345] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
229 Vila OF, Qu Y, Vunjak-Novakovic G. In vitro models of neuromuscular junctions and their potential for novel drug discovery and development. Expert Opin Drug Discov 2020;15:307-17. [PMID: 31846349 DOI: 10.1080/17460441.2020.1700225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
230 Griffin K, Bejoy J, Song L, Hua T, Marzano M, Jeske R, Sang QA, Li Y. Human Stem Cell-derived Aggregates of Forebrain Astroglia Respond to Amyloid Beta Oligomers. Tissue Eng Part A 2020;26:527-42. [PMID: 31696783 DOI: 10.1089/ten.TEA.2019.0227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
231 Jellali R, Lereau Bernier M, Tauran Y, Gilard F, Danoy M, Kido T, Miyajima A, Sakai Y, Leclerc E. Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. Differentiation 2020;112:17-26. [PMID: 31869687 DOI: 10.1016/j.diff.2019.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
232 Jing R, Corbett JL, Cai J, Beeson GC, Beeson CC, Chan SS, Dimmock DP, Lazcares L, Geurts AM, Lemasters JJ, Duncan SA. A Screen Using iPSC-Derived Hepatocytes Reveals NAD+ as a Potential Treatment for mtDNA Depletion Syndrome. Cell Rep 2018;25:1469-1484.e5. [PMID: 30404003 DOI: 10.1016/j.celrep.2018.10.036] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
233 Bejoy J, Bijonowski B, Marzano M, Jeske R, Ma T, Li Y. Wnt-Notch Signaling Interactions During Neural and Astroglial Patterning of Human Stem Cells. Tissue Eng Part A 2020;26:419-31. [PMID: 31686622 DOI: 10.1089/ten.TEA.2019.0202] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
234 Yap L, Tay HG, Nguyen MT, Tjin MS, Tryggvason K. Laminins in Cellular Differentiation. Trends in Cell Biology 2019;29:987-1000. [DOI: 10.1016/j.tcb.2019.10.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
235 Corbett JL, Duncan SA. iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery. Front Med (Lausanne) 2019;6:265. [PMID: 31803747 DOI: 10.3389/fmed.2019.00265] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 15.0] [Reference Citation Analysis]
236 Mun SJ, Ryu JS, Lee MO, Son YS, Oh SJ, Cho HS, Son MY, Kim DS, Kim SJ, Yoo HJ, Lee HJ, Kim J, Jung CR, Chung KS, Son MJ. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol 2019;71:970-85. [PMID: 31299272 DOI: 10.1016/j.jhep.2019.06.030] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 25.0] [Reference Citation Analysis]
237 Park JY, Han J, Jung HS, Lee G, Kim HJ, Cho G, Park H, Han C, Kim JS, Kim J. Synthetic probes for in vitro purification and in vivo tracking of hepatocytes derived from human pluripotent stem cells. Biomaterials 2019;222:119431. [DOI: 10.1016/j.biomaterials.2019.119431] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
238 Wang S, Wang X, Tan Z, Su Y, Liu J, Chang M, Yan F, Chen J, Chen T, Li C, Hu J, Wang Y. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res 2019;29:1009-26. [PMID: 31628434 DOI: 10.1038/s41422-019-0242-8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 16.5] [Reference Citation Analysis]
239 Ashmore-Harris C, Blackford SJ, Grimsdell B, Kurtys E, Glatz MC, Rashid TS, Fruhwirth GO. Reporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible. Stem Cell Res 2019;41:101599. [PMID: 31707210 DOI: 10.1016/j.scr.2019.101599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
240 Li Z, Wu J, Wang L, Han W, Yu J, Liu X, Wang Y, Zhang Y, Feng G, Li W, Stacey GN, Gu Q, Hu B, Wang L, Zhou Q, Hao J. Generation of qualified clinical-grade functional hepatocytes from human embryonic stem cells in chemically defined conditions. Cell Death Dis 2019;10:763. [PMID: 31601782 DOI: 10.1038/s41419-019-1967-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
241 Li Q, Huang Q. Single-cell qPCR demonstrates that Repsox treatment changes cell fate from endoderm to neuroectoderm and disrupts epithelial-mesenchymal transition. PLoS One 2019;14:e0223724. [PMID: 31600351 DOI: 10.1371/journal.pone.0223724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
242 Jiang J, Pieterman CD, Ertaylan G, Peeters RLM, de Kok TMCM. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro. Arch Toxicol 2019;93:3067-98. [PMID: 31586243 DOI: 10.1007/s00204-019-02585-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
243 Furuya K, Zheng YW, Sako D, Iwasaki K, Zheng DX, Ge JY, Liu LP, Furuta T, Akimoto K, Yagi H, Hamada H, Isoda H, Oda T, Ohkohchi N. Enhanced hepatic differentiation in the subpopulation of human amniotic stem cells under 3D multicellular microenvironment. World J Stem Cells 2019; 11(9): 705-721 [PMID: 31616545 DOI: 10.4252/wjsc.v11.i9.705] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
244 Chusilp S, Li B, Lee D, Lee C, Vejchapipat P, Pierro A. Intestinal organoids in infants and children. Pediatr Surg Int 2020;36:1-10. [PMID: 31555860 DOI: 10.1007/s00383-019-04581-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
245 Indapurkar A, Hartman N, Patel V, Matta MK. Simultaneous UHPLC-MS/MS method of estradiol metabolites to support the evaluation of Phase-2 metabolic activity of induced pluripotent stem cell derived hepatocytes. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1126-1127:121765. [PMID: 31434025 DOI: 10.1016/j.jchromb.2019.121765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
246 Akbari S, Sevinç GG, Ersoy N, Basak O, Kaplan K, Sevinç K, Ozel E, Sengun B, Enustun E, Ozcimen B, Bagriyanik A, Arslan N, Önder TT, Erdal E. Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling. Stem Cell Reports 2019;13:627-41. [PMID: 31522975 DOI: 10.1016/j.stemcr.2019.08.007] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 15.8] [Reference Citation Analysis]
247 Kakinuma S, Watanabe M. Analysis of the mechanism underlying liver diseases using human induced pluripotent stem cells. Immunol Med 2019;42:71-8. [PMID: 31498713 DOI: 10.1080/25785826.2019.1657254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
248 Ardalani H, Sengupta S, Harms V, Vickerman V, Thomson JA, Murphy WL. 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes. Acta Biomater 2019;95:371-81. [PMID: 31362140 DOI: 10.1016/j.actbio.2019.07.047] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
249 Calabrese D, Roma G, Bergling S, Carbone W, Mele V, Nuciforo S, Fofana I, Campana B, Szkolnicka D, Hay DC, Tchorz J, Bouwmeester T, Wieland S, Heim MH. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells. PLoS One. 2019;14:e0221762. [PMID: 31465481 DOI: 10.1371/journal.pone.0221762] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
250 Marzano M, Bejoy J, Cheerathodi MR, Sun L, York SB, Zhao J, Kanekiyo T, Bu G, Meckes DG Jr, Li Y. Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids. Cells 2019;8:E993. [PMID: 31466320 DOI: 10.3390/cells8090993] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
251 Li S, Huang SQ, Zhao YX, Ding YJ, Ma DJ, Ding QR. Derivation and applications of human hepatocyte-like cells. World J Stem Cells 2019; 11(8): 535-547 [PMID: 31523372 DOI: 10.4252/wjsc.v11.i8.535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
252 Yiangou L, Ross ADB, Goh KJ, Vallier L. Human Pluripotent Stem Cell-Derived Endoderm for Modeling Development and Clinical Applications. Cell Stem Cell 2018;22:485-99. [PMID: 29625066 DOI: 10.1016/j.stem.2018.03.016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
253 Yasen A, Tuxun T, Apaer S, Li W, Maimaitinijiati Y, Wang H, Aisan M, Aji T, Shao Y, Hao W. Fetal liver stem cell transplantation for liver diseases. Regen Med 2019;14:703-14. [PMID: 31393226 DOI: 10.2217/rme-2018-0160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
254 Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology. Biochem Biophys Res Commun 2019;517:677-83. [PMID: 31402115 DOI: 10.1016/j.bbrc.2019.07.109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
255 Wills LR, Rajagopalan P. Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing. Ann Biomed Eng 2020;48:1045-57. [PMID: 31372857 DOI: 10.1007/s10439-019-02331-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
256 Song L, Yuan X, Jones Z, Vied C, Miao Y, Marzano M, Hua T, Sang QA, Guan J, Ma T, Zhou Y, Li Y. Functionalization of Brain Region-specific Spheroids with Isogenic Microglia-like Cells. Sci Rep 2019;9:11055. [PMID: 31363137 DOI: 10.1038/s41598-019-47444-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 18.8] [Reference Citation Analysis]
257 Fourrier A, Delbos F, Menoret S, Collet C, Thi Thuy LT, Myara A, Petit F, Tolosa L, Laplanche S, Gómez‐lechón MJ, Labrune P, Anegon I, Vallier L, Garnier D, Nguyen TH. Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells‐derived hepatic stem cells. Xenotransplantation 2020;27. [DOI: 10.1111/xen.12544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
258 Ye S, Boeter JWB, Penning LC, Spee B, Schneeberger K. Hydrogels for Liver Tissue Engineering. Bioengineering (Basel) 2019;6:E59. [PMID: 31284412 DOI: 10.3390/bioengineering6030059] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
259 Nakai S, Shibata I, Shitamichi T, Yamaguchi H, Takagi N, Inoue T, Nakagawa T, Kiyokawa J, Wakabayashi S, Miyoshi T, Higashi E, Ishida S, Shiraki N, Kume S. Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte-like cells. Biol Open 2019;8:bio042192. [PMID: 31182631 DOI: 10.1242/bio.042192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
260 Chen Y, Devalliere J, Bulutoglu B, Yarmush ML, Uygun BE. Repopulation of intrahepatic bile ducts in engineered rat liver grafts. Technology (Singap World Sci) 2019;7:46-55. [PMID: 31388515 DOI: 10.1142/S2339547819500043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
261 Pettinato G, Lehoux S, Ramanathan R, Salem MM, He LX, Muse O, Flaumenhaft R, Thompson MT, Rouse EA, Cummings RD, Wen X, Fisher RA. Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells. Sci Rep. 2019;9:8920. [PMID: 31222080 DOI: 10.1038/s41598-019-45514-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 19.5] [Reference Citation Analysis]
262 Axelrad DA, Setzer RW, Bateson TF, DeVito M, Dzubow RC, Fitzpatrick JW, Frame AM, Hogan KA, Houck K, Stewart M. Methods for evaluating variability in human health dose-response characterization. Hum Ecol Risk Assess 2019;25:1-24. [PMID: 31404325 DOI: 10.1080/10807039.2019.1615828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
263 Gupta H, Youn GS, Han SH, Shin MJ, Yoon SJ, Han DH, Lee NY, Kim DJ, Baik SK, Suk KT. Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis. J Clin Med 2019;8:E862. [PMID: 31212896 DOI: 10.3390/jcm8060862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
264 Wang J, Qu B, Zhang F, Zhang C, Deng W, Dao Thi VL, Xia Y. Stem Cell-Derived Hepatocyte-Like Cells as Model for Viral Hepatitis Research. Stem Cells Int 2019;2019:9605252. [PMID: 31281392 DOI: 10.1155/2019/9605252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
265 Yu Q, Wang Y, Cao X, Deng W, Adu Frimpong M, Yu J, Xu X. One-Step Formation of Chondrocytes through Direct Reprogramming via Polysaccharide-Based Gene Delivery. Advances in Polymer Technology 2019;2019:1-12. [DOI: 10.1155/2019/7632873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
266 Coronado RE, Somaraki-Cormier M, Ong JL, Halff GA. Hepatocyte-like cells derived from human amniotic epithelial, bone marrow, and adipose stromal cells display enhanced functionality when cultured on decellularized liver substrate. Stem Cell Res 2019;38:101471. [PMID: 31163390 DOI: 10.1016/j.scr.2019.101471] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
267 Mazzacuva F, Lorvellec M, Cilibrizzi A, Mills K, Clayton P, Gissen P. Measurement of Bile Acids as a Marker of the Functionality of iPSC-Derived Hepatocytes. Methods Mol Biol 2019;1994:141-7. [PMID: 31124111 DOI: 10.1007/978-1-4939-9477-9_12] [Reference Citation Analysis]
268 Ang LT, Tan AKY, Autio MI, Goh SH, Choo SH, Lee KL, Tan J, Pan B, Lee JJH, Lum JJ, Lim CYY, Yeo IKX, Wong CJY, Liu M, Oh JLL, Chia CPL, Loh CH, Chen A, Chen Q, Weissman IL, Loh KM, Lim B. A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells. Cell Rep 2018;22:2190-205. [PMID: 29466743 DOI: 10.1016/j.celrep.2018.01.087] [Cited by in Crossref: 108] [Cited by in F6Publishing: 78] [Article Influence: 27.0] [Reference Citation Analysis]
269 Wang Y, Tatham MH, Schmidt-Heck W, Swann C, Singh-Dolt K, Meseguer-Ripolles J, Lucendo-Villarin B, Kunath T, Rudd TR, Smith AJH, Hengstler JG, Godoy P, Hay RT, Hay DC. Multiomics Analyses of HNF4α Protein Domain Function during Human Pluripotent Stem Cell Differentiation. iScience 2019;16:206-17. [PMID: 31185456 DOI: 10.1016/j.isci.2019.05.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
270 Hurrell T, Segeritz CP, Vallier L, Lilley KS, Cromarty AD. Proteomic Comparison of Various Hepatic Cell Cultures for Preclinical Safety Pharmacology. Toxicol Sci 2018;164:229-39. [PMID: 29635369 DOI: 10.1093/toxsci/kfy084] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
271 Yovchev MI, Lee EJ, Rodriguez-Silva W, Locker J, Oertel M. Biliary Obstruction Promotes Multilineage Differentiation of Hepatic Stem Cells. Hepatol Commun 2019;3:1137-50. [PMID: 31388633 DOI: 10.1002/hep4.1367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
272 Hwang SI, Kwak TH, Kang JH, Kim J, Lee H, Kim KP, Ko K, Schöler HR, Han DW. Metastable Reprogramming State of Single Transcription Factor-Derived Induced Hepatocyte-Like Cells. Stem Cells Int 2019;2019:6937257. [PMID: 31089332 DOI: 10.1155/2019/6937257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
273 Torizal FG, Kimura K, Horiguchi I, Sakai Y. Size-dependent hepatic differentiation of human induced pluripotent stem cells spheroid in suspension culture. Regen Ther 2019;12:66-73. [PMID: 31890768 DOI: 10.1016/j.reth.2019.04.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
274 Rossi EA, Quintanilha LF, Nonaka CKV, Souza BSF. Advances in Hepatic Tissue Bioengineering with Decellularized Liver Bioscaffold. Stem Cells Int 2019;2019:2693189. [PMID: 31198426 DOI: 10.1155/2019/2693189] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
275 Grindheim JM, Nicetto D, Donahue G, Zaret KS. Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice. Gastroenterology 2019;156:1834-48. [PMID: 30689973 DOI: 10.1053/j.gastro.2019.01.041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
276 Unzu C, Planet E, Brandenberg N, Fusil F, Cassano M, Perez-Vargas J, Friedli M, Cosset FL, Lutolf MP, Wildhaber BE, Trono D. Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes. Hepatology 2019;69:2214-31. [PMID: 30549291 DOI: 10.1002/hep.30425] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
277 Regier MC, Tokar JJ, Warrick JW, Pabon L, Berthier E, Beebe DJ, Stevens KR. User-defined morphogen patterning for directing human cell fate stratification. Sci Rep 2019;9:6433. [PMID: 31015521 DOI: 10.1038/s41598-019-42874-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
278 Broda TR, McCracken KW, Wells JM. Generation of human antral and fundic gastric organoids from pluripotent stem cells. Nat Protoc 2019;14:28-50. [PMID: 30470820 DOI: 10.1038/s41596-018-0080-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 10.8] [Reference Citation Analysis]
279 Holloway EM, Capeling MM, Spence JR. Biologically inspired approaches to enhance human organoid complexity. Development 2019;146:dev166173. [PMID: 30992275 DOI: 10.1242/dev.166173] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 14.0] [Reference Citation Analysis]
280 Song L, Yuan X, Jones Z, Griffin K, Zhou Y, Ma T, Li Y. Assembly of Human Stem Cell-Derived Cortical Spheroids and Vascular Spheroids to Model 3-D Brain-like Tissues. Sci Rep 2019;9:5977. [PMID: 30979929 DOI: 10.1038/s41598-019-42439-9] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 18.5] [Reference Citation Analysis]
281 Danoy M, Bernier ML, Kimura K, Poulain S, Kato S, Mori D, Kido T, Plessy C, Kusuhara H, Miyajima A, Sakai Y, Leclerc E. Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment. Biotechnology and Bioengineering 2019;116:1762-76. [DOI: 10.1002/bit.26970] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
282 Okada H, Nakanishi C, Yoshida S, Shimojima M, Yokawa J, Mori M, Tada H, Yoshimuta T, Hayashi K, Yamano T, Hanayama R, Yamagishi M, Kawashiri MA. Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia. Sci Rep 2019;9:4695. [PMID: 30886174 DOI: 10.1038/s41598-019-41056-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
283 Sánchez-Romero N, Sainz-Arnal P, Pla-Palacín I, Dachary PR, Almeida H, Pastor C, Soto DR, Rodriguez MC, Arbizu EO, Martinez LB, Serrano-Aulló T, Baptista PM. The role of extracellular matrix on liver stem cell fate: A dynamic relationship in health and disease. Differentiation 2019;106:49-56. [PMID: 30878881 DOI: 10.1016/j.diff.2019.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
284 Toba Y, Kiso A, Nakamae S, Sakurai F, Takayama K, Mizuguchi H. FGF signal is not required for hepatoblast differentiation of human iPS cells. Sci Rep 2019;9:3713. [PMID: 30842525 DOI: 10.1038/s41598-019-40305-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
285 Viiri LE, Rantapero T, Kiamehr M, Alexanova A, Oittinen M, Viiri K, Niskanen H, Nykter M, Kaikkonen MU, Aalto-Setälä K. Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation. Sci Rep 2019;9:3562. [PMID: 30837492 DOI: 10.1038/s41598-019-39215-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
286 Blau BJ, Miki T. The role of cellular interactions in the induction of hepatocyte polarity and functional maturation in stem cell-derived hepatic cells. Differentiation. 2019;106:42-48. [PMID: 30878880 DOI: 10.1016/j.diff.2019.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
287 Heslop JA, Duncan SA. The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease. Hepatology 2019;69:1306-16. [PMID: 30251414 DOI: 10.1002/hep.30288] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
288 Hurrell T, Segeritz CP, Vallier L, Lilley KS, Cromarty AD. A proteomic time course through the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. Sci Rep 2019;9:3270. [PMID: 30824743 DOI: 10.1038/s41598-019-39400-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
289 Torizal FG, Horiguchi I, Sakai Y. Physiological Microenvironmental Conditions in Different Scalable Culture Systems for Pluripotent Stem Cell Expansion and Differentiation. TOBEJ 2019;13:41-54. [DOI: 10.2174/1874120701913010041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
290 Wang J, Sun M, Liu W, Li Y, Li M. Stem Cell-Based Therapies for Liver Diseases: An Overview and Update. Tissue Eng Regen Med 2019;16:107-18. [PMID: 30989038 DOI: 10.1007/s13770-019-00178-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
291 Miyoshi M, Kakinuma S, Kamiya A, Tsunoda T, Tsuchiya J, Sato A, Kaneko S, Nitta S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Nakauchi H, Asahina Y, Watanabe M. LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. Sci Rep 2019;9:2072. [PMID: 30765795 DOI: 10.1038/s41598-018-37430-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
292 Matsui S, Ochiai M, Yasuda K, Mae SI, Kotaka M, Toyoda T, Yamamoto T, Osafune K. Differentiation and isolation of iPSC-derived remodeling ductal plate-like cells by use of an AQP1-GFP reporter human iPSC line. Stem Cell Res 2019;35:101400. [PMID: 30735882 DOI: 10.1016/j.scr.2019.101400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
293 Yan Y, Bejoy J, Xia J, Griffin K, Guan J, Li Y. Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells. Sci Rep 2019;9:1295. [PMID: 30718597 DOI: 10.1038/s41598-018-37686-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
294 Fabre KM, Delsing L, Hicks R, Colclough N, Crowther DC, Ewart L. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting. Adv Drug Deliv Rev 2019;140:129-35. [PMID: 30253201 DOI: 10.1016/j.addr.2018.09.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
295 Lereau Bernier M, Poulain S, Tauran Y, Danoy M, Shinohara M, Kimura K, Segard BD, Kato S, Kido T, Miyajima A, Sakai Y, Plessy C, Leclerc É. Profiling of derived-hepatocyte progenitors from induced pluripotent stem cells using nanoCAGE promoter analysis. Biochemical Engineering Journal 2019;142:7-17. [DOI: 10.1016/j.bej.2018.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
296 Raasch M, Fritsche E, Kurtz A, Bauer M, Mosig AS. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development. Adv Drug Deliv Rev 2019;140:51-67. [PMID: 29908880 DOI: 10.1016/j.addr.2018.06.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
297 Inagaki NF, Inagaki FF, Kokudo N, Miyajima A. Generation of mesothelial progenitor-like cells from mouse-induced pluripotent stem cells. FEBS Lett 2019;593:386-94. [PMID: 30609020 DOI: 10.1002/1873-3468.13325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
298 Gnecchi M, Ciuffreda MC, Mura M. Mesenchymal Stromal Cell Secretome for Tissue Repair. Cell Engineering and Regeneration 2019. [DOI: 10.1007/978-3-319-37076-7_43-1] [Reference Citation Analysis]
299 Tauran Y, Poulain S, Lereau-bernier M, Danoy M, Shinohara M, Segard B, Kato S, Kido T, Miyajima A, Sakai Y, Plessy C, Leclerc E. Analysis of the transcription factors and their regulatory roles during a step-by-step differentiation of induced pluripotent stem cells into hepatocyte-like cells. Mol Omics 2019;15:383-98. [DOI: 10.1039/c9mo00122k] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
300 Chen Z, Xi D, Chen T, Yang D, Mao Y. Research Methods and Techniques for Acute Exacerbation of Chronic Hepatitis B. Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1606-0_2] [Reference Citation Analysis]
301 Chen HS, Yang J, Nyberg SL. Acute Liver Failure and Bioartificial Liver Support. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00128-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
302 Kido T, Koui Y. Induction of Functional Hepatocytes from Human iPSCs. Methods in Molecular Biology 2019. [DOI: 10.1007/978-1-4939-8961-4_12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
303 Tidball AM. Disease in a Dish: Cellular Models to Understand Human Conditions. Cellular and Animal Models in Human Genomics Research 2019. [DOI: 10.1016/b978-0-12-816573-7.00002-x] [Reference Citation Analysis]
304 Zhavoronkov A, Mamoshina P, Vanhaelen Q, Scheibye-Knudsen M, Moskalev A, Aliper A. Artificial intelligence for aging and longevity research: Recent advances and perspectives. Ageing Res Rev 2019;49:49-66. [PMID: 30472217 DOI: 10.1016/j.arr.2018.11.003] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 19.0] [Reference Citation Analysis]
305 Paganelli M. Cell Therapy in Acute and Chronic Liver Disease. Pediatric Hepatology and Liver Transplantation 2019. [DOI: 10.1007/978-3-319-96400-3_43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
306 Kim J, Kim Y, Choi J, Jung H, Lee K, Kang J, Park N, Rim YA, Nam Y, Ju JH. Recapitulation of methotrexate hepatotoxicity with induced pluripotent stem cell-derived hepatocytes from patients with rheumatoid arthritis. Stem Cell Res Ther 2018;9:357. [PMID: 30594247 DOI: 10.1186/s13287-018-1100-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
307 DeLaForest A, Di Furio F, Jing R, Ludwig-Kubinski A, Twaroski K, Urick A, Pulakanti K, Rao S, Duncan SA. HNF4A Regulates the Formation of Hepatic Progenitor Cells from Human iPSC-Derived Endoderm by Facilitating Efficient Recruitment of RNA Pol II. Genes (Basel) 2018;10:E21. [PMID: 30597922 DOI: 10.3390/genes10010021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
308 Kimura K, Horiguchi I, Kido T, Miyajima A, Sakai Y. Enhanced Hepatic Differentiation of Human Induced Pluripotent Stem Cells Using Gas-Permeable Membrane. Tissue Eng Part A 2019;25:457-67. [PMID: 30141379 DOI: 10.1089/ten.TEA.2018.0084] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
309 Haslund D, Ryø LB, Seidelin Majidi S, Rose I, Skipper KA, Fryland T, Bohn AB, Koch C, Thomsen MK, Palarasah Y, Corydon TJ, Bygum A, Nejsum LN, Mikkelsen JG. Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema. J Clin Invest 2019;129:388-405. [PMID: 30398465 DOI: 10.1172/JCI98869] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
310 Gouliarmou V, Lostia AM, Coecke S, Bernasconi C, Bessems J, Dorne JL, Ferguson S, Testai E, Remy UG, Brian Houston J, Monshouwer M, Nong A, Pelkonen O, Morath S, Wetmore BA, Worth A, Zanelli U, Zorzoli MC, Whelan M. Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance. Toxicology in Vitro 2018;53:233-44. [DOI: 10.1016/j.tiv.2018.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
311 Sung JH, Wang YI, Kim JH, Lee JM, Shuler ML. Application of chemical reaction engineering principles to 'body-on-a-chip' systems. AIChE J 2018;64:4351-60. [PMID: 31402795 DOI: 10.1002/aic.16448] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
312 Yang Y, Li X, Liu W, Chen J, Liu C, Cai Y, Song Y, Tang Q, Zhang C, He Z. Generation of Hepatocyte-Like Cells by Different Strategies for Liver Regeneration. Nano LIFE 2018;08:1841004. [DOI: 10.1142/s1793984418410040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
313 Vanova T, Raska J, Babica P, Sovadinova I, Kunova Bosakova M, Dvorak P, Blaha L, Rotrekl V. Freshwater Cyanotoxin Cylindrospermopsin Has Detrimental Stage-specific Effects on Hepatic Differentiation From Human Embryonic Stem Cells. Toxicological Sciences 2019;168:241-51. [DOI: 10.1093/toxsci/kfy293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
314 Barahman M, Asp P, Roy-Chowdhury N, Kinkhabwala M, Roy-Chowdhury J, Kabarriti R, Guha C. Hepatocyte Transplantation: Quo Vadis? Int J Radiat Oncol Biol Phys 2019;103:922-34. [PMID: 30503786 DOI: 10.1016/j.ijrobp.2018.11.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
315 Blackford SJI, Ng SS, Segal JM, King AJF, Austin AL, Kent D, Moore J, Sheldon M, Ilic D, Dhawan A, Mitry RR, Rashid ST. Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell-Derived Hepatocytes for Cell-Based Therapy. Stem Cells Transl Med 2019;8:124-37. [PMID: 30456803 DOI: 10.1002/sctm.18-0084] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
316 Bejoy J, Wang Z, Bijonowski B, Yang M, Ma T, Sang QX, Li Y. Differential Effects of Heparin and Hyaluronic Acid on Neural Patterning of Human Induced Pluripotent Stem Cells. ACS Biomater Sci Eng 2018;4:4354-66. [PMID: 31572767 DOI: 10.1021/acsbiomaterials.8b01142] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
317 Hu H, Gehart H, Artegiani B, Löpez-iglesias C, Dekkers F, Basak O, van Es J, Chuva de Sousa Lopes SM, Begthel H, Korving J, van den Born M, Zou C, Quirk C, Chiriboga L, Rice CM, Ma S, Rios A, Peters PJ, de Jong YP, Clevers H. Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids. Cell 2018;175:1591-1606.e19. [DOI: 10.1016/j.cell.2018.11.013] [Cited by in Crossref: 320] [Cited by in F6Publishing: 340] [Article Influence: 64.0] [Reference Citation Analysis]
318 Wang Y, Wang H, Deng P, Chen W, Guo Y, Tao T, Qin J. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab Chip 2018;18:3606-16. [PMID: 30357207 DOI: 10.1039/c8lc00869h] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 19.8] [Reference Citation Analysis]
319 Mitra A, Yan J, Zhang L, Li S. A small molecule Hedgehog agonist HhAg1.5 mediated reprogramming breaks the quiescence of noninjured liver stem cells for rescuing liver failure. Transl Res 2019;205:44-50. [PMID: 30399369 DOI: 10.1016/j.trsl.2018.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
320 Yamamoto J, Udono M, Miura S, Sekiya S, Suzuki A. Cell Aggregation Culture Induces Functional Differentiation of Induced Hepatocyte-like Cells through Activation of Hippo Signaling. Cell Reports 2018;25:183-98. [DOI: 10.1016/j.celrep.2018.09.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
321 Gaignerie A, Lefort N, Rousselle M, Forest-Choquet V, Flippe L, Francois-Campion V, Girardeau A, Caillaud A, Chariau C, Francheteau Q, Derevier A, Chaubron F, Knöbel S, Gaborit N, Si-Tayeb K, David L. Urine-derived cells provide a readily accessible cell type for feeder-free mRNA reprogramming. Sci Rep 2018;8:14363. [PMID: 30254308 DOI: 10.1038/s41598-018-32645-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
322 Matoba N, Yamashita T, Takayama K, Sakurai F, Mizuguchi H. Optimal human iPS cell culture method for efficient hepatic differentiation. Differentiation 2018;104:13-21. [PMID: 30273675 DOI: 10.1016/j.diff.2018.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
323 Sasaki E, Mizukami T, Hamaguchi I. Genomic Approaches Enable Evaluation of the Safety and Quality of Influenza Vaccines and Adjuvants. Influenza - Therapeutics and Challenges 2018. [DOI: 10.5772/intechopen.76361] [Reference Citation Analysis]
324 Kaserman JE, Wilson AA. Patient-Derived Induced Pluripotent Stem Cells for Alpha-1 Antitrypsin Deficiency Disease Modeling and Therapeutic Discovery. Chronic Obstr Pulm Dis 2018;5:258-66. [PMID: 30723783 DOI: 10.15326/jcopdf.5.4.2017.0179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
325 Li H, Zhu L, Chen H, Li T, Han Q, Wang S, Yao X, Feng H, Fan L, Gao S, Boyd R, Cao X, Zhu P, Li J, Keating A, Su X, Zhao RC. Generation of Functional Hepatocytes from Human Adipose-Derived MYC+ KLF4+ GMNN+ Stem Cells Analyzed by Single-Cell RNA-Seq Profiling. Stem Cells Transl Med 2018;7:792-805. [PMID: 30272835 DOI: 10.1002/sctm.17-0273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
326 Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases. Biochim Biophys Acta Mol Basis Dis 2019;1865:920-8. [PMID: 30264693 DOI: 10.1016/j.bbadis.2018.08.038] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
327 Han W, Wu Q, Zhang X, Duan Z. Innovation for hepatotoxicity in vitro research models: A review: Innovation for hepatotoxicity in vitro research models. J Appl Toxicol 2019;39:146-62. [DOI: 10.1002/jat.3711] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
328 Kiamehr M, Alexanova A, Viiri LE, Heiskanen L, Vihervaara T, Kauhanen D, Ekroos K, Laaksonen R, Käkelä R, Aalto-Setälä K. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver. J Cell Physiol 2019;234:3744-61. [PMID: 30146765 DOI: 10.1002/jcp.27131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
329 Kamiya A, Chikada H, Ida K, Ando E, Tsuruya K, Kagawa T, Inagaki Y. An in vitro model of polycystic liver disease using genome-edited human inducible pluripotent stem cells. Stem Cell Res 2018;32:17-24. [PMID: 30172093 DOI: 10.1016/j.scr.2018.08.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
330 Xu Z, He X, Shi X, Xia Y, Liu X, Wu H, Li P, Zhang H, Yin W, Du X, Li L, Li Y. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes. Stem Cell Res Ther 2018;9:211. [PMID: 30092828 DOI: 10.1186/s13287-018-0940-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
331 Takebe T, Sekine K, Kimura M, Yoshizawa E, Ayano S, Koido M, Funayama S, Nakanishi N, Hisai T, Kobayashi T, Kasai T, Kitada R, Mori A, Ayabe H, Ejiri Y, Amimoto N, Yamazaki Y, Ogawa S, Ishikawa M, Kiyota Y, Sato Y, Nozawa K, Okamoto S, Ueno Y, Taniguchi H. Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells. Cell Rep. 2017;21:2661-2670. [PMID: 29212014 DOI: 10.1016/j.celrep.2017.11.005] [Cited by in Crossref: 204] [Cited by in F6Publishing: 210] [Article Influence: 40.8] [Reference Citation Analysis]
332 Leyendecker Junior A. TGF-β Inhibitor SB431542 Promotes the Differentiation of Induced Pluripotent Stem Cells and Embryonic Stem Cells into Mesenchymal-Like Cells. Stem Cells Int 2018;2018:7878201. [PMID: 30057627 DOI: 10.1155/2018/7878201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
333 Bejoy J, Song L, Wang Z, Sang QX, Zhou Y, Li Y. Neuroprotective Activities of Heparin, Heparinase III, and Hyaluronic Acid on the Aβ42-Treated Forebrain Spheroids Derived from Human Stem Cells. ACS Biomater Sci Eng 2018;4:2922-33. [PMID: 30533518 DOI: 10.1021/acsbiomaterials.8b00021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
334 Kvist AJ, Kanebratt KP, Walentinsson A, Palmgren H, O'Hara M, Björkbom A, Andersson LC, Ahlqvist M, Andersson TB. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines. Biochem Pharmacol 2018;155:124-40. [PMID: 29953844 DOI: 10.1016/j.bcp.2018.06.026] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
335 Smutný T, Harjumäki R, Kanninen L, Yliperttula M, Pávek P, Lou YR. A feasibility study of the toxic responses of human induced pluripotent stem cell-derived hepatocytes to phytochemicals. Toxicol In Vitro 2018;52:94-105. [PMID: 29902661 DOI: 10.1016/j.tiv.2018.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
336 Lancett P, Williamson B, Barton P, Riley RJ. Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug Discovery. Drug Metab Dispos 2018;46:1169-78. [PMID: 29880630 DOI: 10.1124/dmd.118.081596] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
337 Raju R, Chau D, Notelaers T, Myers CL, Verfaillie CM, Hu WS. In Vitro Pluripotent Stem Cell Differentiation to Hepatocyte Ceases Further Maturation at an Equivalent Stage of E15 in Mouse Embryonic Liver Development. Stem Cells Dev 2018;27:910-21. [PMID: 29851366 DOI: 10.1089/scd.2017.0270] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
338 Li S, Li M, Liu X, Yang Y, Wei Y, Chen Y, Qiu Y, Zhou T, Feng Z, Ma D, Fang J, Ying H, Wang H, Musunuru K, Shao Z, Zhao Y, Ding Q. Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells. Stem Cell Reports. 2018;11:22-31. [PMID: 29861165 DOI: 10.1016/j.stemcr.2018.05.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
339 Song L, Ahmed MF, Li Y, Zeng C, Li Y. Vascular differentiation from pluripotent stem cells in 3-D auxetic scaffolds. J Tissue Eng Regen Med 2018;12:1679-89. [PMID: 29749038 DOI: 10.1002/term.2695] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
340 Schepers A, Li C, Chhabra A, Seney BT, Bhatia S. Engineering a perfusable 3D human liver platform from iPS cells. Lab Chip. 2016;16:2644-2653. [PMID: 27296616 DOI: 10.1039/c6lc00598e] [Cited by in Crossref: 121] [Cited by in F6Publishing: 98] [Article Influence: 24.2] [Reference Citation Analysis]
341 Garnier D, Li R, Delbos F, Fourrier A, Collet C, Guguen-Guillouzo C, Chesné C, Nguyen TH. Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system. Sci Rep 2018;8:8222. [PMID: 29844473 DOI: 10.1038/s41598-018-26584-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
342 Liu JT, Lamprecht MP, Duncan SA. Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery. J Vis Exp 2018. [PMID: 29863663 DOI: 10.3791/57194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
343 Sambathkumar R, Akkerman R, Dastidar S, Roelandt P, Kumar M, Bajaj M, Mestre Rosa AR, Helsen N, Vanslembrouck V, Kalo E, Khurana S, Laureys J, Gysemans C, Faas MM, de Vos P, Verfaillie CM. Generation of hepatocyte- and endocrine pancreatic-like cells from human induced endodermal progenitor cells. PLoS One 2018;13:e0197046. [PMID: 29750821 DOI: 10.1371/journal.pone.0197046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
344 Lim KT, Kim J, Hwang SI, Zhang L, Han H, Bae D, Kim KP, Hu YP, Schöler HR, Lee I, Hui L, Han DW. Direct Conversion of Mouse Fibroblasts into Cholangiocyte Progenitor Cells. Stem Cell Reports 2018;10:1522-36. [PMID: 29606616 DOI: 10.1016/j.stemcr.2018.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
345 Prokop JW, May T, Strong K, Bilinovich SM, Bupp C, Rajasekaran S, Worthey EA, Lazar J. Genome sequencing in the clinic: the past, present, and future of genomic medicine. Physiol Genomics. 2018;50:563-579. [PMID: 29727589 DOI: 10.1152/physiolgenomics.00046.2018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
346 Kulkarni S, Rudnick DA. Induced Pluripotent Stem Cell-Derived Hepatocytes and Precision Medicine in Human Liver Disease. J Pediatr Gastroenterol Nutr 2018;66:716-9. [PMID: 29509632 DOI: 10.1097/MPG.0000000000001948] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
347 Kehtari M, Zeynali B, Soleimani M, Kabiri M, Seyedjafari E. Fabrication of a co-culture micro-bioreactor device for efficient hepatic differentiation of human induced pluripotent stem cells (hiPSCs). Artificial Cells, Nanomedicine, and Biotechnology 2018;46:161-70. [DOI: 10.1080/21691401.2018.1452753] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
348 Lee CA, Sinha S, Fitzpatrick E, Dhawan A. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine. J Mol Med (Berl) 2018;96:469-81. [PMID: 29691598 DOI: 10.1007/s00109-018-1638-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
349 Parisi S, Polishchuk EV, Allocca S, Ciano M, Musto A, Gallo M, Perone L, Ranucci G, Iorio R, Polishchuk RS, Bonatti S. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells. Sci Rep 2018;8:6247. [PMID: 29674751 DOI: 10.1038/s41598-018-24717-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
350 Erdei Z, Schamberger A, Török G, Szebényi K, Várady G, Orbán TI, Homolya L, Sarkadi B, Apáti Á. Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells. PLoS One 2018;13:e0194925. [PMID: 29649238 DOI: 10.1371/journal.pone.0194925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
351 Blackford SJI, Ng SS, Segal JM, King AJF, Moore J, Sheldon M, Ilic D, Dhawan A, Mitry R, Rashid ST. Validation of a library of cGMP-compliant human pluripotent stem cell lines for use in liver therapy.. [DOI: 10.1101/298760] [Reference Citation Analysis]
352 Lyu C, Shen J, Wang R, Gu H, Zhang J, Xue F, Liu X, Liu W, Fu R, Zhang L, Li H, Zhang X, Cheng T, Yang R, Zhang L. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system. Stem Cell Res Ther. 2018;9:92. [PMID: 29625575 DOI: 10.1186/s13287-018-0839-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
353 Starokozhko V, Hemmingsen M, Larsen L, Mohanty S, Merema M, Pimentel RC, Wolff A, Emnéus J, Aspegren A, Groothuis G, Dufva M. Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering. J Tissue Eng Regen Med 2018;12:1273-84. [PMID: 29499107 DOI: 10.1002/term.2659] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
354 Chen C, Soto-Gutierrez A, Baptista PM, Spee B. Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells. Gastroenterology 2018;154:1258-72. [PMID: 29428334 DOI: 10.1053/j.gastro.2018.01.066] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 11.6] [Reference Citation Analysis]
355 Asumda FZ, Hatzistergos KE, Dykxhoorn DM, Jakubski S, Edwards J, Thomas E, Schiff ER. Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules. Differentiation 2018;101:16-24. [PMID: 29626713 DOI: 10.1016/j.diff.2018.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
356 Hanawa M, Takayama K, Sakurai F, Tachibana M, Mizuguchi H. Hepatocyte Nuclear Factor 4 Alpha Promotes Definitive Endoderm Differentiation from Human Induced Pluripotent Stem Cells. Stem Cell Rev. 2017;13:542-551. [PMID: 28000155 DOI: 10.1007/s12015-016-9709-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
357 Khazali AS, Clark AM, Wells A. A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms. Stem Cell Rev Rep 2017;13:364-80. [PMID: 28425064 DOI: 10.1007/s12015-017-9735-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
358 Du C, Feng Y, Qiu D, Xu Y, Pang M, Cai N, Xiang AP, Zhang Q. Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails. Stem Cell Res Ther 2018;9:58. [PMID: 29523187 DOI: 10.1186/s13287-018-0794-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 9.2] [Reference Citation Analysis]
359 Yasuda SY, Ikeda T, Shahsavarani H, Yoshida N, Nayer B, Hino M, Vartak-Sharma N, Suemori H, Hasegawa K. Chemically defined and growth-factor-free culture system for the expansion and derivation of human pluripotent stem cells. Nat Biomed Eng 2018;2:173-82. [PMID: 31015717 DOI: 10.1038/s41551-018-0200-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
360 Schöbel A, Rösch K, Herker E. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes. Sci Rep 2018;8:3893. [PMID: 29497123 DOI: 10.1038/s41598-018-22243-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
361 Yan Y, Song L, Bejoy J, Zhao J, Kanekiyo T, Bu G, Zhou Y, Li Y. Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells. Tissue Eng Part A 2018;24:1125-37. [PMID: 29361890 DOI: 10.1089/ten.TEA.2017.0423] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
362 Morozov VA, Lagaye S. Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol 2018; 10(2): 186-212 [PMID: 29527256 DOI: 10.4254/wjh.v10.i2.186] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 14.4] [Reference Citation Analysis]
363 Du C, Jiang M, Wei X, Qin J, Xu H, Wang Y, Zhang Y, Zhou D, Xue H, Zheng S, Zeng W. Transplantation of human matrix metalloproteinase-1 gene-modified bone marrow-derived mesenchymal stem cell attenuates CCL4-induced liver fibrosis in rats. Int J Mol Med. 2018;41:3175-3184. [PMID: 29512750 DOI: 10.3892/ijmm.2018.3516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
364 Nakamae S, Toba Y, Takayama K, Sakurai F, Mizuguchi H. Nanaomycin A Treatment Promotes Hepatoblast Differentiation from Human iPS Cells. Stem Cells Dev 2018;27:405-14. [PMID: 29378471 DOI: 10.1089/scd.2017.0251] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
365 Siller R, Sullivan GJ. Rapid Screening of the Endodermal Differentiation Potential of Human Pluripotent Stem Cells. Current Protocols in Stem Cell Biology 2017;43. [DOI: 10.1002/cpsc.36] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
366 Luo X, Gupta K, Ananthanarayanan A, Wang Z, Xia L, Li A, Sakban RB, Liu S, Yu H. Directed Differentiation of Adult Liver Derived Mesenchymal Like Stem Cells into Functional Hepatocytes. Sci Rep 2018;8:2818. [PMID: 29434311 DOI: 10.1038/s41598-018-20304-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
367 Fu X, Jiang B, Zheng B, Yan Y, Wang J, Duan Y, Li S, Yan L, Wang H, Chen B, Sang X, Ji W, Xu RH, Si W. Heterogenic transplantation of bone marrow-derived rhesus macaque mesenchymal stem cells ameliorates liver fibrosis induced by carbon tetrachloride in mouse. PeerJ. 2018;6:e4336. [PMID: 29456886 DOI: 10.7717/peerj.4336] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
368 Mizumoto H, Shirakigawa N, Ijima H. Current Status and New Challenges of the Artificial Liver. Biomedical Engineering Challenges 2018. [DOI: 10.1002/9781119296034.ch3] [Reference Citation Analysis]
369 Kwak KA, Cho HJ, Yang JY, Park YS. Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis. Can J Gastroenterol Hepatol. 2018;2018:4197857. [PMID: 29670867 DOI: 10.1155/2018/4197857] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
370 Mah N, Taškova K, El Amrani K, Hariharan K, Kurtz A, Andrade-navarro MA. Evaluating Cell Identity from Transcription Profiles.. [DOI: 10.1101/250431] [Reference Citation Analysis]
371 Takayama K, Hagihara Y, Toba Y, Sekiguchi K, Sakurai F, Mizuguchi H. Enrichment of high-functioning human iPS cell-derived hepatocyte-like cells for pharmaceutical research. Biomaterials 2018;161:24-32. [PMID: 29421559 DOI: 10.1016/j.biomaterials.2018.01.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 7.4] [Reference Citation Analysis]
372 Nie YZ, Zheng YW, Ogawa M, Miyagi E, Taniguchi H. Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure. Stem Cell Res Ther. 2018;9:5. [PMID: 29321049 DOI: 10.1186/s13287-017-0749-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
373 Lin R, Wang Y, Ji K, Liu Z, Xiao S, Zhou D, Chen Q, Shi B. Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes. Mol Med Rep 2018;17:4351-9. [PMID: 29328449 DOI: 10.3892/mmr.2018.8385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
374 Song L, Tsai AC, Yuan X, Bejoy J, Sart S, Ma T, Li Y. Neural Differentiation of Spheroids Derived from Human Induced Pluripotent Stem Cells-Mesenchymal Stem Cells Coculture. Tissue Eng Part A 2018;24:915-29. [PMID: 29160172 DOI: 10.1089/ten.TEA.2017.0403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
375 Wong MW, Pridgeon CS, Schlott C, Park BK, Goldring CEP. Status and Use of Induced Pluripotent Stem Cells (iPSCs) in Toxicity Testing. Methods in Pharmacology and Toxicology 2018. [DOI: 10.1007/978-1-4939-7677-5_10] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
376 Nishina T, Hoshikawa KT, Ueno Y. Current Cell-Based Therapies in the Chronic Liver Diseases. Adv Exp Med Biol 2018;1103:243-53. [PMID: 30484233 DOI: 10.1007/978-4-431-56847-6_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
377 Wang YI, Carmona C, Hickman JJ, Shuler ML. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges. Adv Healthc Mater 2018;7. [PMID: 29205920 DOI: 10.1002/adhm.201701000] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
378 Xu Y, Zhang Q. Clinical Application of Stem Cells in Liver Diseases: From Bench to Bedside. Stem Cells and Cancer in Hepatology 2018. [DOI: 10.1016/b978-0-12-812301-0.00015-3] [Reference Citation Analysis]
379 O’brien S, Park Y, Azarin S, Hu W. Cell Culture Bioprocess Technology: Biologics and Beyond. Cell Culture Technology 2018. [DOI: 10.1007/978-3-319-74854-2_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
380 Huang P, Chen Q. Generation of Hepatocytes by Transdifferentiation. Stem Cells and Cancer in Hepatology 2018. [DOI: 10.1016/b978-0-12-812301-0.00006-2] [Reference Citation Analysis]
381 Hosaka K, Katsuda T, Terai S, Ochiya T. Exploration for Cell Sources for Liver Regenerative Medicine: “CLiP” as a Dawn of Cell Transplantation Therapy. Stem Cells and Cancer in Hepatology 2018. [DOI: 10.1016/b978-0-12-812301-0.00005-0] [Reference Citation Analysis]
382 Horiguchi I, Urabe Y, Kimura K, Sakai Y. Effects of glucose, lactate and basic FGF as limiting factors on the expansion of human induced pluripotent stem cells. Journal of Bioscience and Bioengineering 2018;125:111-5. [DOI: 10.1016/j.jbiosc.2017.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
383 Mishra A, Verma M. Therapeutic Aspects of Stem Cells in Regenerative Medicine. Omics Technologies and Bio-Engineering 2018. [DOI: 10.1016/b978-0-12-804659-3.00021-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
384 Jafarpour Z, Soleimani M, Hosseinkhani S, M H MH, Yaghmaei P, Mobarra N, Geramizadeh B. Efficient Production of Hepatocyte-like Cells from Human-induced Pluripotent Stem Cells by Optimizing Growth Factors. Int J Organ Transplant Med 2018;9:77-87. [PMID: 30834092] [Reference Citation Analysis]
385 Herrera B, Addante A, Sánchez A. BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration. Int J Mol Sci 2017;19:E39. [PMID: 29295498 DOI: 10.3390/ijms19010039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
386 Meseguer-Ripolles J, Khetani SR, Blanco JG, Iredale M, Hay DC. Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety. AAPS J 2017;20:20. [PMID: 29270863 DOI: 10.1208/s12248-017-0171-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
387 Ji M, Hu K. Recent advances in the study of hepatitis B virus covalently closed circular DNA. Virol Sin. 2017;32:454-464. [PMID: 29280054 DOI: 10.1007/s12250-017-4009-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
388 Kamei K, Yoshioka M, Terada S, Tokunaga Y, Chen Y. Three-dimensional cultured Liver-on-a-Chip with mature hepatocyte-like cells derived from human pluripotent stem cells.. [DOI: 10.1101/232215] [Reference Citation Analysis]
389 Takahashi Y, Sato S, Kurashima Y, Yamamoto T, Kurokawa S, Yuki Y, Takemura N, Uematsu S, Lai CY, Otsu M, Matsuno H, Osawa H, Mizushima T, Nishimura J, Hayashi M, Yamaguchi T, Kiyono H. A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids. Stem Cell Reports. 2018;10:314-328. [PMID: 29233552 DOI: 10.1016/j.stemcr.2017.11.004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
390 Grompe M. Fah Knockout Animals as Models for Therapeutic Liver Repopulation. Adv Exp Med Biol 2017;959:215-30. [PMID: 28755199 DOI: 10.1007/978-3-319-55780-9_20] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
391 Kumar A, Placone JK, Engler AJ. Understanding the extracellular forces that determine cell fate and maintenance. Development 2017;144:4261-70. [PMID: 29183939 DOI: 10.1242/dev.158469] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 18.8] [Reference Citation Analysis]
392 Kotaka M, Toyoda T, Yasuda K, Kitano Y, Okada C, Ohta A, Watanabe A, Uesugi M, Osafune K. Adrenergic receptor agonists induce the differentiation of pluripotent stem cell-derived hepatoblasts into hepatocyte-like cells. Sci Rep 2017;7:16734. [PMID: 29196668 DOI: 10.1038/s41598-017-16858-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
393 Nakamori D, Akamine H, Takayama K, Sakurai F, Mizuguchi H. Direct conversion of human fibroblasts into hepatocyte-like cells by ATF5, PROX1, FOXA2, FOXA3, and HNF4A transduction. Sci Rep 2017;7:16675. [PMID: 29192290 DOI: 10.1038/s41598-017-16856-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
394 Ogoke O, Oluwole J, Parashurama N. Bioengineering considerations in liver regenerative medicine. J Biol Eng 2017;11:46. [PMID: 29204185 DOI: 10.1186/s13036-017-0081-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
395 Gao Y, Zhang X, Zhang L, Cen J, Ni X, Liao X, Yang C, Li Y, Chen X, Zhang Z, Shu Y, Cheng X, Hay DC, Lai D, Pan G, Wei G, Hui L. Distinct Gene Expression and Epigenetic Signatures in Hepatocyte-like Cells Produced by Different Strategies from the Same Donor. Stem Cell Reports. 2017;9:1813-1824. [PMID: 29173899 DOI: 10.1016/j.stemcr.2017.10.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
396 Gailhouste L, Liew LC, Yasukawa K, Hagiwara K, Iwazaki N, Yamada Y, Hatada I, Ochiya T. Epigenetic Reprogramming of Human Hepatoma Cells: A Low-Cost Option for Drug Metabolism Assessment. Cell Mol Gastroenterol Hepatol 2018;5:454-457.e1. [PMID: 29675460 DOI: 10.1016/j.jcmgh.2017.11.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
397 Bierwolf J, Volz T, Lütgehetmann M, Allweiss L, Riecken K, Warlich M, Fehse B, Kalff JC, Dandri M, Pollok JM. Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer. Tissue Eng Part A 2016;22:742-53. [PMID: 27068494 DOI: 10.1089/ten.TEA.2015.0427] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
398 Kim D, Cho GS, Han C, Park DH, Park HK, Woo DH, Kim JH. Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases. Tissue Eng Regen Med 2017;14:653-65. [PMID: 30603518 DOI: 10.1007/s13770-017-0093-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
399 Kim DS, Ryu JW, Son MY, Oh JH, Chung KS, Lee S, Lee JJ, Ahn JH, Min JS, Ahn J, Kang HM, Kim J, Jung CR, Kim NS, Cho HS. A liver-specific gene expression panel predicts the differentiation status of in vitro hepatocyte models. Hepatology 2017;66:1662-74. [PMID: 28640507 DOI: 10.1002/hep.29324] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
400 van Grunsven LA. 3D in vitro models of liver fibrosis. Adv Drug Deliv Rev 2017;121:133-46. [PMID: 28697953 DOI: 10.1016/j.addr.2017.07.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 12.0] [Reference Citation Analysis]
401 Sinha S, Sarma P, Sehgal R, Medhi B. Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review. Front Pharmacol 2017;8:754. [PMID: 29123481 DOI: 10.3389/fphar.2017.00754] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
402 Irudayaswamy A, Muthiah M, Zhou L, Hung H, Jumat NHB, Haque J, Teoh N, Farrell G, Riehle KJ, Lin JS, Su LL, Chan JK, Choolani M, Wong PC, Wee A, Lim SG, Campbell J, Fausto N, Dan YY. Long-Term Fate of Human Fetal Liver Progenitor Cells Transplanted in Injured Mouse Livers. Stem Cells 2018;36:103-13. [PMID: 28960647 DOI: 10.1002/stem.2710] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
403 Takayama K, Akita N, Mimura N, Akahira R, Taniguchi Y, Ikeda M, Sakurai F, Ohara O, Morio T, Sekiguchi K, Mizuguchi H. Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine. Hepatol Commun. 2017;1:1058-1069. [PMID: 29404442 DOI: 10.1002/hep4.1111] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
404 Wang Y, Nicolas CT, Chen HS, Ross JJ, De Lorenzo SB, Nyberg SL. Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts. Cells Tissues Organs 2017;204:125-36. [PMID: 28972946 DOI: 10.1159/000479597] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
405 Shan Y, Liang Z, Xing Q, Zhang T, Wang B, Tian S, Huang W, Zhang Y, Yao J, Zhu Y, Huang K, Liu Y, Wang X, Chen Q, Zhang J, Shang B, Li S, Shi X, Liao B, Zhang C, Lai K, Zhong X, Shu X, Wang J, Yao H, Chen J, Pei D, Pan G. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs. Nat Commun 2017;8:672. [PMID: 28939884 DOI: 10.1038/s41467-017-00668-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
406 Peters DT, Henderson CA, Warren CR, Friesen M, Xia F, Becker CE, Musunuru K, Cowan CA. Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells. Development. 2016;143:1475-1481. [PMID: 27143754 DOI: 10.1242/dev.132209] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
407 Yan Y, Song L, Madinya J, Ma T, Li Y. Derivation of Cortical Spheroids from Human Induced Pluripotent Stem Cells in a Suspension Bioreactor. Tissue Eng Part A 2018;24:418-31. [PMID: 28825364 DOI: 10.1089/ten.TEA.2016.0400] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
408 Asai A, Aihara E, Watson C, Mourya R, Mizuochi T, Shivakumar P, Phelan K, Mayhew C, Helmrath M, Takebe T, Wells J, Bezerra JA. Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells. Development. 2017;144:1056-1064. [PMID: 28275009 DOI: 10.1242/dev.142794] [Cited by in Crossref: 75] [Cited by in F6Publishing: 86] [Article Influence: 12.5] [Reference Citation Analysis]
409 Huppert SS, Campbell KM. Emerging advancements in liver regeneration and organogenesis as tools for liver replacement. Curr Opin Organ Transplant 2016;21:581-7. [PMID: 27755169 DOI: 10.1097/MOT.0000000000000365] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
410 Yan F, Wang Y, Zhang W, Chang M, He Z, Xu J, Shang C, Chen T, Liu J, Wang X, Pei X, Wang Y. Human embryonic stem cell-derived hepatoblasts are an optimal lineage stage for hepatitis C virus infection. Hepatology 2017;66:717-35. [PMID: 28236326 DOI: 10.1002/hep.29134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
411 Pettinato G, Thompson MT, Fisher RA. Human embryoid bodies to hepatocyte-like clusters: Preparing for translation. Liver Research 2017;1:88-95. [DOI: 10.1016/j.livres.2017.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
412 Bejoy J, Song L, Zhou Y, Li Y. Wnt/Yes-Associated Protein Interactions During Neural Tissue Patterning of Human Induced Pluripotent Stem Cells. Tissue Eng Part A 2018;24:546-58. [PMID: 28726548 DOI: 10.1089/ten.TEA.2017.0153] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
413 Kholodenko IV, Kholodenko RV, Manukyan GV, Lupatov AY, Yarygin KN. Isolation of Induced Pluripotent Cells from Stromal Liver Cells of Patients with Alcoholic Cirrhosis. Bull Exp Biol Med 2017;163:535-41. [PMID: 28853085 DOI: 10.1007/s10517-017-3845-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
414 Chen Z, Niu M, Sun M, Yuan Q, Yao C, Hou J, Wang H, Wen L, Fu H, Zhou F, Li Z, He Z. Transdifferentiation of human male germline stem cells to hepatocytes in vivo via the transplantation under renal capsules. Oncotarget 2017;8:14576-92. [PMID: 28107194 DOI: 10.18632/oncotarget.14713] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
415 Pournasr B, Duncan SA. Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells. Arterioscler Thromb Vasc Biol 2017;37:1994-9. [PMID: 28818857 DOI: 10.1161/ATVBAHA.117.309199] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
416 Dye BR, Kasputis T, Spence JR, Shea LD. Take a deep breath and digest the material: organoids and biomaterials of the respiratory and digestive systems. MRS Communications 2017;7:502-14. [DOI: 10.1557/mrc.2017.61] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
417 Ang LT, Tan AKY, Autio MI, Goh JS, Choo SH, Lee KL, Tan J, Pan B, Hui Lee JJ, Xin Yeo IK, Yee Wong CJ, Lum JJ, Loh CH, Lim YY, Li Oh JL, Lynn Chia CP, Chen A, Chen QF, Weissman IL, Loh KM, Lim B. Accelerated human liver progenitor generation from pluripotent stem cells by inhibiting formation of unwanted lineages.. [DOI: 10.1101/174698] [Reference Citation Analysis]
418 Freyer N, Greuel S, Knöspel F, Strahl N, Amini L, Jacobs F, Monshouwer M, Zeilinger K. Effects of Co-Culture Media on Hepatic Differentiation of hiPSC with or without HUVEC Co-Culture. Int J Mol Sci 2017;18:E1724. [PMID: 28783133 DOI: 10.3390/ijms18081724] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
419 Kuo Y, Rajesh R. Guided differentiation and tissue regeneration of induced pluripotent stem cells using biomaterials. Journal of the Taiwan Institute of Chemical Engineers 2017;77:41-53. [DOI: 10.1016/j.jtice.2017.04.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
420 Cayo MA, Mallanna SK, Di Furio F, Jing R, Tolliver LB, Bures M, Urick A, Noto FK, Pashos EE, Greseth MD, Czarnecki M, Traktman P, Yang W, Morrisey EE, Grompe M, Rader DJ, Duncan SA. A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia. Cell Stem Cell. 2017;20:478-489.e5. [PMID: 28388428 DOI: 10.1016/j.stem.2017.01.011] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 12.2] [Reference Citation Analysis]
421 Siller R, Greenhough S, Mathapati S, Si-tayeb K, Sullivan GJ. Future Challenges in the Generation of Hepatocyte-Like Cells From Human Pluripotent Stem Cells. Curr Pathobiol Rep 2017;5:301-14. [DOI: 10.1007/s40139-017-0150-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
422 Warren CR, O'Sullivan JF, Friesen M, Becker CE, Zhang X, Liu P, Wakabayashi Y, Morningstar JE, Shi X, Choi J, Xia F, Peters DT, Florido MHC, Tsankov AM, Duberow E, Comisar L, Shay J, Jiang X, Meissner A, Musunuru K, Kathiresan S, Daheron L, Zhu J, Gerszten RE, Deo RC, Vasan RS, O'Donnell CJ, Cowan CA. Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease. Cell Stem Cell. 2017;20:547-557.e7. [PMID: 28388431 DOI: 10.1016/j.stem.2017.01.010] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 17.0] [Reference Citation Analysis]
423 Koui Y, Kido T, Ito T, Oyama H, Chen SW, Katou Y, Shirahige K, Miyajima A. An In Vitro Human Liver Model by iPSC-Derived Parenchymal and Non-parenchymal Cells. Stem Cell Reports. 2017;9:490-498. [PMID: 28757162 DOI: 10.1016/j.stemcr.2017.06.010] [Cited by in Crossref: 96] [Cited by in F6Publishing: 70] [Article Influence: 16.0] [Reference Citation Analysis]
424 Hoepfner J, Kleinsorge M, Papp O, Alfken S, Heiringhoff R, Pich A, Sauer V, Zibert A, Göhring G, Schmidt H, Sgodda M, Cantz T. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells. Biological Chemistry 2017;398:939-54. [DOI: 10.1515/hsz-2016-0258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
425 Fisher JB, Pulakanti K, Rao S, Duncan SA. GATA6 is essential for endoderm formation from human pluripotent stem cells. Biol Open 2017;6:1084-95. [PMID: 28606935 DOI: 10.1242/bio.026120] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
426 Mahmoodinia Maymand M, Soleimanpour-lichaei HR, Ardeshirylajimi A, Soleimani M, Enderami SE, Nojehdehi S, Behjati F, Kabir Salmani M. Improvement of hepatogenic differentiation of iPS cells on an aligned polyethersulfone compared to random nanofibers. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:853-60. [DOI: 10.1080/21691401.2017.1345929] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
427 Tonello JM, Kawashima S, Sato K, Kawabe Y, Ito A, Kamihira M. Three-dimensional culture of a genetically modified hepatoma cell line using macroporous gelatin beads. Cytotechnology 2017;69:925-31. [PMID: 28689279 DOI: 10.1007/s10616-017-0117-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
428 Melgar-Lesmes P, Balcells M, Edelman ER. Implantation of healthy matrix-embedded endothelial cells rescues dysfunctional endothelium and ischaemic tissue in liver engraftment. Gut 2017;66:1297-305. [PMID: 26851165 DOI: 10.1136/gutjnl-2015-310409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
429 Camp JG, Sekine K, Gerber T, Loeffler-Wirth H, Binder H, Gac M, Kanton S, Kageyama J, Damm G, Seehofer D, Belicova L, Bickle M, Barsacchi R, Okuda R, Yoshizawa E, Kimura M, Ayabe H, Taniguchi H, Takebe T, Treutlein B. Multilineage communication regulates human liver bud development from pluripotency. Nature. 2017;546:533-538. [PMID: 28614297 DOI: 10.1038/nature22796] [Cited by in Crossref: 333] [Cited by in F6Publishing: 331] [Article Influence: 55.5] [Reference Citation Analysis]
430 Tolosa L, Pareja E, Gómez-Lechón MJ. Clinical Application of Pluripotent Stem Cells: An Alternative Cell-Based Therapy for Treating Liver Diseases? Transplantation 2016;100:2548-57. [PMID: 27495745 DOI: 10.1097/TP.0000000000001426] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
431 Sin YY, Price PR, Ballantyne LL, Funk CD. Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency. Sci Rep 2017;7:2585. [PMID: 28566761 DOI: 10.1038/s41598-017-02927-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
432 Gu Q, Wang J, Wang L, Liu ZX, Zhu WW, Tan YQ, Han WF, Wu J, Feng CJ, Fang JH, Liu L, Wang L, Li W, Zhao XY, Hu BY, Hao J, Zhou Q. Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations. Stem Cell Reports 2017;9:366-80. [PMID: 28506532 DOI: 10.1016/j.stemcr.2017.04.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
433 Li Q, Hutchins AP, Chen Y, Li S, Shan Y, Liao B, Zheng D, Shi X, Li Y, Chan WY, Pan G, Wei S, Shu X, Pei D. A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes. Nat Commun 2017;8:15166. [PMID: 28466868 DOI: 10.1038/ncomms15166] [Cited by in Crossref: 73] [Cited by in F6Publishing: 83] [Article Influence: 12.2] [Reference Citation Analysis]
434 Chung JJ, Arisi MF, Zaman S, Atluri P. Engineering the Future One Cell at a Time: Advancements in Cell-Based Techniques from Novel Three-Dimensional Cell Culture to a Bionic Kidney. ASAIO J 2017;63:236-8. [PMID: 28459740 DOI: 10.1097/MAT.0000000000000570] [Reference Citation Analysis]
435 Mahmoodinia Maymand M, Soleimanpour-lichaei HR, Ardeshirylajimi A, Soleimani M, Mirzaei S, Hajarizadeh A, Kabir Salmani M. Hepatogenic Differentiation of Human Induced Pluripotent Stem cells on Collagen-Coated Polyethersulfone Nanofibers. ASAIO Journal 2017;63:316-23. [DOI: 10.1097/mat.0000000000000469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
436 Mitani S, Takayama K, Nagamoto Y, Imagawa K, Sakurai F, Tachibana M, Sumazaki R, Mizuguchi H. Human ESC/iPSC-Derived Hepatocyte-like Cells Achieve Zone-Specific Hepatic Properties by Modulation of WNT Signaling. Mol Ther 2017;25:1420-33. [PMID: 28462819 DOI: 10.1016/j.ymthe.2017.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
437 Lin H, Li Q, Lei Y. Three-dimensional tissues using human pluripotent stem cell spheroids as biofabrication building blocks. Biofabrication 2017;9:025007. [PMID: 28287080 DOI: 10.1088/1758-5090/aa663b] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
438 Kang SJ, Park YI, Hwang SR, Yi H, Tham N, Ku HO, Song JY, Kang HG. Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155. Stem Cell Res Ther 2017;8:78. [PMID: 28412976 DOI: 10.1186/s13287-017-0517-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
439 Jing R, Duncan CB, Duncan SA. A small-molecule screen reveals that HSP90β promotes the conversion of induced pluripotent stem cell-derived endoderm to a hepatic fate and regulates HNF4A turnover. Development 2017;144:1764-74. [PMID: 28360131 DOI: 10.1242/dev.146845] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
440 Sakiyama R, Blau BJ, Miki T. Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells. World J Gastroenterol 2017; 23(11): 1974-1979 [PMID: 28373763 DOI: 10.3748/wjg.v23.i11.1974] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
441 Katayama H, Yasuchika K, Miyauchi Y, Kojima H, Yamaoka R, Kawai T, Yukie Yoshitoshi E, Ogiso S, Kita S, Yasuda K, Sasaki N, Fukumitsu K, Komori J, Ishii T, Uemoto S. Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon. Sci Rep 2017;7:44498. [PMID: 28295042 DOI: 10.1038/srep44498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
442 Yoshitoshi-Uebayashi EY, Toyoda T, Yasuda K, Kotaka M, Nomoto K, Okita K, Yasuchika K, Okamoto S, Takubo N, Nishikubo T, Soga T, Uemoto S, Osafune K. Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs. Biochem Biophys Res Commun 2017;486:613-9. [PMID: 28302489 DOI: 10.1016/j.bbrc.2017.03.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
443 Bi X, Pashos EE, Cuchel M, Lyssenko NN, Hernandez M, Picataggi A, McParland J, Yang W, Liu Y, Yan R, Yu C, DerOhannessian SL, Phillips MC, Morrisey EE, Duncan SA, Rader DJ. ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion. EBioMedicine 2017;18:139-45. [PMID: 28330813 DOI: 10.1016/j.ebiom.2017.03.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
444 Wang Y, Alhaque S, Cameron K, Meseguer-Ripolles J, Lucendo-Villarin B, Rashidi H, Hay DC. Defined and Scalable Generation of Hepatocyte-like Cells from Human Pluripotent Stem Cells. J Vis Exp 2017. [PMID: 28287600 DOI: 10.3791/55355] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
445 Palakkan AA, Nanda J, Ross JA. Pluripotent stem cells to hepatocytes, the journey so far. Biomed Rep 2017;6:367-73. [PMID: 28413633 DOI: 10.3892/br.2017.867] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
446 Rohart F, Eslami A, Matigian N, Bougeard S, Lê Cao KA. MINT: a multivariate integrative method to identify reproducible molecular signatures across independent experiments and platforms. BMC Bioinformatics 2017;18:128. [PMID: 28241739 DOI: 10.1186/s12859-017-1553-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 8.2] [Reference Citation Analysis]
447 Zakikhan K, Pournasr B, Vosough M, Nassiri-Asl M. In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery. Cell J 2017;19:204-17. [PMID: 28670513 DOI: 10.22074/cellj.2016.4362] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
448 Fukuda T, Takayama K, Hirata M, Liu YJ, Yanagihara K, Suga M, Mizuguchi H, Furue MK. Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions. Exp Cell Res 2017;352:333-45. [PMID: 28215634 DOI: 10.1016/j.yexcr.2017.02.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
449 Tanimizu N, Mitaka T. Which is better source for functional hepatocytes? Stem Cell Investig 2017;4:12. [PMID: 28275642 DOI: 10.21037/sci.2017.02.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
450 De Assuncao TM, Jalan-Sakrikar N, Huebert RC. Regenerative Medicine and the Biliary Tree. Semin Liver Dis 2017;37:17-27. [PMID: 28201845 DOI: 10.1055/s-0036-1597818] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
451 Arora N, Imran Alsous J, Guggenheim JW, Mak M, Munera J, Wells JM, Kamm RD, Asada HH, Shvartsman SY, Griffith LG. A process engineering approach to increase organoid yield. Development 2017;144:1128-36. [PMID: 28174251 DOI: 10.1242/dev.142919] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
452 Yan Y, Li Y, Song L, Zeng C, Li Y. Pluripotent stem cell expansion and neural differentiation in 3-D scaffolds of tunable Poisson's ratio. Acta Biomater 2017;49:192-203. [PMID: 27845272 DOI: 10.1016/j.actbio.2016.11.025] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
453 Goldring C, Antoine DJ, Bonner F, Crozier J, Denning C, Fontana RJ, Hanley NA, Hay DC, Ingelman-Sundberg M, Juhila S, Kitteringham N, Silva-Lima B, Norris A, Pridgeon C, Ross JA, Young RS, Tagle D, Tornesi B, van de Water B, Weaver RJ, Zhang F, Park BK. Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury. Hepatology 2017;65:710-21. [PMID: 27775817 DOI: 10.1002/hep.28886] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
454 Gao X, Liu Y. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines. Cell Biol Toxicol 2017;33:407-21. [PMID: 28144825 DOI: 10.1007/s10565-017-9383-z] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
455 Choudhury Y, Toh YC, Xing J, Qu Y, Poh J, Li H, Tan HS, Kanesvaran R, Yu H, Tan MH. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity. Sci Rep 2017;7:41238. [PMID: 28120901 DOI: 10.1038/srep41238] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
456 Orbach SM, Less RR, Kothari A, Rajagopalan P. In Vitro Intestinal and Liver Models for Toxicity Testing. ACS Biomater Sci Eng 2017;3:1898-910. [PMID: 33440548 DOI: 10.1021/acsbiomaterials.6b00699] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
457 Kholodenko IV, Yarygin KN. Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases. Biomed Res Int. 2017;2017:8910821. [PMID: 28210629 DOI: 10.1155/2017/8910821] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 9.5] [Reference Citation Analysis]
458 Wang S, Miller SR, Ober EA, Sadler KC. Making It New Again: Insight Into Liver Development, Regeneration, and Disease From Zebrafish Research. Curr Top Dev Biol 2017;124:161-95. [PMID: 28335859 DOI: 10.1016/bs.ctdb.2016.11.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
459 Lin H, Li Q, Lei Y. An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells. Sci Rep 2017;7:40191. [PMID: 28057917 DOI: 10.1038/srep40191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
460 Cervantes-Alvarez E, Wang Y, Collin de l'Hortet A, Guzman-Lepe J, Zhu J, Takeishi K. Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications. Organogenesis 2017;13:1-15. [PMID: 28055309 DOI: 10.1080/15476278.2016.1278133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
461 Matz P, Spitzhorn L, Otte J, Kawala M, Woestmann J, Yigit H, Wruck W, Adjaye J. Use of Stem Cells in Toxicology. Comprehensive Medicinal Chemistry III 2017. [DOI: 10.1016/b978-0-12-409547-2.12380-7] [Reference Citation Analysis]
462 Kamiya A, Chikada H. Characteristics of Hepatic Progenitor Cells During Liver Development and Regeneration. Stem Cells in Clinical Applications 2017. [DOI: 10.1007/978-3-319-46693-4_1] [Reference Citation Analysis]
463 Park Y, Cha S. Directed Cell Differentiation by Inductive Signals in Salivary Gland Regeneration: Lessons Learned from Pancreas and Liver Regeneration. Salivary Gland Development and Regeneration 2017. [DOI: 10.1007/978-3-319-43513-8_6] [Reference Citation Analysis]
464 Mao H, Ito Y. Engineering Niches for Embryonic and Induced Pluripotent Stem Cells. Biology and Engineering of Stem Cell Niches. Elsevier; 2017. pp. 445-57. [DOI: 10.1016/b978-0-12-802734-9.00028-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
465 Sekine K, Takebe T, Taniguchi H. Liver Regeneration Using Cultured Liver Bud. Organ Regeneration Based on Developmental Biology 2017. [DOI: 10.1007/978-981-10-3768-9_12] [Reference Citation Analysis]
466 Gupta K, Song Z, Tang H, Fong E, Ng I, Yu H. 6.28 Liver Tissue Engineering ☆. Comprehensive Biomaterials II 2017. [DOI: 10.1016/b978-0-12-803581-8.10163-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
467 Sekine K, Takebe T, Taniguchi H. Liver Regeneration Using Cultured Liver Bud. Methods Mol Biol 2017;1597:207-16. [PMID: 28361320 DOI: 10.1007/978-1-4939-6949-4_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
468 Luo X, Wang H, Leighton J, O'Sullivan M, Wang P. Generation of endoderm lineages from pluripotent stem cells. Regen Med 2017;12:77-89. [PMID: 27976977 DOI: 10.2217/rme-2016-0086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
469 Asplund A, Pradip A, van Giezen M, Aspegren A, Choukair H, Rehnström M, Jacobsson S, Ghosheh N, El Hajjam D, Holmgren S, Larsson S, Benecke J, Butron M, Wigander A, Noaksson K, Sartipy P, Björquist P, Edsbagge J, Küppers-Munther B. One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells. Stem Cell Rev Rep 2016;12:90-104. [PMID: 26385115 DOI: 10.1007/s12015-015-9621-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
470 Rastegar-Pouyani S, Khazaei N, Wee P, Mohammadnia A, Yaqubi M. Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate. PLoS One 2016;11:e0167081. [PMID: 27902735 DOI: 10.1371/journal.pone.0167081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
471 Suk KT, Yoon JH, Kim MY, Kim CW, Kim JK, Park H, Hwang SG, Kim DJ, Lee BS, Lee SH, Kim HS, Jang JY, Lee CH, Kim BS, Jang YO, Cho MY, Jung ES, Kim YM, Bae SH, Baik SK. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial. Hepatology 2016;64:2185-97. [PMID: 27339398 DOI: 10.1002/hep.28693] [Cited by in Crossref: 157] [Cited by in F6Publishing: 161] [Article Influence: 22.4] [Reference Citation Analysis]
472 Leclerc E, Kimura K, Shinohara M, Danoy M, Le Gall M, Kido T, Miyajima A, Fujii T, Sakai Y. Comparison of the transcriptomic profile of hepatic human induced pluripotent stem like cells cultured in plates and in a 3D microscale dynamic environment. Genomics 2017;109:16-26. [PMID: 27913249 DOI: 10.1016/j.ygeno.2016.11.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
473 Qin J, Chang M, Wang S, Liu Z, Zhu W, Wang Y, Yan F, Li J, Zhang B, Dou G, Liu J, Pei X, Wang Y. Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells. Sci Rep 2016;6:37388. [PMID: 27874032 DOI: 10.1038/srep37388] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
474 Siller R, Naumovska E, Mathapati S, Lycke M, Greenhough S, Sullivan GJ. Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines. Sci Rep. 2016;6:37178. [PMID: 27872482 DOI: 10.1038/srep37178] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
475 Huang GT, El Ayachi I, Zou X. Induced pluripotent stem cell technologies for tissue engineering. Tissue Engineering and Regeneration in Dentistry 2016. [DOI: 10.1002/9781119282181.ch1] [Reference Citation Analysis]
476 Pareja E, Gómez-Lechón MJ, Tolosa L. Alternative Cell Sources to Adult Hepatocytes for Hepatic Cell Therapy. Methods Mol Biol 2017;1506:17-42. [PMID: 27830543 DOI: 10.1007/978-1-4939-6506-9_2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
477 Sun Y, Chi BR. Application of induced pluripotent stem cells in cholangiopathies. Shijie Huaren Xiaohua Zazhi 2016; 24(31): 4247-4252 [DOI: 10.11569/wcjd.v24.i31.4247] [Reference Citation Analysis]
478 Yanagihara K, Liu Y, Kanie K, Takayama K, Kokunugi M, Hirata M, Fukuda T, Suga M, Nikawa H, Mizuguchi H, Kato R, Furue MK. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells. Stem Cells Dev. 2016;25:1884-1897. [PMID: 27733097 DOI: 10.1089/scd.2016.0099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
479 Kitade M, Kaji K, Yoshiji H. Relationship between hepatic progenitor cell-mediated liver regeneration and non-parenchymal cells. Hepatol Res 2016;46:1187-93. [PMID: 26895456 DOI: 10.1111/hepr.12682] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
480 Vasconcellos R, Alvarenga ÉC, Parreira RC, Lima SS, Resende RR. Exploring the cell signalling in hepatocyte differentiation. Cellular Signalling 2016;28:1773-88. [DOI: 10.1016/j.cellsig.2016.08.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
481 Raju R, Chau D, Cho DS, Park Y, Verfaillie CM, Hu WS. Cell Expansion During Directed Differentiation of Stem Cells Toward the Hepatic Lineage. Stem Cells Dev 2017;26:274-84. [PMID: 27806669 DOI: 10.1089/scd.2016.0119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
482 Haque A, Gheibi P, Stybayeva G, Gao Y, Torok N, Revzin A. Ductular reaction-on-a-chip: Microfluidic co-cultures to study stem cell fate selection during liver injury. Sci Rep 2016;6:36077. [PMID: 27796316 DOI: 10.1038/srep36077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
483 Hamooda M. Hepatocyte transplantation in children with liver cell failure. Electron Physician 2016;8:3096-101. [PMID: 27957309 DOI: 10.19082/3096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
484 Ogiso S, Yasuchika K, Fukumitsu K, Ishii T, Kojima H, Miyauchi Y, Yamaoka R, Komori J, Katayama H, Kawai T, Yoshitoshi EY, Kita S, Yasuda K, Uemoto S. Efficient recellularisation of decellularised whole-liver grafts using biliary tree and foetal hepatocytes. Sci Rep 2016;6:35887. [PMID: 27767181 DOI: 10.1038/srep35887] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
485 Rashidi H, Hay D. Generation and Application of 3D Culture Systems in Human Drug Discovery and Medicine. Stem Cells in Toxicology and Medicine 2016. [DOI: 10.1002/9781119135449.ch14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
486 Zhang R, Zheng Y, Taniguchi H. Three-Dimensional Culture Systems and Humanized Liver Models Using Hepatic Stem Cells for Enhanced Toxicity Assessment. Stem Cells in Toxicology and Medicine 2016. [DOI: 10.1002/9781119135449.ch8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
487 Yamazoe T, Shiraki N, Kume S. Hepatic Differentiation from Murine and Human iPS Cells Using Nanofiber Scaffolds. Methods Mol Biol 2016;1357:475-83. [PMID: 25410288 DOI: 10.1007/7651_2014_138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
488 Kamaraj US, Gough J, Polo JM, Petretto E, Rackham OJ. Computational methods for direct cell conversion. Cell Cycle 2016;15:3343-54. [PMID: 27736295 DOI: 10.1080/15384101.2016.1238119] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
489 Kanninen LK, Harjumäki R, Peltoniemi P, Bogacheva MS, Salmi T, Porola P, Niklander J, Smutný T, Urtti A, Yliperttula ML, Lou Y. Laminin-511 and laminin-521-based matrices for efficient hepatic specification of human pluripotent stem cells. Biomaterials 2016;103:86-100. [DOI: 10.1016/j.biomaterials.2016.06.054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
490 Es-salah-lamoureux Z, Jouni M, Malak OA, Belbachir N, Al Sayed ZR, Gandon-renard M, Lamirault G, Gauthier C, Baró I, Charpentier F, Zibara K, Lemarchand P, Beaumelle B, Gaborit N, Loussouarn G. HIV-Tat induces a decrease in I Kr and I Ks via reduction in phosphatidylinositol-(4,5)-bisphosphate availability. Journal of Molecular and Cellular Cardiology 2016;99:1-13. [DOI: 10.1016/j.yjmcc.2016.08.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
491 Lauschke VM, Hendriks DFG, Bell CC, Andersson TB, Ingelman-sundberg M. Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. Chem Res Toxicol 2016;29:1936-55. [DOI: 10.1021/acs.chemrestox.6b00150] [Cited by in Crossref: 164] [Cited by in F6Publishing: 166] [Article Influence: 23.4] [Reference Citation Analysis]
492 Skrzypczyk A, Giri S, Bader A. Generation of induced pluripotent stem cell line from foreskin fibroblasts. Stem Cell Res 2016;17:572-5. [PMID: 27789413 DOI: 10.1016/j.scr.2016.09.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
493 Yan Y, Bejoy J, Xia J, Guan J, Zhou Y, Li Y. Neural patterning of human induced pluripotent stem cells in 3-D cultures for studying biomolecule-directed differential cellular responses. Acta Biomater 2016;42:114-26. [PMID: 27345135 DOI: 10.1016/j.actbio.2016.06.027] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
494 Pettinato G, Ramanathan R, Fisher RA, Mangino MJ, Zhang N, Wen X. Scalable Differentiation of Human iPSCs in a Multicellular Spheroid-based 3D Culture into Hepatocyte-like Cells through Direct Wnt/β-catenin Pathway Inhibition. Sci Rep 2016;6:32888. [PMID: 27616299 DOI: 10.1038/srep32888] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
495 Sasaki A, Kimura F, Miura M, Toshima G, Takahashi J, Maruya S, Kobayashi M, Hata K. Lipoprotein profiles of hepatic cell lines at various stages of differentiation. In Vitro Cell Dev Biol -Animal 2017;53:93-5. [DOI: 10.1007/s11626-016-0091-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
496 Wu J, Izpisua Belmonte JC. Dynamic Pluripotent Stem Cell States and Their Applications. Cell Stem Cell 2015;17:509-25. [PMID: 26544113 DOI: 10.1016/j.stem.2015.10.009] [Cited by in Crossref: 116] [Cited by in F6Publishing: 102] [Article Influence: 16.6] [Reference Citation Analysis]
497 Canfield SG, Zaja I, Godshaw B, Twaroski D, Bai X, Bosnjak ZJ. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission. Anesth Analg 2016;122:1269-79. [PMID: 26991754 DOI: 10.1213/ANE.0000000000001254] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
498 Waraky A, Aleem E, Larsson O. Downregulation of IGF-1 receptor occurs after hepatic linage commitment during hepatocyte differentiation from human embryonic stem cells. Biochemical and Biophysical Research Communications 2016;478:1575-81. [DOI: 10.1016/j.bbrc.2016.08.157] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
499 Tanimizu N, Mitaka T. Morphogenesis of liver epithelial cells. Hepatol Res 2016;46:964-76. [PMID: 26785307 DOI: 10.1111/hepr.12654] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
500 Wang J, Zhao P, Wan Z, Jin X, Cheng Y, Yan T, Qing S, Ding N, Xin S. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells. Cell Biochem Funct 2016;34:475-82. [PMID: 27569862 DOI: 10.1002/cbf.3210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
501 Mallanna SK, Cayo MA, Twaroski K, Gundry RL, Duncan SA. Mapping the Cell-Surface N-Glycoproteome of Human Hepatocytes Reveals Markers for Selecting a Homogeneous Population of iPSC-Derived Hepatocytes. Stem Cell Reports 2016;7:543-56. [PMID: 27569060 DOI: 10.1016/j.stemcr.2016.07.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
502 Song L, Wang K, Li Y, Yang Y. Nanotopography promoted neuronal differentiation of human induced pluripotent stem cells. Colloids Surf B Biointerfaces 2016;148:49-58. [PMID: 27591570 DOI: 10.1016/j.colsurfb.2016.08.041] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 11.7] [Reference Citation Analysis]
503 Gingold J, Zhou R, Lemischka IR, Lee DF. Modeling Cancer with Pluripotent Stem Cells. Trends Cancer 2016;2:485-94. [PMID: 27722205 DOI: 10.1016/j.trecan.2016.07.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
504 Lang J, Vera D, Cheng Y, Tang H. Modeling Dengue Virus-Hepatic Cell Interactions Using Human Pluripotent Stem Cell-Derived Hepatocyte-like Cells. Stem Cell Reports 2016;7:341-54. [PMID: 27546535 DOI: 10.1016/j.stemcr.2016.07.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
505 Désert R, Mebarki S, Desille M, Sicard M, Lavergne E, Renaud S, Bergeat D, Sulpice L, Perret C, Turlin B, Clément B, Musso O. "Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome. Int J Biochem Cell Biol 2016;81:195-207. [PMID: 27545991 DOI: 10.1016/j.biocel.2016.08.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
506 Mathapati S, Siller R, Impellizzeri AA, Lycke M, Vegheim K, Almaas R, Sullivan GJ. Small-Molecule-Directed Hepatocyte-Like Cell Differentiation of Human Pluripotent Stem Cells. Curr Protoc Stem Cell Biol 2016;38:1G.6.1-1G.6.18. [PMID: 27532814 DOI: 10.1002/cpsc.13] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
507 Schwartz RE, Bram Y, Frankel A. Pluripotent Stem Cell-Derived Hepatocyte-like Cells: A Tool to Study Infectious Disease. Curr Pathobiol Rep 2016;4:147-56. [PMID: 29910973 DOI: 10.1007/s40139-016-0113-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
508 Mandal A, Raju S, Viswanathan C. Cryopreserved hepatic progenitor cells derived from human embryonic stem cells can arrest progression of liver fibrosis in rats. Cell Biol Int 2016;40:1107-15. [PMID: 27453189 DOI: 10.1002/cbin.10649] [Reference Citation Analysis]
509 Wang B, Jakus AE, Baptista PM, Soker S, Soto-Gutierrez A, Abecassis MM, Shah RN, Wertheim JA. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments. Stem Cells Transl Med 2016;5:1257-67. [PMID: 27421950 DOI: 10.5966/sctm.2015-0235] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 11.6] [Reference Citation Analysis]
510 Kaneko S, Kakinuma S, Asahina Y, Kamiya A, Miyoshi M, Tsunoda T, Nitta S, Asano Y, Nagata H, Otani S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Nakauchi H, Nishitsuji H, Ujino S, Shimotohno K, Iwamoto M, Watashi K, Wakita T, Watanabe M. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep. 2016;6:29358. [PMID: 27386799 DOI: 10.1038/srep29358] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
511 Rezvani M, Grimm AA, Willenbring H. Assessing the therapeutic potential of lab-made hepatocytes. Hepatology 2016;64:287-94. [PMID: 27014802 DOI: 10.1002/hep.28569] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
512 Shinozawa T, Yoshikawa HY, Takebe T. Reverse engineering liver buds through self-driven condensation and organization towards medical application. Dev Biol 2016;420:221-9. [PMID: 27364470 DOI: 10.1016/j.ydbio.2016.06.036] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
513 Gómez-Lechón MJ, Tolosa L. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Arch Toxicol. 2016;90:2049-2061. [PMID: 27325232 DOI: 10.1007/s00204-016-1756-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
514 Kang SJ, Lee HM, Park YI, Yi H, Lee H, So B, Song JY, Kang HG. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2. Cell Biol Toxicol. 2016;32:403-417. [PMID: 27287938 DOI: 10.1007/s10565-016-9342-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
515 Sauer V, Tchaikovskaya T, Wang X, Li Y, Zhang W, Tar K, Polgar Z, Ding J, Guha C, Fox IJ, Roy-Chowdhury N, Roy-Chowdhury J. Human Urinary Epithelial Cells as a Source of Engraftable Hepatocyte-Like Cells Using Stem Cell Technology. Cell Transplant 2016;25:2221-43. [PMID: 27512979 DOI: 10.3727/096368916X692014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
516 Aurora M, Spence JR. hPSC-derived lung and intestinal organoids as models of human fetal tissue. Dev Biol 2016;420:230-8. [PMID: 27287882 DOI: 10.1016/j.ydbio.2016.06.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
517 Sharma R. iPS Cells-The Triumphs and Tribulations. Dent J (Basel) 2016;4:E19. [PMID: 29563461 DOI: 10.3390/dj4020019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
518 Touboul T, Chen S, To CC, Mora-Castilla S, Sabatini K, Tukey RH, Laurent LC. Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes. J Hepatol 2016;64:1315-26. [PMID: 26921690 DOI: 10.1016/j.jhep.2016.02.028] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
519 Bale SS, Moore L, Yarmush M, Jindal R. Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions. Tissue Eng Part B Rev 2016;22:383-94. [PMID: 27049038 DOI: 10.1089/ten.TEB.2016.0031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
520 Tasnim F, Toh Y, Qu Y, Li H, Phan D, Narmada BC, Ananthanarayanan A, Mittal N, Meng RQ, Yu H. Functionally Enhanced Human Stem Cell Derived Hepatocytes in Galactosylated Cellulosic Sponges for Hepatotoxicity Testing. Mol Pharmaceutics 2016;13:1947-57. [DOI: 10.1021/acs.molpharmaceut.6b00119] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
521 Lucendo-Villarin B, Rashidi H, Cameron K, Hay DC. Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. J Mater Chem B 2016;4:3433-42. [PMID: 27746914 DOI: 10.1039/c6tb00331a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
522 Park KM, Lee J, Hussein KH, Hong SH, Yang SR, Lee E, Woo HM. Generation of liver-specific TGF-α/c-Myc-overexpressing porcine induced pluripotent stem-like cells and blastocyst formation using nuclear transfer. J Vet Med Sci 2016;78:709-13. [PMID: 26725870 DOI: 10.1292/jvms.15-0363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
523 Dedhia PH, Bertaux-Skeirik N, Zavros Y, Spence JR. Organoid Models of Human Gastrointestinal Development and Disease. Gastroenterology 2016;150:1098-112. [PMID: 26774180 DOI: 10.1053/j.gastro.2015.12.042] [Cited by in Crossref: 178] [Cited by in F6Publishing: 183] [Article Influence: 25.4] [Reference Citation Analysis]
524 Ramanan V, Trehan K, Ong ML, Luna JM, Hoffmann HH, Espiritu C, Sheahan TP, Chandrasekar H, Schwartz RE, Christine KS, Rice CM, van Oudenaarden A, Bhatia SN. Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies. Virology 2016;494:236-47. [PMID: 27128351 DOI: 10.1016/j.virol.2016.04.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
525 Szkolnicka D, Hay DC. Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine. Stem Cells 2016;34:1421-6. [PMID: 27015786 DOI: 10.1002/stem.2368] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
526 Zakikhan K, Pournasr B, Nassiri-Asl M, Baharvand H. Enhanced direct conversion of fibroblasts into hepatocyte-like cells by Kdm2b. Biochem Biophys Res Commun 2016;474:97-103. [PMID: 27103435 DOI: 10.1016/j.bbrc.2016.04.076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
527 Dye BR, Miller AJ, Spence JR. How to Grow a Lung: Applying Principles of Developmental Biology to Generate Lung Lineages from Human Pluripotent Stem Cells. Curr Pathobiol Rep 2016;4:47-57. [PMID: 27340610 DOI: 10.1007/s40139-016-0102-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
528 Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Improved Survival and Initiation of Differentiation of Human Induced Pluripotent Stem Cells to Hepatocyte-Like Cells upon Culture in William's E Medium followed by Hepatocyte Differentiation Inducer Treatment. PLoS One 2016;11:e0153435. [PMID: 27073925 DOI: 10.1371/journal.pone.0153435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
529 Yu H, Cowan CA. Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease. Mol Endocrinol. 2016;30:575-586. [PMID: 27075706 DOI: 10.1210/me.2015-1290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
530 Bavli D, Ezra E, Kitsberg D, Vosk-Artzi M, Murthy SK, Nahmias Y. One step antibody-mediated isolation and patterning of multiple cell types in microfluidic devices. Biomicrofluidics 2016;10:024112. [PMID: 27051469 DOI: 10.1063/1.4944741] [Reference Citation Analysis]
531 Shi X, Lv S, He X, Liu X, Sun M, Li M, Chi G, Li Y. Differentiation of hepatocytes from induced pluripotent stem cells derived from human hair follicle mesenchymal stem cells. Cell Tissue Res. 2016;366:89-99. [PMID: 27053247 DOI: 10.1007/s00441-016-2399-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
532 Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. An Optimal Medium Supplementation Regimen for Initiation of Hepatocyte Differentiation in Human Induced Pluripotent Stem Cells. J Cell Biochem. 2015;116:1479-1489. [PMID: 25683148 DOI: 10.1002/jcb.25139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
533 Sa-Ngiamsuntorn K, Wongkajornsilp A, Phanthong P, Borwornpinyo S, Kitiyanant N, Chantratita W, Hongeng S. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Virol J. 2016;13:59. [PMID: 27044429 DOI: 10.1186/s12985-016-0519-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
534 Allweiss L, Dandri M. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. J Hepatol 2016;64:S17-31. [PMID: 27084033 DOI: 10.1016/j.jhep.2016.02.012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 12.1] [Reference Citation Analysis]
535 Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, Cuchel M, DerOhannessian S, Kontush A, Surendran P, Saleheen D, Trompet S, Jukema JW, De Craen A, Deloukas P, Sattar N, Ford I, Packard C, Majumder Aa, Alam DS, Di Angelantonio E, Abecasis G, Chowdhury R, Erdmann J, Nordestgaard BG, Nielsen SF, Tybjærg-Hansen A, Schmidt RF, Kuulasmaa K, Liu DJ, Perola M, Blankenberg S, Salomaa V, Männistö S, Amouyel P, Arveiler D, Ferrieres J, Müller-Nurasyid M, Ferrario M, Kee F, Willer CJ, Samani N, Schunkert H, Butterworth AS, Howson JM, Peloso GM, Stitziel NO, Danesh J, Kathiresan S, Rader DJ; CHD Exome+ Consortium., CARDIoGRAM Exome Consortium., Global Lipids Genetics Consortium. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 2016;351:1166-71. [PMID: 26965621 DOI: 10.1126/science.aad3517] [Cited by in Crossref: 353] [Cited by in F6Publishing: 366] [Article Influence: 50.4] [Reference Citation Analysis]
536 Twaroski K, Mallanna SK, Jing R, DiFurio F, Urick A, Duncan SA. FGF2 mediates hepatic progenitor cell formation during human pluripotent stem cell differentiation by inducing the WNT antagonist NKD1. Genes Dev 2015;29:2463-74. [PMID: 26637527 DOI: 10.1101/gad.268961.115] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
537 Carpentier A, Nimgaonkar I, Chu V, Xia Y, Hu Z, Liang TJ. Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen. Stem Cell Res. 2016;16:640-650. [PMID: 27062358 DOI: 10.1016/j.scr.2016.03.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 8.1] [Reference Citation Analysis]
538 Raju R, Sharma S, Hu W. Stem cell culture processes. Stem Cells in Regenerative Medicine 2016. [DOI: 10.1002/9781118846193.ch19] [Reference Citation Analysis]
539 Cameron K, Marriage H, Hay D, Medine C. Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications. Stem Cells in Regenerative Medicine 2016. [DOI: 10.1002/9781118846193.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
540 Khazaie N, Massumi M, Wee P, Salimi M, Mohammadnia A, Yaqubi M. Involvement of Polycomb Repressive Complex 2 in Maturation of Induced Pluripotent Stem Cells during Reprogramming of Mouse and Human Fibroblasts. PLoS One 2016;11:e0150518. [PMID: 26938987 DOI: 10.1371/journal.pone.0150518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
541 Arslan-yildiz A, Assal RE, Chen P, Guven S, Inci F, Demirci U. Towards artificial tissue models: past, present, and future of 3D bioprinting. Biofabrication 2016;8:014103. [DOI: 10.1088/1758-5090/8/1/014103] [Cited by in Crossref: 169] [Cited by in F6Publishing: 179] [Article Influence: 24.1] [Reference Citation Analysis]
542 Hoepfner J, Kleinsorge M, Papp O, Ackermann M, Alfken S, Rinas U, Solodenko W, Kirschning A, Sgodda M, Cantz T. Biphasic modulation of Wnt signaling supports efficient foregut endoderm formation from human pluripotent stem cells: Wnt-mediated foregut endoderm formation from hPSCs. Cell Biol Int 2016;40:534-48. [DOI: 10.1002/cbin.10590] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
543 Park KM, Hussein KH, Hong SH, Ahn C, Yang SR, Park SM, Kweon OK, Kim BM, Woo HM. Decellularized Liver Extracellular Matrix as Promising Tools for Transplantable Bioengineered Liver Promotes Hepatic Lineage Commitments of Induced Pluripotent Stem Cells. Tissue Eng Part A. 2016;22:449-460. [PMID: 26801816 DOI: 10.1089/ten.tea.2015.0313] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 11.1] [Reference Citation Analysis]
544 Kanninen LK, Porola P, Niklander J, Malinen MM, Corlu A, Guguen-Guillouzo C, Urtti A, Yliperttula ML, Lou YR. Hepatic differentiation of human pluripotent stem cells on human liver progenitor HepaRG-derived acellular matrix. Exp Cell Res 2016;341:207-17. [PMID: 26854693 DOI: 10.1016/j.yexcr.2016.02.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
545 Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Transcription Factors and Medium Suitable for Initiating the Differentiation of Human-Induced Pluripotent Stem Cells to the Hepatocyte Lineage. J Cell Biochem. 2016;117:2001-2009. [PMID: 26773721 DOI: 10.1002/jcb.25494] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
546 Csöbönyeiová M, Polák Š, Danišovič L. Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells. Can J Physiol Pharmacol 2016;94:687-94. [PMID: 27128322 DOI: 10.1139/cjpp-2015-0459] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
547 Hansel MC, Davila JC, Vosough M, Gramignoli R, Skvorak KJ, Dorko K, Marongiu F, Blake W, Strom SC. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases. Curr Protoc Toxicol 2016;67:14.13.1-14.13.27. [PMID: 26828329 DOI: 10.1002/0471140856.tx1413s67] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
548 Jung KH, McCarthy RL, Zhou C, Uprety N, Barton MC, Beretta L. MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1. Stem Cells 2016;34:1284-96. [PMID: 26731713 DOI: 10.1002/stem.2283] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
549 Mohammadnia A, Yaqubi M, Pourasgari F, Neely E, Fallahi H, Massumi M. Signaling and Gene Regulatory Networks Governing Definitive Endoderm Derivation From Pluripotent Stem Cells. J Cell Physiol 2016;231:1994-2006. [PMID: 26755186 DOI: 10.1002/jcp.25308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
550 Witt-Kehati D, Bitton Alaluf M, Shlomai A. Advances and Challenges in Studying Hepatitis B Virus In Vitro. Viruses. 2016;8. [PMID: 26784218 DOI: 10.3390/v8010021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
551 Dvorak Z. Opportunities and challenges in using human hepatocytes in cytochromes P450 induction assays. Expert Opin Drug Metab Toxicol 2016;12:169-74. [PMID: 26612411 DOI: 10.1517/17425255.2016.1125881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
552 Carter MG, Smagghe BJ, Stewart AK, Rapley JA, Lynch E, Bernier KJ, Keating KW, Hatziioannou VM, Hartman EJ, Bamdad CC. A Primitive Growth Factor, NME7AB , Is Sufficient to Induce Stable Naïve State Human Pluripotency; Reprogramming in This Novel Growth Factor Confers Superior Differentiation. Stem Cells 2016;34:847-59. [PMID: 26749426 DOI: 10.1002/stem.2261] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
553 Carroll B, Maetzel D, Maddocks OD, Otten G, Ratcliff M, Smith GR, Dunlop EA, Passos JF, Davies OR, Jaenisch R, Tee AR, Sarkar S, Korolchuk VI. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. Elife 2016;5:e11058. [PMID: 26742086 DOI: 10.7554/eLife.11058] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 16.1] [Reference Citation Analysis]
554 Nicolas C, Wang Y, Luebke-Wheeler J, Nyberg SL. Stem Cell Therapies for Treatment of Liver Disease. Biomedicines 2016;4:E2. [PMID: 28536370 DOI: 10.3390/biomedicines4010002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
555 Dao Thi VL, Debing Y, Wu X, Rice CM, Neyts J, Moradpour D, Gouttenoire J. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. Gastroenterology 2016;150:82-85.e4. [PMID: 26408347 DOI: 10.1053/j.gastro.2015.09.011] [Cited by in Crossref: 136] [Cited by in F6Publishing: 142] [Article Influence: 19.4] [Reference Citation Analysis]
556 von Schaewen M, Gaska JM, Ploss A. New Animal Models for Hepatitis C. Hepatitis C Virus I 2016. [DOI: 10.1007/978-4-431-56098-2_12] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
557 Cantz T, Sharma AD, Manns MP, Ott M. Liver. Regenerative Medicine - from Protocol to Patient 2016. [DOI: 10.1007/978-3-319-28386-9_5] [Reference Citation Analysis]
558 Pane LS, My I, Moretti A. Induced Pluripotent Stem Cells in Regenerative Medicine. Regenerative Medicine - from Protocol to Patient 2016. [DOI: 10.1007/978-3-319-27610-6_3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
559 Rasmussen TP. Genomic Medicine and Lipid Metabolism. Translational Cardiometabolic Genomic Medicine 2016. [DOI: 10.1016/b978-0-12-799961-6.00005-6] [Reference Citation Analysis]
560 Wang B, Wertheim JA. Experimental Cell Therapy for Liver Dysfunction. Translating Regenerative Medicine to the Clinic 2016. [DOI: 10.1016/b978-0-12-800548-4.00021-8] [Reference Citation Analysis]
561 Jaafarpour Z, Soleimani M, Hosseinkhani S, Karimi MH, Yaghmaei P, Mobarra N, Geramizadeh B. Differentiation of Definitive Endoderm from Human Induced Pluripotent Stem Cells on hMSCs Feeder in a Defined Medium. Avicenna J Med Biotechnol 2016;8:2-8. [PMID: 26855729] [Reference Citation Analysis]
562 Hausburg F, David R. Cell Programming for Future Regenerative Medicine. Regenerative Medicine - from Protocol to Patient 2016. [DOI: 10.1007/978-3-319-27610-6_15] [Reference Citation Analysis]
563 Gómez-Lechón MJ, Tolosa L, Donato MT. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs. J Appl Toxicol 2016;36:752-68. [PMID: 26691983 DOI: 10.1002/jat.3277] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
564 Zachos NC, Kovbasnjuk O, Foulke-Abel J, In J, Blutt SE, de Jonge HR, Estes MK, Donowitz M. Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology. J Biol Chem. 2016;291:3759-3766. [PMID: 26677228 DOI: 10.1074/jbc.r114.635995] [Cited by in Crossref: 181] [Cited by in F6Publishing: 187] [Article Influence: 22.6] [Reference Citation Analysis]
565 Tolosa L, Caron J, Hannoun Z, Antoni M, López S, Burks D, Castell JV, Weber A, Gomez-Lechon MJ, Dubart-Kupperschmitt A. Transplantation of hESC-derived hepatocytes protects mice from liver injury. Stem Cell Res Ther 2015;6:246. [PMID: 26652177 DOI: 10.1186/s13287-015-0227-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
566 Yarygin KN, Lupatov AY, Kholodenko IV. Cell-based therapies of liver diseases: age-related challenges. Clin Interv Aging. 2015;10:1909-1924. [PMID: 26664104 DOI: 10.2147/cia.s97926] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
567 Yan Y, Martin LM, Bosco DB, Bundy JL, Nowakowski RS, Sang QA, Li Y. Differential effects of acellular embryonic matrices on pluripotent stem cell expansion and neural differentiation. Biomaterials 2015;73:231-42. [DOI: 10.1016/j.biomaterials.2015.09.020] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
568 Cameron K, Tan R, Schmidt-Heck W, Campos G, Lyall MJ, Wang Y, Lucendo-Villarin B, Szkolnicka D, Bates N, Kimber SJ, Hengstler JG, Godoy P, Forbes SJ, Hay DC. Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes. Stem Cell Reports. 2015;5:1250-1262. [PMID: 26626180 DOI: 10.1016/j.stemcr.2015.10.016] [Cited by in Crossref: 104] [Cited by in F6Publishing: 110] [Article Influence: 13.0] [Reference Citation Analysis]
569 Song W, Lu YC, Frankel AS, An D, Schwartz RE, Ma M. Engraftment of human induced pluripotent stem cell-derived hepatocytes in immunocompetent mice via 3D co-aggregation and encapsulation. Sci Rep. 2015;5:16884. [PMID: 26592180 DOI: 10.1038/srep16884] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
570 Park KM, Hussein KH, Ghim JH, Ahn C, Cha SH, Lee GS, Hong SH, Yang S, Woo HM. Hepatic differentiation of porcine embryonic stem cells for translational research of hepatocyte transplantation. Transplant Proc. 2015;47:775-779. [PMID: 25891729 DOI: 10.1016/j.transproceed.2015.01.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
571 Si-Tayeb K, Idriss S, Champon B, Caillaud A, Pichelin M, Arnaud L, Lemarchand P, Le May C, Zibara K, Cariou B. Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia. Dis Model Mech. 2016;9:81-90. [PMID: 26586530 DOI: 10.1242/dmm.022277] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
572 Ji F, Hu AB. Hepatic differentiation of pluripotent stem cells. Shijie Huaren Xiaohua Zazhi 2015; 23(32): 5101-5106 [DOI: 10.11569/wcjd.v23.i32.5101] [Reference Citation Analysis]
573 Lin JS, Zhou L, Sagayaraj A, Jumat NH, Choolani M, Chan JK, Biswas A, Wong PC, Lim SG, Dan YY. Hepatic differentiation of human amniotic epithelial cells and in vivo therapeutic effect on animal model of cirrhosis. J Gastroenterol Hepatol 2015;30:1673-82. [PMID: 25973537 DOI: 10.1111/jgh.12991] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
574 Levy G, Bomze D, Heinz S, Ramachandran SD, Noerenberg A, Cohen M, Shibolet O, Sklan E, Braspenning J, Nahmias Y. Long-term culture and expansion of primary human hepatocytes. Nat Biotechnol 2015;33:1264-71. [PMID: 26501953 DOI: 10.1038/nbt.3377] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 12.4] [Reference Citation Analysis]
575 Holtzinger A, Streeter PR, Sarangi F, Hillborn S, Niapour M, Ogawa S, Keller G. New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells. Development 2015;142:4253-65. [PMID: 26493401 DOI: 10.1242/dev.121020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
576 Sun C, Hu JJ, Pan Q, Cao Y, Fan JG, Li GM. Hepatic differentiation of rat induced pluripotent stem cells in vitroWorld J Gastroenterol 2015; 21(39): 11118-11126 [PMID: 26494966 DOI: 10.3748/wjg.v21.i39.11118] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
577 Mandal A, Raju S, Viswanathan C. Long-term culture and cryopreservation does not affect the stability and functionality of human embryonic stem cell-derived hepatocyte-like cells. In Vitro Cell Dev Biol Anim 2016;52:243-51. [PMID: 26487432 DOI: 10.1007/s11626-015-9956-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
578 Busser BW, Lin Y, Yang Y, Zhu J, Chen G, Michelson AM. An Orthologous Epigenetic Gene Expression Signature Derived from Differentiating Embryonic Stem Cells Identifies Regulators of Cardiogenesis. PLoS One 2015;10:e0141066. [PMID: 26485529 DOI: 10.1371/journal.pone.0141066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
579 Chikada H, Ito K, Yanagida A, Nakauchi H, Kamiya A. The basic helix-loop-helix transcription factor, Mist1, induces maturation of mouse fetal hepatoblasts. Sci Rep 2015;5:14989. [PMID: 26456005 DOI: 10.1038/srep14989] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
580 Ginocchio VM, Brunetti-Pierri N. Progress toward improved therapies for inborn errors of metabolism. Hum Mol Genet 2016;25:R27-35. [PMID: 26443595 DOI: 10.1093/hmg/ddv418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
581 Zhu X, Pan X, Yao L, Li W, Cui J, Wang G, Mrsny RJ, Hoffman AR, Hu J. Converting Skin Fibroblasts into Hepatic-like Cells by Transient Programming: H EPATIC -L IKE C ELLSBY T RANSIENT R EPROGRAMMING. J Cell Biochem 2016;117:589-98. [DOI: 10.1002/jcb.25355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
582 Eom YW, Kim G, Baik SK. Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives. World J Gastroenterol 2015; 21(36): 10253-10261 [PMID: 26420953 DOI: 10.3748/wjg.v21.i36.10253] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
583 Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes. World J Methodol 2015; 5(3): 108-114 [PMID: 26413482 DOI: 10.5662/wjm.v5.i3.108] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
584 Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M. Dual gene expression in embryoid bodies derived from human induced pluripotent stem cells using episomal vectors. Tissue Eng Part A 2014;20:3154-62. [PMID: 24980753 DOI: 10.1089/ten.TEA.2014.0132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
585 Kido T, Koui Y, Suzuki K, Kobayashi A, Miura Y, Chern EY, Tanaka M, Miyajima A. CPM Is a Useful Cell Surface Marker to Isolate Expandable Bi-Potential Liver Progenitor Cells Derived from Human iPS Cells. Stem Cell Reports 2015;5:508-15. [PMID: 26365514 DOI: 10.1016/j.stemcr.2015.08.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
586 Jouni M, Si-Tayeb K, Es-Salah-Lamoureux Z, Latypova X, Champon B, Caillaud A, Rungoat A, Charpentier F, Loussouarn G, Baró I, Zibara K, Lemarchand P, Gaborit N. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome. J Am Heart Assoc 2015;4:e002159. [PMID: 26330336 DOI: 10.1161/JAHA.115.002159] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
587 Hu C, Li L. Two Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to Hepatocytes. Int J Mol Sci 2015;16:20873-95. [PMID: 26340624 DOI: 10.3390/ijms160920873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
588 Eom YW, Shim KY, Baik SK. Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med. 2015;30:580-589. [PMID: 26354051 DOI: 10.3904/kjim.2015.30.5.580] [Cited by in Crossref: 129] [Cited by in F6Publishing: 141] [Article Influence: 16.1] [Reference Citation Analysis]
589 Nagaoka M, Kobayashi M, Kawai C, Mallanna SK, Duncan SA. Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells. PLoS One 2015;10:e0136350. [PMID: 26308339 DOI: 10.1371/journal.pone.0136350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
590 Yang W, Liu Y, Slovik KJ, Wu JC, Duncan SA, Rader DJ, Morrisey EE. Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells. PLoS One 2015;10:e0134995. [PMID: 26281015 DOI: 10.1371/journal.pone.0134995] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
591 Stoltz JF, de Isla N, Li YP, Bensoussan D, Zhang L, Huselstein C, Chen Y, Decot V, Magdalou J, Li N. Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century. Stem Cells Int. 2015;2015:734731. [PMID: 26300923 DOI: 10.1155/2015/734731] [Cited by in Crossref: 93] [Cited by in F6Publishing: 109] [Article Influence: 11.6] [Reference Citation Analysis]
592 Bartlett DC, Newsome PN. Hepatocyte cell therapy in liver disease. Expert Rev Gastroenterol Hepatol 2015;9:1261-72. [PMID: 26212798 DOI: 10.1586/17474124.2015.1073106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
593 Mou L, Chen F, Dai Y, Cai Z, Cooper DKC. Potential alternative approaches to xenotransplantation. Int J Surg 2015;23:322-6. [PMID: 26209781 DOI: 10.1016/j.ijsu.2015.06.085] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
594 Lee JG, Bak SY, Nahm JH, Lee SW, Min SO, Kim KS. Toward angiogenesis of implanted bio-artificial liver using scaffolds with type I collagen and adipose tissue-derived stem cells. Korean J Hepatobiliary Pancreat Surg 2015;19:47-58. [PMID: 26155277 DOI: 10.14701/kjhbps.2015.19.2.47] [Reference Citation Analysis]
595 Habka D, Mann D, Landes R, Soto-Gutierrez A. Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts. PLoS One 2015;10:e0131764. [PMID: 26177505 DOI: 10.1371/journal.pone.0131764] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
596 Ogawa M, Ogawa S, Bear CE, Ahmadi S, Chin S, Li B, Grompe M, Keller G, Kamath BM, Ghanekar A. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat Biotechnol. 2015;33:853-861. [PMID: 26167630 DOI: 10.1038/nbt.3294] [Cited by in Crossref: 202] [Cited by in F6Publishing: 211] [Article Influence: 25.3] [Reference Citation Analysis]
597 Jiang J, Wolters JE, van Breda SG, Kleinjans JC, de Kok TM. Development of novel tools for the in vitro investigation of drug-induced liver injury. Expert Opin Drug Metab Toxicol. 2015;11:1523-1537. [PMID: 26155718 DOI: 10.1517/17425255.2015.1065814] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
598 Di Ruscio A, Patti F, Welner RS, Tenen DG, Amabile G. Multiple sclerosis: getting personal with induced pluripotent stem cells. Cell Death Dis 2015;6:e1806. [PMID: 26158512 DOI: 10.1038/cddis.2015.179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
599 Winer BY, Ploss A. Determinants of hepatitis B and delta virus host tropism. Curr Opin Virol 2015;13:109-16. [PMID: 26164658 DOI: 10.1016/j.coviro.2015.06.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
600 Sampaziotis F, Segeritz CP, Vallier L. Potential of human induced pluripotent stem cells in studies of liver disease. Hepatology 2015;62:303-11. [PMID: 25502113 DOI: 10.1002/hep.27651] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
601 Avior Y, Levy G, Zimerman M, Kitsberg D, Schwartz R, Sadeh R, Moussaieff A, Cohen M, Itskovitz-Eldor J, Nahmias Y. Microbial-derived lithocholic acid and vitamin K2 drive the metabolic maturation of pluripotent stem cells-derived and fetal hepatocytes. Hepatology 2015;62:265-78. [PMID: 25808545 DOI: 10.1002/hep.27803] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
602 Tafaleng EN, Chakraborty S, Han B, Hale P, Wu W, Soto-Gutierrez A, Feghali-Bostwick CA, Wilson AA, Kotton DN, Nagaya M, Strom SC, Roy-Chowdhury J, Stolz DB, Perlmutter DH, Fox IJ. Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency. Hepatology 2015;62:147-57. [PMID: 25690322 DOI: 10.1002/hep.27753] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
603 Hu C, Li L. In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration. Protein Cell. 2015;6:562-574. [PMID: 26088193 DOI: 10.1007/s13238-015-0180-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 7.4] [Reference Citation Analysis]
604 Moulin F, Flint O. In Vitro Models for the Prediction of Drug-Induced Liver Injury in Lead Discovery. In: Urbán L, Patel VF, Vaz RJ, editors. Antitargets and Drug Safety. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2015. pp. 125-58. [DOI: 10.1002/9783527673643.ch07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
605 Lu J, Einhorn S, Venkatarangan L, Miller M, Mann DA, Watkins PB, LeCluyse E. Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing. Toxicol Sci 2015;147:39-54. [PMID: 26092927 DOI: 10.1093/toxsci/kfv117] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 10.9] [Reference Citation Analysis]
606 Kim JH, Jang YJ, An SY, Son J, Lee J, Lee G, Park JY, Park H, Hwang D, Kim J, Han J. Enhanced Metabolizing Activity of Human ES Cell-Derived Hepatocytes Using a 3D Culture System with Repeated Exposures to Xenobiotics. Toxicol Sci 2015;147:190-206. [DOI: 10.1093/toxsci/kfv121] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
607 Chen Y, Li Y, Wang X, Zhang W, Sauer V, Chang CJ, Han B, Tchaikovskaya T, Avsar Y, Tafaleng E, Madhusudana Girija S, Tar K, Polgar Z, Strom S, Bouhassira EE, Guha C, Fox IJ, Roy-Chowdhury J, Roy-Chowdhury N. Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes. Stem Cell Reports 2015;5:22-30. [PMID: 26074313 DOI: 10.1016/j.stemcr.2015.04.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
608 Sanal MG. Cell therapy from bench to bedside: Hepatocytes from fibroblasts - the truth and myth of transdifferentiation. World J Gastroenterol 2015; 21(21): 6427-6433 [PMID: 26074681 DOI: 10.3748/wjg.v21.i21.6427] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
609 Zhu S, Wang H, Ding S. Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signaling-directed lineage conversion. Nat Protoc. 2015;10:959-973. [PMID: 26042385 DOI: 10.1038/nprot.2015.059] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
610 Pettinato G, Wen X, Zhang N. Engineering Strategies for the Formation of Embryoid Bodies from Human Pluripotent Stem Cells. Stem Cells Dev. 2015;24:1595-1609. [PMID: 25900308 DOI: 10.1089/scd.2014.0427] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
611 Aravalli RN, Belcher JD, Steer CJ. Liver-targeted gene therapy: Approaches and challenges. Liver Transpl 2015;21:718-37. [PMID: 25824605 DOI: 10.1002/lt.24122] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
612 Zhu P, Wang Y, Du Y, He L, Huang G, Zhang G, Yan X, Fan Z. C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling. Nat Commun 2015;6:7122. [PMID: 25985737 DOI: 10.1038/ncomms8122] [Cited by in Crossref: 89] [Cited by in F6Publishing: 101] [Article Influence: 11.1] [Reference Citation Analysis]
613 Kamiya A, Chikada H. Human pluripotent stem cell-derived cholangiocytes: current status and future applications. Curr Opin Gastroenterol 2015;31:233-8. [PMID: 25850348 DOI: 10.1097/MOG.0000000000000180] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
614 Siller R, Greenhough S, Naumovska E, Sullivan Gareth J. Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem Cell Reports. 2015;4:939-952. [PMID: 25937370 DOI: 10.1016/j.stemcr.2015.04.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 147] [Article Influence: 17.5] [Reference Citation Analysis]
615 Tsuruya K, Chikada H, Ida K, Anzai K, Kagawa T, Inagaki Y, Mine T, Kamiya A. A Paracrine Mechanism Accelerating Expansion of Human Induced Pluripotent Stem Cell-Derived Hepatic Progenitor-Like Cells. Stem Cells Dev 2015;24:1691-702. [PMID: 25808356 DOI: 10.1089/scd.2014.0479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
616 Moser PT, Ott HC. Recellularization of organs: what is the future for solid organ transplantation? Curr Opin Organ Transplant 2014;19:603-9. [PMID: 25304814 DOI: 10.1097/MOT.0000000000000131] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
617 Ferrer JR, Chokechanachaisakul A, Wertheim JA. New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases. Curr Transplant Rep 2015;2:202-10. [PMID: 26317066 DOI: 10.1007/s40472-015-0059-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
618 De Assuncao TM, Sun Y, Jalan-Sakrikar N, Drinane MC, Huang BQ, Li Y, Davila JI, Wang R, O'Hara SP, Lomberk GA, Urrutia RA, Ikeda Y, Huebert RC. Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. Lab Invest. 2015;95:684-696. [PMID: 25867762 DOI: 10.1038/labinvest.2015.51] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
619 Ishikawa T, Kobayashi M, Yanagi S, Kato C, Takashima R, Kobayashi E, Hagiwara K, Ochiya T. Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors. PLoS One. 2015;10:e0123193. [PMID: 25875613 DOI: 10.1371/journal.pone.0123193] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
620 Carpentier A, Jake Liang T. Transplantation d’hépatocytes humains dérivés de cellules souches dans le foie de souris: Un nouveau modèle murin d’infection par le virus de l’hépatite C. Med Sci (Paris) 2015;31:256-9. [DOI: 10.1051/medsci/20153103010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
621 Zhang Z, Elsayed AK, Shi Q, Zhang Y, Zuo Q, Li D, Lian C, Tang B, Xiao T, Xu Q, Chang G, Chen G, Zhang L, Wang K, Wang Y, Jin K, Wang Y, Song J, Cui H, Li B. Crucial genes and pathways in chicken germ stem cell differentiation. J Biol Chem 2015;290:13605-21. [PMID: 25847247 DOI: 10.1074/jbc.M114.601401] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
622 Wilson AA, Ying L, Liesa M, Segeritz CP, Mills JA, Shen SS, Jean J, Lonza GC, Liberti DC, Lang AH, Nazaire J, Gower AC, Müeller FJ, Mehta P, Ordóñez A, Lomas DA, Vallier L, Murphy GJ, Mostoslavsky G, Spira A, Shirihai OS, Ramirez MI, Gadue P, Kotton DN. Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells. Stem Cell Reports 2015;4:873-85. [PMID: 25843048 DOI: 10.1016/j.stemcr.2015.02.021] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
623 Berger DR, Ware BR, Davidson MD, Allsup SR, Khetani SR. Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro. Hepatology 2015;61:1370-81. [PMID: 25421237 DOI: 10.1002/hep.27621] [Cited by in Crossref: 152] [Cited by in F6Publishing: 150] [Article Influence: 19.0] [Reference Citation Analysis]
624 Bhatia SN, Underhill GH, Zaret KS, Fox IJ. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6:245sr2. [PMID: 25031271 DOI: 10.1126/scitranslmed.3005975] [Cited by in Crossref: 210] [Cited by in F6Publishing: 217] [Article Influence: 26.3] [Reference Citation Analysis]
625 Liao J, Karnik R, Gu H, Ziller MJ, Clement K, Tsankov AM, Akopian V, Gifford CA, Donaghey J, Galonska C, Pop R, Reyon D, Tsai SQ, Mallard W, Joung JK, Rinn JL, Gnirke A, Meissner A. Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells. Nat Genet 2015;47:469-78. [PMID: 25822089 DOI: 10.1038/ng.3258] [Cited by in Crossref: 312] [Cited by in F6Publishing: 320] [Article Influence: 39.0] [Reference Citation Analysis]
626 Zhang RR, Zheng YW, Li B, Tsuchida T, Ueno Y, Nie YZ, Taniguchi H. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities. Stem Cell Res Ther 2015;6:49. [PMID: 25889844 DOI: 10.1186/s13287-015-0038-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
627 Dye BR, Hill DR, Ferguson MA, Tsai YH, Nagy MS, Dyal R, Wells JM, Mayhew CN, Nattiv R, Klein OD, White ES, Deutsch GH, Spence JR. In vitro generation of human pluripotent stem cell derived lung organoids. Elife 2015;4. [PMID: 25803487 DOI: 10.7554/eLife.05098] [Cited by in Crossref: 456] [Cited by in F6Publishing: 481] [Article Influence: 57.0] [Reference Citation Analysis]
628 Baxter M, Withey S, Harrison S, Segeritz CP, Zhang F, Atkinson-Dell R, Rowe C, Gerrard DT, Sison-Young R, Jenkins R, Henry J, Berry AA, Mohamet L, Best M, Fenwick SW, Malik H, Kitteringham NR, Goldring CE, Piper Hanley K, Vallier L, Hanley NA. Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol 2015;62:581-9. [PMID: 25457200 DOI: 10.1016/j.jhep.2014.10.016] [Cited by in Crossref: 234] [Cited by in F6Publishing: 230] [Article Influence: 29.3] [Reference Citation Analysis]
629 Yanagida A, Nakauchi H, Kamiya A. Generation and In Vitro Expansion of Hepatic Progenitor Cells from Human iPS Cells. Methods Mol Biol 2016;1357:295-310. [PMID: 25697415 DOI: 10.1007/7651_2015_199] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
630 Kim MS, Horst A, Blinka S, Stamm K, Mahnke D, Schuman J, Gundry R, Tomita-Mitchell A, Lough J. Activin-A and Bmp4 levels modulate cell type specification during CHIR-induced cardiomyogenesis. PLoS One 2015;10:e0118670. [PMID: 25706534 DOI: 10.1371/journal.pone.0118670] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
631 Chaturvedi RR, Stevens KR, Solorzano RD, Schwartz RE, Eyckmans J, Baranski JD, Stapleton SC, Bhatia SN, Chen CS. Patterning vascular networks in vivo for tissue engineering applications. Tissue Eng Part C Methods 2015;21:509-17. [PMID: 25390971 DOI: 10.1089/ten.TEC.2014.0258] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
632 Skalova S, Svadlakova T, Shaikh Qureshi WM, Dev K, Mokry J. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine. Int J Mol Sci 2015;16:4043-67. [PMID: 25689424 DOI: 10.3390/ijms16024043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
633 Idriss S, Zibara K, Cariou B, Si-tayeb K. From Human-Induced Pluripotent Stem Cells to Liver Disease Modeling: A Focus on Dyslipidemia. Curr Pathobiol Rep 2015;3:47-56. [DOI: 10.1007/s40139-015-0067-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
634 Iwao T, Kodama N, Kondo Y, Kabeya T, Nakamura K, Horikawa T, Niwa T, Kurose K, Matsunaga T. Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds. Drug Metab Dispos. 2015;43:603-610. [PMID: 25650381 DOI: 10.1124/dmd.114.062604] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
635 Khetani SR, Berger DR, Ballinger KR, Davidson MD, Lin C, Ware BR. Microengineered liver tissues for drug testing. J Lab Autom 2015;20:216-50. [PMID: 25617027 DOI: 10.1177/2211068214566939] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 10.4] [Reference Citation Analysis]
636 Sullivan DC, Repper JP, Frock AW, Mcfetridge PS, Petersen BE. Current Translational Challenges for Tissue Engineering: 3D Culture, Nanotechnology, and Decellularized Matrices. Curr Pathobiol Rep 2015;3:99-106. [DOI: 10.1007/s40139-015-0066-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
637 Kim JJ, Khalid O, Namazi A, Tu TG, Elie O, Lee C, Kim Y. Discovery of consensus gene signature and intermodular connectivity defining self-renewal of human embryonic stem cells. Stem Cells 2014;32:1468-79. [PMID: 24519983 DOI: 10.1002/stem.1675] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
638 Kikuchi C, Bienengraeber M, Canfield S, Koopmeiner A, Schäfer R, Bosnjak ZJ, Bai X. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells. Cell Transplant 2015;24:2491-504. [PMID: 25562386 DOI: 10.3727/096368914X685762] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
639 Sekine K, Takebe T, Taniguchi H. Fluorescent labeling and visualization of human induced pluripotent stem cells with the use of transcription activator-like effector nucleases. Transplant Proc 2014;46:1205-7. [PMID: 24815161 DOI: 10.1016/j.transproceed.2014.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
640 Zhang R, Takebe T, Sekine K, Koike H, Zheng Y, Taniguchi H. Identification of proliferating human hepatic cells from human induced pluripotent stem cells. Transplant Proc 2014;46:1201-4. [PMID: 24815160 DOI: 10.1016/j.transproceed.2013.12.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
641 Yan Y, Song L, Tsai A, Ma T, Li Y. Generation of Neural Progenitor Spheres from Human Pluripotent Stem Cells in a Suspension Bioreactor. Methods in Molecular Biology 2015. [DOI: 10.1007/7651_2015_310] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
642 Zhang R, Koike H, Takebe T. The Visualization of Human Organogenesis from Stem Cells by Recapitulating Multicellular Interactions. Hyper Bio Assembler for 3D Cellular Systems 2015. [DOI: 10.1007/978-4-431-55297-0_17] [Reference Citation Analysis]
643 Shafritz DA. Hepatic Progenitor Cell Transplantation. Liver Regeneration 2015. [DOI: 10.1016/b978-0-12-420128-6.00020-8] [Reference Citation Analysis]
644 Goldman O, Han S, Sourisseau M, Dziedzic N, Hamou W, Corneo B, D'Souza S, Sato T, Kotton DN, Bissig KD, Kalir T, Jacobs A, Evans T, Evans MJ, Gouon-Evans V. KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development. Cell Stem Cell 2013;12:748-60. [PMID: 23746980 DOI: 10.1016/j.stem.2013.04.026] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
645 Chen KT, Pernelle K, Tsai YH, Wu YH, Hsieh JY, Liao KH, Guguen-Guillouzo C, Wang HW. Liver X receptor α (LXRα/NR1H3) regulates differentiation of hepatocyte-like cells via reciprocal regulation of HNF4α. J Hepatol 2014;61:1276-86. [PMID: 25073010 DOI: 10.1016/j.jhep.2014.07.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
646 Lui KO, Howie D, Ng SW, Liu S, Chien KR, Waldmann H. Tolerance induction to human stem cell transplants with extension to their differentiated progeny. Nat Commun. 2014;5:5629. [PMID: 25434740 DOI: 10.1038/ncomms6629] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
647 Mann DA. Human induced pluripotent stem cell-derived hepatocytes for toxicology testing. Expert Opinion on Drug Metabolism & Toxicology 2014;11:1-5. [DOI: 10.1517/17425255.2015.981523] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
648 Demasi M, Simões V, Bonatto D. Cross-talk between redox regulation and the ubiquitin-proteasome system in mammalian cell differentiation. Biochim Biophys Acta 2015;1850:1594-606. [PMID: 25450485 DOI: 10.1016/j.bbagen.2014.10.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
649 van Wenum M, Chamuleau RA, van Gulik TM, Siliakus A, Seppen J, Hoekstra R. Bioartificial livers in vitro and in vivo : tailoring biocomponents to the expanding variety of applications. Expert Opinion on Biological Therapy 2014;14:1745-60. [DOI: 10.1517/14712598.2014.950651] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
650 Ramanan V, Scull MA, Sheahan TP, Rice CM, Bhatia SN. New Methods in Tissue Engineering: Improved Models for Viral Infection. Annu Rev Virol. 2014;1:475-499. [PMID: 25893203 DOI: 10.1146/annurev-virology-031413-085437] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
651 Ohgane H, Takebe T, Sekine K, Taniguchi H. Efficient generation of mature hepatocyte-like cells from human iPSCs. 2014 International Symposium on Micro-NanoMechatronics and Human Science (MHS) 2014. [DOI: 10.1109/mhs.2014.7006151] [Reference Citation Analysis]
652 McCracken KW, Catá EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE, Tsai YH, Mayhew CN, Spence JR, Zavros Y, Wells JM. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 2014;516:400-4. [PMID: 25363776 DOI: 10.1038/nature13863] [Cited by in Crossref: 649] [Cited by in F6Publishing: 656] [Article Influence: 72.1] [Reference Citation Analysis]
653 Pimton P, Lecht S, Stabler CT, Johannes G, Schulman ES, Lelkes PI. Hypoxia enhances differentiation of mouse embryonic stem cells into definitive endoderm and distal lung cells. Stem Cells Dev 2015;24:663-76. [PMID: 25226206 DOI: 10.1089/scd.2014.0343] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
654 Litterman NK, Ekins S. Databases and collaboration require standards for human stem cell research. Drug Discov Today 2015;20:247-54. [PMID: 25449658 DOI: 10.1016/j.drudis.2014.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
655 Skowron K, Tomsia M, Czekaj P. An experimental approach to the generation of human embryonic stem cells equivalents. Mol Biotechnol 2014;56:12-37. [PMID: 24146427 DOI: 10.1007/s12033-013-9702-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
656 Mournetas V, Nunes QM, Murray PA, Sanderson CM, Fernig DG. Network based meta-analysis prediction of microenvironmental relays involved in stemness of human embryonic stem cells. PeerJ. 2014;2:e618. [PMID: 25374775 DOI: 10.7717/peerj.618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
657 Mong J, Panman L, Alekseenko Z, Kee N, Stanton LW, Ericson J, Perlmann T. Transcription factor-induced lineage programming of noradrenaline and motor neurons from embryonic stem cells. Stem Cells 2014;32:609-22. [PMID: 24549637 DOI: 10.1002/stem.1585] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
658 Gómez-Lechón MJ, Tolosa L, Conde I, Donato MT. Competency of different cell models to predict human hepatotoxic drugs. Expert Opin Drug Metab Toxicol. 2014;10:1553-1568. [PMID: 25297626 DOI: 10.1517/17425255.2014.967680] [Cited by in Crossref: 126] [Cited by in F6Publishing: 129] [Article Influence: 14.0] [Reference Citation Analysis]
659 Carpentier A, Tesfaye A, Chu V, Nimgaonkar I, Zhang F, Lee SB, Thorgeirsson SS, Feinstone SM, Liang TJ. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J Clin Invest. 2014;124:4953-4964. [PMID: 25295540 DOI: 10.1172/jci75456] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 12.9] [Reference Citation Analysis]
660 Monga SP. Hepatic regenerative medicine: exploiting the liver's will to live. Am J Pathol 2014;184:306-8. [PMID: 24418096 DOI: 10.1016/j.ajpath.2013.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
661 Krueger W, Boelsterli UA, Rasmussen TP. Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury. J Clin Transl Hepatol. 2014;2:143-152. [PMID: 26355943 DOI: 10.14218/jcth.2014.00012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
662 Yu Y, Wang X, Nyberg SL. Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment. J Clin Med 2014;3:997-1017. [PMID: 26237490 DOI: 10.3390/jcm3030997] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
663 Vellonen K, Malinen M, Mannermaa E, Subrizi A, Toropainen E, Lou Y, Kidron H, Yliperttula M, Urtti A. A critical assessment of in vitro tissue models for ADME and drug delivery. Journal of Controlled Release 2014;190:94-114. [DOI: 10.1016/j.jconrel.2014.06.044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
664 Miura S, Suzuki A. Acquisition of lipid metabolic capability in hepatocyte-like cells directly induced from mouse fibroblasts. Front Cell Dev Biol 2014;2:43. [PMID: 25364750 DOI: 10.3389/fcell.2014.00043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
665 Shlomai A, Schwartz RE, Ramanan V, Bhatta A, de Jong YP, Bhatia SN, Rice CM. Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc Natl Acad Sci USA. 2014;111:12193-12198. [PMID: 25092305 DOI: 10.1073/pnas.1412631111] [Cited by in Crossref: 187] [Cited by in F6Publishing: 196] [Article Influence: 20.8] [Reference Citation Analysis]
666 Savla JJ, Nelson BC, Perry CN, Adler ED. Induced Pluripotent Stem Cells for the Study of Cardiovascular Disease. Journal of the American College of Cardiology 2014;64:512-9. [DOI: 10.1016/j.jacc.2014.05.038] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
667 Kondo Y, Iwao T, Yoshihashi S, Mimori K, Ogihara R, Nagata K, Kurose K, Saito M, Niwa T, Suzuki T, Miyata N, Ohmori S, Nakamura K, Matsunaga T. Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. PLoS One 2014;9:e104010. [PMID: 25084468 DOI: 10.1371/journal.pone.0104010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
668 Grikscheit TC, Barthel ER. Tissue and Organ Bioengineering. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch52] [Reference Citation Analysis]
669 Yao R, Wang J, Li X, Jung Jung D, Qi H, Kee KK, Du Y. Hepatic differentiation of human embryonic stem cells as microscaled multilayered colonies leading to enhanced homogeneity and maturation. Small 2014;10:4311-23. [PMID: 25059765 DOI: 10.1002/smll.201401040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
670 Theunissen TW, Powell BE, Wang H, Mitalipova M, Faddah DA, Reddy J, Fan ZP, Maetzel D, Ganz K, Shi L. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell. 2014;15:471-487. [PMID: 25090446 DOI: 10.1016/j.stem.2014.07.002] [Cited by in Crossref: 535] [Cited by in F6Publishing: 455] [Article Influence: 59.4] [Reference Citation Analysis]
671 Csobonyeiova M, Polak S, Koller J, Danisovic L. Induced pluripotent stem cells and their implication for regenerative medicine. Cell Tissue Bank 2015;16:171-80. [DOI: 10.1007/s10561-014-9462-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
672 Noto FK, Determan MR, Cai J, Cayo MA, Mallanna SK, Duncan SA. Aneuploidy is permissive for hepatocyte-like cell differentiation from human induced pluripotent stem cells. BMC Res Notes 2014;7:437. [PMID: 25002137 DOI: 10.1186/1756-0500-7-437] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
673 Du C, Narayanan K, Leong MF, Wan AC. Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering. Biomaterials 2014;35:6006-14. [DOI: 10.1016/j.biomaterials.2014.04.011] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 10.9] [Reference Citation Analysis]
674 Holmgren G, Sjögren A, Barragan I, Sabirsh A, Sartipy P, Synnergren J, Björquist P, Ingelman-sundberg M, Andersson TB, Edsbagge J. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes. Drug Metab Dispos 2014;42:1401-6. [DOI: 10.1124/dmd.114.059154] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 8.9] [Reference Citation Analysis]
675 Ao Y, Mich-Basso JD, Lin B, Yang L. High efficient differentiation of functional hepatocytes from porcine induced pluripotent stem cells. PLoS One 2014;9:e100417. [PMID: 24949734 DOI: 10.1371/journal.pone.0100417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
676 Park CY, Kim J, Kweon J, Son JS, Lee JS, Yoo JE, Cho SR, Kim JH, Kim JS, Kim DW. Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs. Proc Natl Acad Sci USA. 2014;111:9253-9258. [PMID: 24927536 DOI: 10.1073/pnas.1323941111] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 11.7] [Reference Citation Analysis]
677 Efthymiou AG, Chen G, Rao M, Chen G, Boehm M. Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. Expert Opin Biol Ther 2014;14:1333-44. [PMID: 24881868 DOI: 10.1517/14712598.2014.922533] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
678 Zhou X, Sun P, Lucendo-Villarin B, Angus AG, Szkolnicka D, Cameron K, Farnworth SL, Patel AH, Hay DC. Modulating innate immunity improves hepatitis C virus infection and replication in stem cell-derived hepatocytes. Stem Cell Reports. 2014;3:204-214. [PMID: 25068132 DOI: 10.1016/j.stemcr.2014.04.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
679 Maetzel D, Sarkar S, Wang H, Abi-Mosleh L, Xu P, Cheng AW, Gao Q, Mitalipova M, Jaenisch R. Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells. Stem Cell Reports. 2014;2:866-880. [PMID: 24936472 DOI: 10.1016/j.stemcr.2014.03.014] [Cited by in Crossref: 153] [Cited by in F6Publishing: 155] [Article Influence: 17.0] [Reference Citation Analysis]
680 Hickey RD, Mao SA, Glorioso J, Lillegard JB, Fisher JE, Amiot B, Rinaldo P, Harding CO, Marler R, Finegold MJ, Grompe M, Nyberg SL. Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease. Stem Cell Res 2014;13:144-53. [PMID: 24879068 DOI: 10.1016/j.scr.2014.05.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
681 Shiraki N, Ogaki S, Kume S. Profiling of embryonic stem cell differentiation. Rev Diabet Stud 2014;11:102-14. [PMID: 25148369 DOI: 10.1900/RDS.2014.11.102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
682 Ebrahimkhani MR, Young CL, Lauffenburger DA, Griffith LG, Borenstein JT. Approaches to in vitro tissue regeneration with application for human disease modeling and drug development. Drug Discov Today 2014;19:754-62. [PMID: 24793141 DOI: 10.1016/j.drudis.2014.04.017] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
683 Miyajima A, Tanaka M, Itoh T. Stem/Progenitor Cells in Liver Development, Homeostasis, Regeneration, and Reprogramming. Cell Stem Cell 2014;14:561-74. [DOI: 10.1016/j.stem.2014.04.010] [Cited by in Crossref: 374] [Cited by in F6Publishing: 384] [Article Influence: 41.6] [Reference Citation Analysis]
684 Huebert RC, Rakela J. Cellular therapy for liver disease. Mayo Clin Proc. 2014;89:414-424. [PMID: 24582199 DOI: 10.1016/j.mayocp.2013.10.023] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
685 Yu Y, Wang X, Nyberg SL. Application of Induced Pluripotent Stem Cells in Liver Diseases. Cell Med 2014;7:1-13. [PMID: 26858888 DOI: 10.3727/215517914X680056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
686 Wells JM, Spence JR. How to make an intestine. Development 2014;141:752-60. [PMID: 24496613 DOI: 10.1242/dev.097386] [Cited by in Crossref: 128] [Cited by in F6Publishing: 133] [Article Influence: 14.2] [Reference Citation Analysis]
687 Lê Cao K, Rohart F, Mchugh L, Korn O, Wells CA. YuGene: A simple approach to scale gene expression data derived from different platforms for integrated analyses. Genomics 2014;103:239-51. [DOI: 10.1016/j.ygeno.2014.03.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
688 Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology 2014;146:914-28. [PMID: 24389305 DOI: 10.1053/j.gastro.2013.12.032] [Cited by in Crossref: 177] [Cited by in F6Publishing: 184] [Article Influence: 19.7] [Reference Citation Analysis]
689 Asgari S, Moslem M, Bagheri-Lankarani K, Pournasr B, Miryounesi M, Baharvand H. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Rev. 2013;9:493-504. [PMID: 22076752 DOI: 10.1007/s12015-011-9330-y] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 7.9] [Reference Citation Analysis]
690 Kozhich OA, Hamilton RS, Mallon BS. Standardized generation and differentiation of neural precursor cells from human pluripotent stem cells. Stem Cell Rev. 2013;9:531-536. [PMID: 22388559 DOI: 10.1007/s12015-012-9357-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
691 Watanabe H, Takayama K, Inamura M, Tachibana M, Mimura N, Katayama K, Tashiro K, Nagamoto Y, Sakurai F, Kawabata K, Furue MK, Mizuguchi H. HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin. PLoS One 2014;9:e90791. [PMID: 24651531 DOI: 10.1371/journal.pone.0090791] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
692 Bishi DK, Mathapati S, Cherian KM, Guhathakurta S, Verma RS. In vitro hepatic trans-differentiation of human mesenchymal stem cells using sera from congestive/ischemic liver during cardiac failure. PLoS One 2014;9:e92397. [PMID: 24642599 DOI: 10.1371/journal.pone.0092397] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
693 Shiokawa M, Fukuhara T, Ono C, Yamamoto S, Okamoto T, Watanabe N, Wakita T, Matsuura Y. Novel permissive cell lines for complete propagation of hepatitis C virus. J Virol. 2014;88:5578-5594. [PMID: 24599999 DOI: 10.1128/JVI.03839-13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
694 de Lima Toccafondo Vieira M, Tagliati CA. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools. Expert Opin Drug Metab Toxicol 2014;10:581-97. [PMID: 24588537 DOI: 10.1517/17425255.2014.884069] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
695 Machado MV, Diehl AM. Liver renewal: detecting misrepair and optimizing regeneration. Mayo Clin Proc 2014;89:120-30. [PMID: 24388030 DOI: 10.1016/j.mayocp.2013.10.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
696 Zhu S, Rezvani M, Harbell J, Mattis AN, Wolfe AR, Benet LZ, Willenbring H, Ding S. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature. 2014;508:93-97. [PMID: 24572354 DOI: 10.1038/nature13020] [Cited by in Crossref: 195] [Cited by in F6Publishing: 208] [Article Influence: 21.7] [Reference Citation Analysis]
697 Liebau S, Stockmann M, Illing A, Seufferlein T, Kleger A. Induzierte pluripotente Stammzellen: Eine neue Ressource in der modernen Medizin. Internist 2014;55:460-9. [DOI: 10.1007/s00108-013-3397-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
698 Bageritz J, Puccio L, Piro RM, Hovestadt V, Phillips E, Pankert T, Lohr J, Herold-Mende C, Lichter P, Goidts V. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1. Cell Death Differ 2014;21:929-40. [PMID: 24531536 DOI: 10.1038/cdd.2014.12] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
699 Huch M, Boj SF, Clevers H. Lgr5(+) liver stem cells, hepatic organoids and regenerative medicine. Regen Med. 2013;8:385-387. [PMID: 23826690 DOI: 10.2217/rme.13.39] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 7.1] [Reference Citation Analysis]
700 Khanjani S, Khanmohammadi M, Zarnani AH, Akhondi MM, Ahani A, Ghaempanah Z, Naderi MM, Eghtesad S, Kazemnejad S. Comparative evaluation of differentiation potential of menstrual blood- versus bone marrow-derived stem cells into hepatocyte-like cells. PLoS One 2014;9:e86075. [PMID: 24505254 DOI: 10.1371/journal.pone.0086075] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
701 Franco D. Towards a bioengineered liver. J Hepatol 2014;60:455-6. [PMID: 24060856 DOI: 10.1016/j.jhep.2013.09.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
702 Farzaneh Z, Pakzad M, Vosough M, Pournasr B, Baharvand H. Differentiation of human embryonic stem cells to hepatocyte-like cells on a new developed xeno-free extracellular matrix. Histochem Cell Biol. 2014;142:217-226. [PMID: 24477550 DOI: 10.1007/s00418-014-1183-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
703 Park Y, Chen Y, Ordovas L, Verfaillie CM. Hepatic differentiation of human embryonic stem cells on microcarriers. J Biotechnol. 2014;174:39-48. [PMID: 24480567 DOI: 10.1016/j.jbiotec.2014.01.025] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
704 von Schaewen M, Ploss A. Murine models of hepatitis C: what can we look forward to? Antiviral Res. 2014;104:15-22. [PMID: 24462693 DOI: 10.1016/j.antiviral.2014.01.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
705 Takebe T, Zhang RR, Koike H, Kimura M, Yoshizawa E, Enomura M, Koike N, Sekine K, Taniguchi H. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc. 2014;9:396-409. [PMID: 24457331 DOI: 10.1038/nprot.2014.020] [Cited by in Crossref: 250] [Cited by in F6Publishing: 258] [Article Influence: 27.8] [Reference Citation Analysis]
706 Huang K, Liu P, Li X, Chen S, Wang L, Qin L, Su Z, Huang W, Liu J, Jia B, Liu J, Cai J, Pei D, Pan G. Neural progenitor cells from human induced pluripotent stem cells generated less autogenous immune response. Sci China Life Sci 2014;57:162-70. [PMID: 24443177 DOI: 10.1007/s11427-013-4598-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
707 Schwartz RE, Fleming HE, Khetani SR, Bhatia SN. Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv 2014;32:504-13. [PMID: 24440487 DOI: 10.1016/j.biotechadv.2014.01.003] [Cited by in Crossref: 201] [Cited by in F6Publishing: 203] [Article Influence: 22.3] [Reference Citation Analysis]
708 Furth ME, Atala A. Tissue Engineering. Principles of Tissue Engineering 2014. [DOI: 10.1016/b978-0-12-398358-9.00006-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
709 Zhao X. Introduction. Studies of Pluripotency in Embryonic Stem Cells and Induced Pluripotent Stem Cells 2014. [DOI: 10.1007/978-94-017-8819-9_1] [Reference Citation Analysis]
710 Nyberg S, Mao S, Glorioso J. Bioartificial Liver. Pathobiology of Human Disease 2014. [DOI: 10.1016/b978-0-12-386456-7.04205-2] [Reference Citation Analysis]
711 Manohar R, Lagasse E. Liver Stem Cells. Principles of Tissue Engineering 2014. [DOI: 10.1016/b978-0-12-398358-9.00045-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
712 Stevens KR, Schwartz RE, Ng S, Shan J, Bhatia SN. Hepatic Tissue Engineering. Principles of Tissue Engineering 2014. [DOI: 10.1016/b978-0-12-398358-9.00046-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
713 Kim Y, Ozer S, Uygun BE. Liver Regeneration. Regenerative Medicine Applications in Organ Transplantation. Elsevier; 2014. pp. 333-52. [DOI: 10.1016/b978-0-12-398523-1.00024-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
714 Russo FP, Burra P, Parola M. Adult Liver Stem Cells. Adult Stem Cells 2014. [DOI: 10.1007/978-1-4614-9569-7_13] [Reference Citation Analysis]
715 Hämäläinen RH. Induced pluripotent stem cell-derived models for mtDNA diseases. Methods Enzymol 2014;547:399-415. [PMID: 25416367 DOI: 10.1016/B978-0-12-801415-8.00019-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
716 Strick-marchand H, Ploss A. Dual Reconstituted Mice for Hepatotropic Pathogens. Humanized Mice for HIV Research 2014. [DOI: 10.1007/978-1-4939-1655-9_36] [Reference Citation Analysis]
717 Zhang R, Takebe T, Miyazaki L, Takayama M, Koike H, Kimura M, Enomura M, Zheng Y, Sekine K, Taniguchi H. Efficient Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Three-Dimensional Microscale Culture. Stem Cells and Tissue Repair 2014. [DOI: 10.1007/978-1-4939-1435-7_10] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
718 Joshi MG, Gadgil A, Bhonde RR. Stem Cell Therapy for Acute and Chronic Liver Failure. Stem Cell Therapy for Organ Failure 2014. [DOI: 10.1007/978-81-322-2110-4_16] [Reference Citation Analysis]
719 Dusséaux M, Darche S, Strick-Marchand H. Animal models to test hiPS-derived hepatocytes in the context of inherited metabolic liver diseases. Methods Mol Biol 2014;1213:81-8. [PMID: 25173376 DOI: 10.1007/978-1-4939-1453-1_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
720 Loya K. Stem Cells. Handbook of Pharmacogenomics and Stratified Medicine 2014. [DOI: 10.1016/b978-0-12-386882-4.00011-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
721 Higuchi M, Mizuguchi H. Hepatic Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells by Two- and Three-Dimensional Culture Systems In Vitro. Nanomedicine and Nanotoxicology 2014. [DOI: 10.1007/978-4-431-55139-3_7] [Reference Citation Analysis]
722 Stevens KR, Ungrin MD, Schwartz RE, Ng S, Carvalho B, Christine KS, Chaturvedi RR, Li CY, Zandstra PW, Chen CS, Bhatia SN. InVERT molding for scalable control of tissue microarchitecture. Nat Commun 2013;4:1847. [PMID: 23673632 DOI: 10.1038/ncomms2853] [Cited by in Crossref: 104] [Cited by in F6Publishing: 107] [Article Influence: 10.4] [Reference Citation Analysis]
723 Lam AQ, Freedman BS, Morizane R, Lerou PH, Valerius MT, Bonventre JV. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 2014;25:1211-25. [PMID: 24357672 DOI: 10.1681/ASN.2013080831] [Cited by in Crossref: 227] [Cited by in F6Publishing: 231] [Article Influence: 22.7] [Reference Citation Analysis]
724 Handa K, Matsubara K, Fukumitsu K, Guzman-Lepe J, Watson A, Soto-Gutierrez A. Assembly of human organs from stem cells to study liver disease. Am J Pathol 2014;184:348-57. [PMID: 24333262 DOI: 10.1016/j.ajpath.2013.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
725 Kondo Y, Iwao T, Nakamura K, Sasaki T, Takahashi S, Kamada N, Matsubara T, Gonzalez FJ, Akutsu H, Miyagawa Y, Okita H, Kiyokawa N, Toyoda M, Umezawa A, Nagata K, Matsunaga T, Ohmori S. An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity. Drug Metab Pharmacokinet. 2014;29:237-243. [PMID: 24334537 DOI: 10.2133/dmpk.dmpk-13-rg-104] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
726 Mallon BS, Hamilton RS, Kozhich OA, Johnson KR, Fann YC, Rao MS, Robey PG. Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res 2014;12:376-86. [PMID: 24374290 DOI: 10.1016/j.scr.2013.11.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
727 Kinney MA, Hookway TA, Wang Y, McDevitt TC. Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics. Ann Biomed Eng 2014;42:352-67. [PMID: 24297495 DOI: 10.1007/s10439-013-0953-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
728 Fox IJ, Duncan SA. Engineering liver tissue from induced pluripotent stem cells: a first step in generating new organs for transplantation? Hepatology 2013;58:2198-201. [PMID: 24114924 DOI: 10.1002/hep.26737] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
729 Liu WH, Ren LN, Chen T, You N, Liu LY, Wang T, Yan HT, Luo H, Tang LJ. Unbalanced distribution of materials: the art of giving rise to hepatocytes from liver stem/progenitor cells. J Cell Mol Med 2014;18:1-14. [PMID: 24286303 DOI: 10.1111/jcmm.12183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
730 Gerbal-Chaloin S, Funakoshi N, Caillaud A, Gondeau C, Champon B, Si-Tayeb K. Human induced pluripotent stem cells in hepatology: beyond the proof of concept. Am J Pathol. 2014;184:332-347. [PMID: 24269594 DOI: 10.1016/j.ajpath.2013.09.026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
731 Shin D, Monga SP. Cellular and molecular basis of liver development. Compr Physiol 2013;3:799-815. [PMID: 23720330 DOI: 10.1002/cphy.c120022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
732 Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol. 2013;3:485-513. [PMID: 23720294 DOI: 10.1002/cphy.c120014] [Cited by in Crossref: 150] [Cited by in F6Publishing: 166] [Article Influence: 15.0] [Reference Citation Analysis]
733 Lu B, Atala A. Small molecules and small molecule drugs in regenerative medicine. Drug Discov Today 2014;19:801-8. [PMID: 24252867 DOI: 10.1016/j.drudis.2013.11.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
734 Närvä E, Pursiheimo JP, Laiho A, Rahkonen N, Emani MR, Viitala M, Laurila K, Sahla R, Lund R, Lähdesmäki H, Jaakkola P, Lahesmaa R. Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels. PLoS One 2013;8:e78847. [PMID: 24236059 DOI: 10.1371/journal.pone.0078847] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
735 Fattahi F, Asgari S, Pournasr B, Seifinejad A, Totonchi M, Taei A, Aghdami N, Salekdeh GH, Baharvand H. Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells. Mol Biotechnol. 2013;54:863-873. [PMID: 23247991 DOI: 10.1007/s12033-012-9635-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
736 Lucas M, Mato E, Barceló-batllori S, Gomis R, Novials A. Proteomics Characterization of the Secretome from Rat Pancreatic Stellate Cells with ATP-Binding Cassette Transporters (ABCG2) and NCAM Phenotype. ISRN Cell Biology 2013;2013:1-18. [DOI: 10.1155/2013/828060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
737 Kitade M, Factor VM, Andersen JB, Tomokuni A, Kaji K, Akita H, Holczbauer A, Seo D, Marquardt JU, Conner EA, Lee SB, Lee YH, Thorgeirsson SS. Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling. Genes Dev 2013;27:1706-17. [PMID: 23913923 DOI: 10.1101/gad.214601.113] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 8.0] [Reference Citation Analysis]
738 Wang HW, Hsieh TH, Huang SY, Chau GY, Tung CY, Su CW, Wu JC. Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC. BMC Genomics 2013;14:736. [PMID: 24160375 DOI: 10.1186/1471-2164-14-736] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
739 GENE AND CELL THERAPY. Biotechnology and Biopharmaceuticals 2013. [DOI: 10.1002/9781118660485.ch18] [Reference Citation Analysis]
740 Subramanian K, Owens DJ, Raju R, Firpo M, O'Brien TD, Verfaillie CM, Hu WS. Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells. Stem Cells Dev. 2014;23:124-131. [PMID: 24020366 DOI: 10.1089/scd.2013.0097] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
741 Hannan NR, Fordham RP, Syed YA, Moignard V, Berry A, Bautista R, Hanley NA, Jensen KB, Vallier L. Generation of multipotent foregut stem cells from human pluripotent stem cells. Stem Cell Reports 2013;1:293-306. [PMID: 24319665 DOI: 10.1016/j.stemcr.2013.09.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 6.8] [Reference Citation Analysis]
742 Yamazoe T, Shiraki N, Toyoda M, Kiyokawa N, Okita H, Miyagawa Y, Akutsu H, Umezawa A, Sasaki Y, Kume K, Kume S. A synthetic nanofibrillar matrix promotes in vitro hepatic differentiation of embryonic stem cells and induced pluripotent stem cells. J Cell Sci 2013;126:5391-9. [PMID: 24101719 DOI: 10.1242/jcs.129767] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]